<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01887912</url>
  </required_header>
  <id_info>
    <org_study_id>H-030-014</org_study_id>
    <secondary_id>2013-000775-32</secondary_id>
    <secondary_id>U1111-1127-7162</secondary_id>
    <nct_id>NCT01887912</nct_id>
  </id_info>
  <brief_title>Study of a Candidate Clostridium Difficile Toxoid Vaccine in Subjects at Risk for C. Difficile Infection</brief_title>
  <official_title>Efficacy, Immunogenicity, and Safety Study of Clostridium Difficile Toxoid Vaccine in Subjects at Risk for C. Difficile Infection (Cdiffense™)</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Sanofi Pasteur, a Sanofi Company</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Sanofi</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>Yes</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The aim of this study was to evaluate the efficacy of the Clostridium difficile vaccine to
      prevent primary symptomatic C. difficile infection (CDI) in participants at risk for CDI
      where there is a substantial unmet medical need.

      Primary objective:

        -  To assess the efficacy of the C. difficile vaccine in preventing the onset of
           symptomatic primary CDI confirmed by polymerase chain reaction (PCR) in adult
           participants aged &gt;= 50 years who are at risk for CDI and have received at least 1
           injection.

      Secondary Objectives:

      Efficacy:

        -  To assess prevention of symptomatic PCR-confirmed primary CDI cases after 3 injections
           administered at 0, 7, and 30 days.

        -  To assess prevention of symptomatic PCR-confirmed primary CDI cases after completion of
           at least 2 injections.

      Immunogenicity:

        -  To describe the immunogenicity to toxin A and toxin B at specific time points in a
           subset of participant and in participants with CDI at Day 0 and Day 60.

      Safety:

        -  To describe the safety profile of all participants who received at least 1 injection.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The study was designed as an event-driven group sequential protocol with 4 interim analyses
      at defined information milestones and a final analysis when a specific number of clinical
      endpoints are reached. Analyses of trial futility (non-efficacy) were to be performed at the
      first 2 interim analyses, and the study was to be stopped if either of those analyses
      provided robust and compelling evidence that meaningful levels of vaccine efficacy (VE) would
      not be demonstrated.

      Following completion of the first interim analysis (50 cases of confirmed CDI observed), the
      futility criterion was met and in accordance with IDMC recommendation, enrollment and further
      vaccination ceased in November 2017.

      Due to the early termination of the study, some of the planned secondary efficacy endpoints
      could not be analyzed as all planned data were not collected.

      Participants were randomized to receive either the candidate vaccine or a placebo that was to
      be administered in a 3-dose schedule. At the time of group assignment, 928 participants (10%
      of total enrollment) were randomized to an immunogenicity subset; and 1859 participants (20%
      of total enrollment) were randomized to a reactogenicity subset.

      Safety was assessed in all participants in terms of unsolicited adverse events from Day 0 to
      Day 60, as well as serious adverse events (SAEs) throughout the study. Solicited adverse
      reactions were collected for 6 days following each injection in the reactogenicity subset.
    </textblock>
  </detailed_description>
  <overall_status>Terminated</overall_status>
  <why_stopped>
    The Independent Data Monitoring Committee (IDMC) concluded that the probability that the study
    will meet its primary objective is low.
  </why_stopped>
  <start_date type="Actual">July 30, 2013</start_date>
  <completion_date type="Actual">June 12, 2018</completion_date>
  <primary_completion_date type="Actual">June 12, 2018</primary_completion_date>
  <phase>Phase 3</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <intervention_model_description>This study was observer-blind. The vaccine preparer and administrator may have been unblinded to treatment assignment due to the steps necessary for vaccine preparation. However, the participant, the Investigator, and study staff members who collected the safety data and laboratory personnel who analyzed the blood and stool samples were all blinded to the group assignment.</intervention_model_description>
    <primary_purpose>Prevention</primary_purpose>
    <masking>Triple (Participant, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Number of Participants With Symptomatic Polymerase Chain Reaction (PCR)-Confirmed Primary C. Difficile Infection (CDI) Cases</measure>
    <time_frame>Up to 3 years post injection 1</time_frame>
    <description>Symptomatic PCR-confirmed CDI cases were defined as the number of participants with combination of clinical and laboratory findings. Clinical components were: &gt;= 3 loose stools in &lt;= 24 hours, loose stools (defined as type 6 [fluffy pieces with ragged edges, mushy] or type 7 [watery, no solid pieces] according to the Bristol Stool Chart) lasting &gt;= 24 hours. Laboratory findings were: stool sample positive for C. difficile Toxin B by PCR at central laboratory or diagnosis of pseudomembranous colitis visualized at colonoscopy.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Number of Participants With Severe PCR-Confirmed Primary CDI Cases</measure>
    <time_frame>Up to 3 years post injection 1</time_frame>
    <description>Severe CDI cases were defined as number of participants with at least one of the following symptoms: fever &gt;= 38.5 degree Celsius (°C), white blood cell count &gt;= 15,000 cells/mm^3, ileus, pseudomembranous colitis, serum albumin &lt;3 gram per deciliter, abdominal distension, abdominal tenderness, or admission to the intensive care unit within 7 days of CDI diagnosis.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Number of Participants With Loose Stool Episodes</measure>
    <time_frame>Up to 3 years post injection 1</time_frame>
    <description>Loose stools were defined as type 6 (fluffy pieces with ragged edges, mushy) or type 7 (watery, no solid pieces) according to the Bristol Stool Chart. In this outcome measure, participants with number of loose stool episodes (categorized as: loose stool episodes less than 3, 3 to 6, 7 to 10, 11 to 15 and greater than 15) were reported.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Number of Participants With Symptomatic PCR Confirmed CDI Cases: Per-Protocol Population</measure>
    <time_frame>Up to 3 years post injection 1</time_frame>
    <description>Symptomatic PCR confirmed CDI cases were defined as the number of participants with combination of clinical and laboratory findings. Clinical components were: &gt;= 3 loose stools in &lt;= 24 hours, loose stools (defined as type 6 [fluffy pieces with ragged edges, mushy] or type 7 [watery, no solid pieces] according to the Bristol Stool Chart) lasting &gt;= 24 hours. Laboratory findings were: stool sample positive for C. difficile Toxin B by PCR at central laboratory or diagnosis of pseudomembranous colitis visualized at colonoscopy. Analysis was performed on per-protocol efficacy analysis set (PPEAS).</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Serum Antibody Concentrations Against Toxins A and B Measured by Enzyme-Linked Immunosorbent Assay (ELISA)</measure>
    <time_frame>Day 0, Day 14, Day 30, Day 60, Day 210, Day 390, Day 570, Day 750, Day 930, and Day 1110</time_frame>
    <description>Serum antibody concentrations against toxins A and B were measured by ELISA and expressed as geometric mean concentration (GMC). The 2-sided 95% Confidence Interval (CI) of GMC was based on the Student t-distribution. Analysis was performed on Per Protocol Immunogenicity Analysis Set, which included participants who had at least 1 injection, no relevant protocol deviations (not met inclusion criteria/ met exclusion criteria, not received vaccine/ not received in proper time window, received different vaccine than randomized, preparation and/ or administration of vaccine not per protocol, protocol-restricted therapy, not provided post-dose serology sample/serology sample did not produced a valid test result).</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Percentage of Participants With &gt;= 2 and 4-Fold Rise in Serum Antibody Concentrations From Baseline Against Toxins A and B Measured by ELISA</measure>
    <time_frame>Day 60</time_frame>
    <description>Percentage of Participants with &gt;= 2 and 4-fold rise in serum antibody concentrations against toxins A and B were measured by ELISA. The 2-sided 95% Cl of the percentage was based on Exact method calculations.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Serum Antibody Concentrations Against Toxins A and B Measured by ELISA in Participants With CDI</measure>
    <time_frame>Day 0 and Day 60</time_frame>
    <description>Serum antibody concentrations against toxins A and B were measured by ELISA and expressed as GMC. The 2-sided 95% CI GMC was based on the Student t-distribution. Symptomatic PCR-confirmed CDI cases were defined as the number of participants with combination of clinical and laboratory findings. Clinical components were: &gt;= 3 loose stools in &lt;= 24 hours, loose stools (defined as type 6 [fluffy pieces with ragged edges, mushy] or type 7 [watery, no solid pieces] according to the Bristol Stool Chart) lasting &gt;= 24 hours. Laboratory findings were: stool sample positive for C. difficile Toxin B by PCR at central laboratory or diagnosis of pseudomembranous colitis visualized at colonoscopy.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Serum Antibody Concentrations Against Toxins A and B Measured by Toxin Neutralization Assay (TNA)</measure>
    <time_frame>Day 0, Day 14, Day 30, Day 60, Day 210, Day 390, Day 570, Day 750, Day 930, and Day 1110</time_frame>
    <description>Serum antibody concentrations against toxins A and B were measured by TNA and expressed as geometric mean titer (GMT). The 2-sided 95% Cl of GMT was based on the Student t-distribution.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Percentage of Participants With &gt;= 2 and 4-Fold Rise in Serum Antibody Concentrations From Baseline Against Toxins A and B Measured by TNA</measure>
    <time_frame>Day 60</time_frame>
    <description>Percentage of Participants with &gt;= 2 and 4-fold rise in serum antibody concentrations against toxins A and B were measured by TNA. The 2-sided 95% CI of the percentage was based on Exact method calculations.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Serum Antibody Concentrations Against Toxins A and B Measured by TNA in Participants With CDI</measure>
    <time_frame>Day 0 and Day 60</time_frame>
    <description>Serum antibody concentrations against toxins A and B were measured by TNA and were expressed as GMT. The 2-sided 95% CI GMC was based on the Student t-distribution. Symptomatic PCR confirmed CDI cases were defined as the number of participants with combination of clinical and laboratory findings. Clinical components were: &gt;= 3 loose stools in &lt;= 24 hours, loose stools (defined as type 6 [fluffy pieces with ragged edges, mushy] or type 7 [watery, no solid pieces] according to the Bristol Stool Chart) lasting &gt;= 24 hours. Laboratory findings were: stool sample positive for C. difficile Toxin B by PCR at central laboratory or diagnosis of pseudomembranous colitis visualized at colonoscopy.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Percentage of Participants Reporting Solicited Injection Site and Systemic Reactions</measure>
    <time_frame>Day 0 to Day 6 after any vaccination</time_frame>
    <description>Solicited injection site reactions: pain, erythema, and swelling. Pain: Grade 1: no interference with activity, Grade 2: some interference with activity, Grade 3: significant; prevents daily activity; Erythema and swelling: Grade 1: &gt;= 25 to &lt;=50 mm, Grade 2: &gt;51 to &lt;=100 mm, Grade 3: &gt;100 mm. Solicited systemic reactions: fever, headache, malaise, myalgia, and arthralgia. Fever: Grade 1: &gt;= 38.0°C to &lt;=38.4°C or &gt;= 100.4° Fahrenheit (F) to &lt;=101.1°F, Grade 2: &gt;=38.5°C to &lt;= 38.9°C or &gt;=101.2°F to &lt;=102.0°F, Grade 3: &gt;=39.0°C or &gt;=102.1°F. Headache, malaise, and myalgia: Grade 1: no interference with activity, Grade 2: some interference with activity, Grade 3: significant; prevents daily activity; Arthralgia: Grade 1: free range of motion but complains of pain or discomfort, Grade 2: decreased range of motion due to pain or discomfort, Grade 3: unwilling to move due to pain.</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">9302</enrollment>
  <condition>Clostridium Difficile Infection</condition>
  <arm_group>
    <arm_group_label>C. difficile Vaccine Group</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Participants received 1 injection of 0.5 mL C. difficile toxoid vaccine at Days 0 (Injection 1), 7 (Injection 2), and 30 (Injection 3).</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Placebo Group</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>Participants received 1 injection of 0.5 mL placebo matched to vaccine at Days 0 (Injection 1), 7 (Injection 2), and 30 (Injection 3).</description>
  </arm_group>
  <intervention>
    <intervention_type>Biological</intervention_type>
    <intervention_name>C. difficile Toxoid Vaccine</intervention_name>
    <description>0.5 mL, Intramuscular</description>
    <arm_group_label>C. difficile Vaccine Group</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Biological</intervention_type>
    <intervention_name>Placebo: 0.9% normal saline</intervention_name>
    <description>0.5 mL, Intramuscular</description>
    <arm_group_label>Placebo Group</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Aged &gt;= 50 years on the day of inclusion

          -  Informed consent form had been signed and dated.

          -  Attended all scheduled visits and complied with all trial procedures.

          -  Covered by health insurance (if required).

          -  Must fulfill at least 1 of the following criteria

        Risk Stratum 1:

          -  Had at least 2 hospital stays, each lasting at least &gt;= 24 hours, in the 12 months
             before enrollment, and

          -  Had received systemic (not topical) antibiotics in the 12 months before enrollment, or

        Risk Stratum 2:

          -  Was anticipated to have an in-patient hospitalization for a planned surgical procedure
             within 60 days of enrollment. The impending hospital stay was planned to be &gt;= 72
             hours for a surgery involving 1 of the following:

          -  Kidney/bladder/urinary system

          -  Musculoskeletal system

          -  Respiratory system

          -  Circulatory system

          -  Central nervous system.

        Exclusion Criteria:

          -  Participant was pregnant, or lactating, or of childbearing potential (to be considered
             of non-childbearing potential, a female must be post-menopausal for at least 1 year,
             surgically sterile, or using an effective method of contraception or abstinence from
             at least 4 weeks prior to the first vaccination and until at least 4 weeks after the
             last vaccination).

          -  Participation in the 4 weeks preceding the first trial vaccination or participation
             during the present trial period in another clinical trial investigating a vaccine,
             drug, medical device, or medical procedure.

          -  Receipt of any vaccine in the 4 weeks preceding the first trial vaccination except for
             influenza (seasonal or pandemic) and pneumococcal vaccines. This exception includes
             monovalent pandemic influenza vaccines and multivalent influenza vaccines.

          -  Previous vaccination against C. difficile with either the trial vaccine, another
             vaccine, or monoclonal antibodies.

          -  Diarrhea on day of enrollment.

          -  Self-reported current or prior CDI episode.

          -  Anticipated or current receipt of kidney dialysis treatment.

          -  History of gastrointestinal surgery for gastrointestinal malignancy (Note:
             Colonoscopy, polypectomy, and appendectomy are not exclusion criteria).

          -  History of inflammatory bowel disease, irritable bowel syndrome (must include diarrhea
             as a symptom), colostomy, or small or large intestine bowel surgery where resection
             was performed.

          -  Receiving enteral feeding (e.g., nasogastric, gastrostomy, and jejunostomy tube
             feeding).

          -  Known or suspected congenital or acquired immunodeficiency; or receipt of
             immunosuppressive therapy, such as anti-cancer chemotherapy or radiation therapy,
             within the preceding 6 months; or long-term systemic corticosteroid therapy
             (prednisone or equivalent for more than 2 consecutive weeks within the past 3 months).

          -  Known systemic hypersensitivity to any of the vaccine components, or history of a
             life-threatening reaction to the vaccine used in the trial or to a vaccine containing
             any of the same substances.

          -  Self-reported thrombocytopenia, contraindicating intramuscular vaccination.

          -  Deprived of freedom by an administrative or court order, or in an emergency setting,
             or hospitalized involuntarily.

          -  Current alcohol abuse or drug addiction that might interfere with the ability to
             comply with trial procedures in the opinion of the Investigator.

          -  Chronic illness that, in the opinion of the investigator, is at a stage where it might
             interfere with trial conduct or completion.

          -  Moderate or severe acute illness/infection (according to investigator judgment) on the
             day of vaccination or febrile illness (temperature &gt;= 38.0 degree Celsius [&gt;=
             100.4°Fahrenheit]). A prospective participant should not be included in the study
             until the condition has resolved or the febrile event has subsided.

          -  Identified as an Investigator or employee of the Investigator or study center with
             direct involvement in the proposed study, or identified as an immediate family member
             (i.e., parent, spouse, natural or adopted child) of the Investigator or employee with
             direct involvement in the proposed study.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>50 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Medical Director</last_name>
    <role>Study Director</role>
    <affiliation>Sanofi Pasteur Inc.</affiliation>
  </overall_official>
  <location>
    <facility>
      <address>
        <city>Huntsville</city>
        <state>Alabama</state>
        <zip>35803</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Investigational Site 104</name>
      <address>
        <city>Mobile</city>
        <state>Alabama</state>
        <zip>36608</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Flagstaff</city>
        <state>Arizona</state>
        <zip>86001</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Investigational Site 194</name>
      <address>
        <city>Phoenix</city>
        <state>Arizona</state>
        <zip>85018</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Investigational Site 503</name>
      <address>
        <city>Surprise</city>
        <state>Arizona</state>
        <zip>85374</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Little Rock</city>
        <state>Arkansas</state>
        <zip>72205</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Bakersfield</city>
        <state>California</state>
        <zip>93301</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Banning</city>
        <state>California</state>
        <zip>92220</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Garden Grove</city>
        <state>California</state>
        <zip>92844</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>La Mesa</city>
        <state>California</state>
        <zip>91942</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Investigational Site 534</name>
      <address>
        <city>Los Angeles</city>
        <state>California</state>
        <zip>90022</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Investigational Site 051</name>
      <address>
        <city>Los Angeles</city>
        <state>California</state>
        <zip>90027</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Modesto</city>
        <state>California</state>
        <zip>95350</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Redding</city>
        <state>California</state>
        <zip>96001</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Sacramento</city>
        <state>California</state>
        <zip>95817</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Investigational Site 504</name>
      <address>
        <city>Simi Valley</city>
        <state>California</state>
        <zip>93065</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Investigational Site 057</name>
      <address>
        <city>Stanford</city>
        <state>California</state>
        <zip>94305</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Investigational Site 176</name>
      <address>
        <city>Upland</city>
        <state>California</state>
        <zip>91786</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Ventura</city>
        <state>California</state>
        <zip>93003</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Investigational Site 546</name>
      <address>
        <city>Wheat Ridge</city>
        <state>Colorado</state>
        <zip>90033</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Bristol</city>
        <state>Connecticut</state>
        <zip>06010</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Danbury</city>
        <state>Connecticut</state>
        <zip>06810</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Investigational Site 143</name>
      <address>
        <city>Bradenton</city>
        <state>Florida</state>
        <zip>34209</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Investigational Site 187</name>
      <address>
        <city>Brandon</city>
        <state>Florida</state>
        <zip>33511</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Investigational Site 075</name>
      <address>
        <city>Clearwater</city>
        <state>Florida</state>
        <zip>33756</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Investigational Site 517</name>
      <address>
        <city>Clearwater</city>
        <state>Florida</state>
        <zip>33765</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Investigational Site 055</name>
      <address>
        <city>Crystal River</city>
        <state>Florida</state>
        <zip>34429</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>DeLand</city>
        <state>Florida</state>
        <zip>32720</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Investigational Site 506</name>
      <address>
        <city>Gainesville</city>
        <state>Florida</state>
        <zip>32607</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Investigational Site 099</name>
      <address>
        <city>Hialeah</city>
        <state>Florida</state>
        <zip>33012</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Investigational Site 009</name>
      <address>
        <city>Jacksonville</city>
        <state>Florida</state>
        <zip>32216</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Lauderdale Lakes</city>
        <state>Florida</state>
        <zip>33319</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Miami</city>
        <state>Florida</state>
        <zip>33165</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Orange Park</city>
        <state>Florida</state>
        <zip>32073</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Investigational Site 112</name>
      <address>
        <city>Pensacola</city>
        <state>Florida</state>
        <zip>32504</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Port Saint Lucie</city>
        <state>Florida</state>
        <zip>34987</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Investigational Site 040</name>
      <address>
        <city>Saint Petersburg</city>
        <state>Florida</state>
        <zip>33709</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Investigational Site 114</name>
      <address>
        <city>Saint Petersburg</city>
        <state>Florida</state>
        <zip>33713</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Investigational Site 088</name>
      <address>
        <city>Sarasota</city>
        <state>Florida</state>
        <zip>34239</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Tamarac</city>
        <state>Florida</state>
        <zip>33321</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Tampa</city>
        <state>Florida</state>
        <zip>33612</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>West Palm Beach</city>
        <state>Florida</state>
        <zip>33401</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Investigational Site 149</name>
      <address>
        <city>Augusta</city>
        <state>Georgia</state>
        <zip>30912</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Investigational Site 529</name>
      <address>
        <city>Decatur</city>
        <state>Georgia</state>
        <zip>30030</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Macon</city>
        <state>Georgia</state>
        <zip>31201</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Investigational Site 010</name>
      <address>
        <city>Savannah</city>
        <state>Georgia</state>
        <zip>31406</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Investigational Site 049</name>
      <address>
        <city>Idaho Falls</city>
        <state>Idaho</state>
        <zip>83494</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Investigational Site 543</name>
      <address>
        <city>Pocatello</city>
        <state>Idaho</state>
        <zip>83201</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Evanston</city>
        <state>Illinois</state>
        <zip>60201</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Peoria</city>
        <state>Illinois</state>
        <zip>61602</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Peoria</city>
        <state>Illinois</state>
        <zip>61614</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Anderson</city>
        <state>Indiana</state>
        <zip>46011</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Investigational Site 101</name>
      <address>
        <city>Iowa City</city>
        <state>Iowa</state>
        <zip>52242</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Topeka</city>
        <state>Kansas</state>
        <zip>66606</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Louisville</city>
        <state>Kentucky</state>
        <zip>40202</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Investigational Site 091</name>
      <address>
        <city>Metairie</city>
        <state>Louisiana</state>
        <zip>70006</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Investigational Site 084</name>
      <address>
        <city>New Orleans</city>
        <state>Louisiana</state>
        <zip>70121</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Opelousas</city>
        <state>Louisiana</state>
        <zip>70570</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Investigational Site 077</name>
      <address>
        <city>Shreveport</city>
        <state>Louisiana</state>
        <zip>71101</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Auburn</city>
        <state>Maine</state>
        <zip>04210</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Baltimore</city>
        <state>Maryland</state>
        <zip>21224</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Investigational Site 002</name>
      <address>
        <city>Boston</city>
        <state>Massachusetts</state>
        <zip>02215</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Investigational Site 035</name>
      <address>
        <city>West Roxbury</city>
        <state>Massachusetts</state>
        <zip>02132</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Investigational Site 190</name>
      <address>
        <city>Ann Arbor</city>
        <state>Michigan</state>
        <zip>48106</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Investigational Site 175</name>
      <address>
        <city>Detroit</city>
        <state>Michigan</state>
        <zip>48202</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Investigational Site 183</name>
      <address>
        <city>Flint</city>
        <state>Michigan</state>
        <zip>48504</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Grosse Pointe Woods</city>
        <state>Michigan</state>
        <zip>48236</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Kalamazoo</city>
        <state>Michigan</state>
        <zip>49007</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Livonia</city>
        <state>Michigan</state>
        <zip>48152</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Investigational Site 069</name>
      <address>
        <city>Royal Oak</city>
        <state>Michigan</state>
        <zip>48073</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Stevensville</city>
        <state>Michigan</state>
        <zip>49127</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Troy</city>
        <state>Michigan</state>
        <zip>48098</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Butte</city>
        <state>Montana</state>
        <zip>59701</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Investigational Site 189</name>
      <address>
        <city>Hillsborough</city>
        <state>New Jersey</state>
        <zip>8844</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Investigational Site 044</name>
      <address>
        <city>Neptune</city>
        <state>New Jersey</state>
        <zip>07753</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Teaneck</city>
        <state>New Jersey</state>
        <zip>07666</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Albuquerque</city>
        <state>New Mexico</state>
        <zip>27103</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Albuquerque</city>
        <state>New Mexico</state>
        <zip>87102</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Bronx</city>
        <state>New York</state>
        <zip>10467</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Investigational Site 013</name>
      <address>
        <city>Bronx</city>
        <state>New York</state>
        <zip>10468</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Investigational Site 022</name>
      <address>
        <city>Endwell</city>
        <state>New York</state>
        <zip>13760</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Rochester</city>
        <state>New York</state>
        <zip>14621</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Rochester</city>
        <state>New York</state>
        <zip>14642</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Syracuse</city>
        <state>New York</state>
        <zip>13210</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Investigational Site 146</name>
      <address>
        <city>Asheville</city>
        <state>North Carolina</state>
        <zip>28805</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Cary</city>
        <state>North Carolina</state>
        <zip>27518</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Charlotte</city>
        <state>North Carolina</state>
        <zip>28209</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Hickory</city>
        <state>North Carolina</state>
        <zip>28602</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Raleigh</city>
        <state>North Carolina</state>
        <zip>27612</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Raleigh</city>
        <state>North Carolina</state>
        <zip>48202</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Statesville</city>
        <state>North Carolina</state>
        <zip>28625</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Wilmington</city>
        <state>North Carolina</state>
        <zip>28401</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Winston-Salem</city>
        <state>North Carolina</state>
        <zip>27103</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Investigational Site 031</name>
      <address>
        <city>Fargo</city>
        <state>North Dakota</state>
        <zip>58104</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Fargo</city>
        <state>North Dakota</state>
        <zip>58122</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Investigational Site 523</name>
      <address>
        <city>Canton</city>
        <state>Ohio</state>
        <zip>44710</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Cincinnati</city>
        <state>Ohio</state>
        <zip>45219</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Cleveland</city>
        <state>Ohio</state>
        <zip>44106</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Investigational Site 129</name>
      <address>
        <city>Cleveland</city>
        <state>Ohio</state>
        <zip>44109</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Cleveland</city>
        <state>Ohio</state>
        <zip>44118</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Investigational Site 003</name>
      <address>
        <city>Columbus</city>
        <state>Ohio</state>
        <zip>43215</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Investigational Site 061</name>
      <address>
        <city>Dayton</city>
        <state>Ohio</state>
        <zip>45419</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Dayton</city>
        <state>Ohio</state>
        <zip>45428</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Kettering</city>
        <state>Ohio</state>
        <zip>45429</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Marion</city>
        <state>Ohio</state>
        <zip>43302</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Investigational Site 095</name>
      <address>
        <city>Middletown</city>
        <state>Ohio</state>
        <zip>45005</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Bend</city>
        <state>Oregon</state>
        <zip>97701</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Investigational Site 528</name>
      <address>
        <city>Camp Hill</city>
        <state>Pennsylvania</state>
        <zip>17011</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Hershey</city>
        <state>Pennsylvania</state>
        <zip>17033</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Philadelphia</city>
        <state>Pennsylvania</state>
        <zip>19140</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Pittsburgh</city>
        <state>Pennsylvania</state>
        <zip>15212</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Pittsburgh</city>
        <state>Pennsylvania</state>
        <zip>15240</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Investigational Site 083</name>
      <address>
        <city>Uniontown</city>
        <state>Pennsylvania</state>
        <zip>15401</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>West Reading</city>
        <state>Pennsylvania</state>
        <zip>19611</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Investigational Site 020</name>
      <address>
        <city>Wilkes-Barre</city>
        <state>Pennsylvania</state>
        <zip>18711</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Investigational Site 050</name>
      <address>
        <city>Pawtucket</city>
        <state>Rhode Island</state>
        <zip>02860</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Providence</city>
        <state>Rhode Island</state>
        <zip>02906</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Providence</city>
        <state>Rhode Island</state>
        <zip>02908</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Investigational Site 540</name>
      <address>
        <city>Charleston</city>
        <state>South Carolina</state>
        <zip>29407</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Investigational Site 047</name>
      <address>
        <city>Mount Pleasant</city>
        <state>South Carolina</state>
        <zip>29464</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Investigational Site 180</name>
      <address>
        <city>Spartanburg</city>
        <state>South Carolina</state>
        <zip>29303</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Investigational Site 086</name>
      <address>
        <city>Rapid City</city>
        <state>South Dakota</state>
        <zip>57701</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Franklin</city>
        <state>Tennessee</state>
        <zip>37067</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Jackson</city>
        <state>Tennessee</state>
        <zip>38305</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Nashville</city>
        <state>Tennessee</state>
        <zip>37082</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Nashville</city>
        <state>Tennessee</state>
        <zip>37203</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Investigational Site 544</name>
      <address>
        <city>Austin</city>
        <state>Texas</state>
        <zip>78726</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Corpus Christi</city>
        <state>Texas</state>
        <zip>78413</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Investigational Site 006</name>
      <address>
        <city>Dallas</city>
        <state>Texas</state>
        <zip>75216</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Investigational Site 119</name>
      <address>
        <city>Fort Worth</city>
        <state>Texas</state>
        <zip>76104</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Groesbeck</city>
        <state>Texas</state>
        <zip>76642</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Investigational Site 193</name>
      <address>
        <city>San Antonio</city>
        <state>Texas</state>
        <zip>78229</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Tomball</city>
        <state>Texas</state>
        <zip>77375</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Investigational Site 135</name>
      <address>
        <city>Orem</city>
        <state>Utah</state>
        <zip>84058</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Investigational Site 080</name>
      <address>
        <city>Salt Lake City</city>
        <state>Utah</state>
        <zip>84124</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Investigational Site 012</name>
      <address>
        <city>Lynchburg</city>
        <state>Virginia</state>
        <zip>24501</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Williamsburg</city>
        <state>Virginia</state>
        <zip>23185</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Investigational Site 196</name>
      <address>
        <city>Winchester</city>
        <state>Virginia</state>
        <zip>22601</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Spokane</city>
        <state>Washington</state>
        <zip>99202</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Tacoma</city>
        <state>Washington</state>
        <zip>98405</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Investigational Site 030</name>
      <address>
        <city>Marshfield</city>
        <state>Wisconsin</state>
        <zip>54449</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Weston</city>
        <state>Wisconsin</state>
        <zip>54476</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Westmead</city>
        <state>New South Wales</state>
        <zip>2145</zip>
        <country>Australia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Investigational Site 401</name>
      <address>
        <city>Cairns</city>
        <state>Queensland</state>
        <zip>4870</zip>
        <country>Australia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Woolloongabba</city>
        <state>Queensland</state>
        <zip>4102</zip>
        <country>Australia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Investigational Site 404</name>
      <address>
        <city>Bedford Park</city>
        <state>South Australia</state>
        <zip>5042</zip>
        <country>Australia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Investigational Site 403</name>
      <address>
        <city>Clayton</city>
        <state>Victoria</state>
        <zip>3168</zip>
        <country>Australia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Nedlands</city>
        <state>Western Australia</state>
        <zip>6009</zip>
        <country>Australia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Subiaco</city>
        <state>Western Australia</state>
        <zip>6008</zip>
        <country>Australia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Salvador</city>
        <state>BA</state>
        <zip>40420-000</zip>
        <country>Brazil</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Salvador</city>
        <state>BA</state>
        <zip>41253-190</zip>
        <country>Brazil</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Aparecida de Goiânia</city>
        <state>GO</state>
        <zip>74935-530</zip>
        <country>Brazil</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Belo Horizonte</city>
        <state>MG</state>
        <zip>30150-221</zip>
        <country>Brazil</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Belo Horizonte</city>
        <state>MG</state>
        <zip>30190-130</zip>
        <country>Brazil</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Juiz De Fora</city>
        <state>MG</state>
        <zip>36010-570</zip>
        <country>Brazil</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Recife</city>
        <state>PE</state>
        <zip>52020-010</zip>
        <country>Brazil</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Curitiba</city>
        <state>PR</state>
        <zip>80810-040</zip>
        <country>Brazil</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Nova Iguaçu</city>
        <state>RJ</state>
        <zip>26030-380</zip>
        <country>Brazil</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Rio de Janeiro</city>
        <state>RJ</state>
        <zip>22271-100</zip>
        <country>Brazil</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Natal</city>
        <state>RN</state>
        <zip>59025-600</zip>
        <country>Brazil</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Canoas</city>
        <state>RS</state>
        <zip>92425-900</zip>
        <country>Brazil</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Porto Alegre</city>
        <state>RS</state>
        <zip>90035-003</zip>
        <country>Brazil</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Santo Andre</city>
        <state>SP</state>
        <zip>09060-650</zip>
        <country>Brazil</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Campinas</city>
        <zip>13020431</zip>
        <country>Brazil</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>New Westminster</city>
        <state>British Columbia</state>
        <zip>V3L 3W7</zip>
        <country>Canada</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Investigational Site 156</name>
      <address>
        <city>Surrey</city>
        <state>British Columbia</state>
        <zip>V3V 1Z2</zip>
        <country>Canada</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Investigational Site 158</name>
      <address>
        <city>Vancouver</city>
        <state>British Columbia</state>
        <zip>V5Z IM9</zip>
        <country>Canada</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Winnipeg</city>
        <state>Manitoba</state>
        <zip>R3A IR9</zip>
        <country>Canada</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Halifax</city>
        <state>Nova Scotia</state>
        <zip>B3K 6R8</zip>
        <country>Canada</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Investigational Site 163</name>
      <address>
        <city>Truro</city>
        <state>Nova Scotia</state>
        <zip>B2N 1L2</zip>
        <country>Canada</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Guelph</city>
        <state>Ontario</state>
        <zip>N1H 1B1</zip>
        <country>Canada</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Toronto</city>
        <state>Ontario</state>
        <zip>M5G 1X5</zip>
        <country>Canada</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Montreal</city>
        <state>Quebec</state>
        <zip>H3T 1E2</zip>
        <country>Canada</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Pierrefonds</city>
        <state>Quebec</state>
        <zip>H9H 4Y6</zip>
        <country>Canada</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Investigational Site 152</name>
      <address>
        <city>Québec</city>
        <state>Quebec</state>
        <zip>G1E 7G9</zip>
        <country>Canada</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Investigational Site 151</name>
      <address>
        <city>Sherbrooke</city>
        <state>Quebec</state>
        <zip>J1H5N4</zip>
        <country>Canada</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Investigational Site 161</name>
      <address>
        <city>Trois-Rivières</city>
        <state>Quebec</state>
        <zip>G8Z 3R9</zip>
        <country>Canada</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Barranquilla</city>
        <state>Alantico</state>
        <country>Colombia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Medellin</city>
        <state>Antioquia</state>
        <country>Colombia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Bogota</city>
        <state>Ditrito Capital</state>
        <country>Colombia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Bogota</city>
        <state>Ditrito</state>
        <country>Colombia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Armenia</city>
        <state>Quindio</state>
        <country>Colombia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Bucaramanga</city>
        <state>Santander</state>
        <country>Colombia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Floridablanca</city>
        <state>Santander</state>
        <country>Colombia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Yopal</city>
        <country>Colombia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>San José</city>
        <zip>250-1000</zip>
        <country>Costa Rica</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Investigational Site 215</name>
      <address>
        <city>Aarhus</city>
        <zip>8200</zip>
        <country>Denmark</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Investigational Site 347</name>
      <address>
        <city>Santo Domingo</city>
        <country>Dominican Republic</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Espoo</city>
        <zip>FIN-02100</zip>
        <country>Finland</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Helsinki</city>
        <zip>FIN-00100</zip>
        <country>Finland</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Helsinki</city>
        <zip>FIN-00930</zip>
        <country>Finland</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Investigational Site 203</name>
      <address>
        <city>Järvenpää</city>
        <zip>FIN-04400</zip>
        <country>Finland</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Kokkola</city>
        <zip>67100</zip>
        <country>Finland</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Oulu</city>
        <zip>FIN-90220</zip>
        <country>Finland</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Pori</city>
        <zip>28100</zip>
        <country>Finland</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Seinajoki</city>
        <zip>60100</zip>
        <country>Finland</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Investigational Site 201</name>
      <address>
        <city>Tampere</city>
        <zip>FIN-33100</zip>
        <country>Finland</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Investigational Site 202</name>
      <address>
        <city>Turku</city>
        <zip>FIN-20520</zip>
        <country>Finland</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Vantaa</city>
        <zip>FIN-01300</zip>
        <country>Finland</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Investigational Site 230</name>
      <address>
        <city>Dijon</city>
        <zip>21079</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Lille</city>
        <zip>49100</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Limoges</city>
        <zip>87042</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Lyon</city>
        <zip>69004</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Montpellier</city>
        <zip>34295</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Orleans</city>
        <zip>45100</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Investigational Site 221</name>
      <address>
        <city>Paris</city>
        <zip>75014</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Investigational Site 229</name>
      <address>
        <city>Pringy</city>
        <zip>21079</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Saint Etienne</city>
        <zip>42055</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Investigational Site 223</name>
      <address>
        <city>St Priest en Jarez</city>
        <zip>42270</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Tourcoing</city>
        <zip>59208</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Investigational Site 232</name>
      <address>
        <city>Tours</city>
        <zip>37044</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Munich</city>
        <state>Bavaria</state>
        <zip>81675</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Investigational Site 242</name>
      <address>
        <city>Wurzburg</city>
        <state>Bayern</state>
        <zip>97074</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Investigational Site 244</name>
      <address>
        <city>Deggingen</city>
        <state>BW</state>
        <zip>73326</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Cologne</city>
        <state>NRW</state>
        <zip>50937</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Leipzig</city>
        <state>Sachsen</state>
        <zip>04109</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Jena</city>
        <state>Thuringia</state>
        <zip>07747</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Berlin</city>
        <zip>10629</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Berlin</city>
        <zip>13347</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Essen</city>
        <zip>45355</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Goch</city>
        <zip>47574</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Investigational Site 247</name>
      <address>
        <city>Hamburg</city>
        <zip>20359</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Investigational Site 245</name>
      <address>
        <city>Hamburg</city>
        <zip>22143</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Leipzig</city>
        <zip>97074</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Guatemala</city>
        <zip>1001</zip>
        <country>Guatemala</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Investigational Site 450</name>
      <address>
        <city>Aichi</city>
        <zip>491-8551</zip>
        <country>Japan</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Investigational Site 468</name>
      <address>
        <city>Chiba</city>
        <zip>278-0004</zip>
        <country>Japan</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Investigational Site 467</name>
      <address>
        <city>Fukui</city>
        <zip>910-0067</zip>
        <country>Japan</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Investigational Site 464</name>
      <address>
        <city>Fukuoka</city>
        <zip>800-0344</zip>
        <country>Japan</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Investigational Site 465</name>
      <address>
        <city>Fukuoka</city>
        <zip>814-8525</zip>
        <country>Japan</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Investigational Site 466</name>
      <address>
        <city>Fukuoka</city>
        <zip>838-0069</zip>
        <country>Japan</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Investigational Site 457</name>
      <address>
        <city>Gunma</city>
        <zip>371-0014</zip>
        <country>Japan</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Investigational Site 455</name>
      <address>
        <city>Hyōgo</city>
        <zip>666-0125</zip>
        <country>Japan</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Investigational Site 453</name>
      <address>
        <city>Ibaraki</city>
        <zip>300-0028</zip>
        <country>Japan</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Investigational Site 460</name>
      <address>
        <city>Kyoto</city>
        <zip>611-0041</zip>
        <country>Japan</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Investigational Site 454</name>
      <address>
        <city>Kyoto</city>
        <zip>613-0034</zip>
        <country>Japan</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Investigational Site 456</name>
      <address>
        <city>Nagano</city>
        <zip>382-0091</zip>
        <country>Japan</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Investigational Site 452</name>
      <address>
        <city>Nagano</city>
        <zip>390-8601</zip>
        <country>Japan</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Investigational Site 458</name>
      <address>
        <city>Nagano</city>
        <zip>392-8510</zip>
        <country>Japan</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Investigational Site 469</name>
      <address>
        <city>Okinawa</city>
        <zip>904-2293</zip>
        <country>Japan</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Investigational Site 459</name>
      <address>
        <city>Saitama</city>
        <zip>348-0044</zip>
        <country>Japan</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Investigational Site 467</name>
      <address>
        <city>Shimonoseki</city>
        <zip>750-8520</zip>
        <country>Japan</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Investigational Site 451</name>
      <address>
        <city>Tokyo</city>
        <zip>171-0014</zip>
        <country>Japan</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Investigational Site 463</name>
      <address>
        <city>Yamaguchi</city>
        <zip>750-8520</zip>
        <country>Japan</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Investigational Site 461</name>
      <address>
        <city>Ōsaka</city>
        <zip>596-8522</zip>
        <country>Japan</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Seoul</city>
        <state>Gangnam-gu</state>
        <zip>135-710</zip>
        <country>Korea, Republic of</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Investigational Site 407</name>
      <address>
        <city>Wŏnju</city>
        <state>Gangwon-do</state>
        <zip>26427</zip>
        <country>Korea, Republic of</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Investigational Site 413</name>
      <address>
        <city>Ansan</city>
        <state>Gyeonggi-do</state>
        <zip>15355</zip>
        <country>Korea, Republic of</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Daegu</city>
        <state>Jung-Gu</state>
        <zip>700-721</zip>
        <country>Korea, Republic of</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Investigational Site 427</name>
      <address>
        <city>Incheon</city>
        <state>Namdong-gu</state>
        <zip>22332</zip>
        <country>Korea, Republic of</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Seoul</city>
        <state>Seocho-gu</state>
        <zip>137-701</zip>
        <country>Korea, Republic of</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Seoul</city>
        <state>Seodaemun-gu</state>
        <zip>120-752</zip>
        <country>Korea, Republic of</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Seoul</city>
        <state>Seongbuk-gu</state>
        <zip>136-705</zip>
        <country>Korea, Republic of</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Seoul</city>
        <state>Seongdong-gu</state>
        <zip>132-792</zip>
        <country>Korea, Republic of</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Seoul</city>
        <state>Songpa-gu</state>
        <zip>138-736</zip>
        <country>Korea, Republic of</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Investigational Site 446</name>
      <address>
        <city>Busan</city>
        <zip>49201</zip>
        <country>Korea, Republic of</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Cheongju</city>
        <zip>361-711</zip>
        <country>Korea, Republic of</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Investigational Site 439</name>
      <address>
        <city>Gyeonggi-do</city>
        <zip>16247</zip>
        <country>Korea, Republic of</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Gyeonggi-do</city>
        <zip>443-380</zip>
        <country>Korea, Republic of</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Investigational Site 412</name>
      <address>
        <city>Incheon</city>
        <zip>21565</zip>
        <country>Korea, Republic of</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Investigational Site 409</name>
      <address>
        <city>Seoul</city>
        <zip>2841</zip>
        <country>Korea, Republic of</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Investigational Site 408</name>
      <address>
        <city>Seoul</city>
        <zip>3722</zip>
        <country>Korea, Republic of</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Investigational Site 415</name>
      <address>
        <city>Seoul</city>
        <zip>5355</zip>
        <country>Korea, Republic of</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Investigational Site 418</name>
      <address>
        <city>Seoul</city>
        <zip>5505</zip>
        <country>Korea, Republic of</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Investigational Site 411</name>
      <address>
        <city>Seoul</city>
        <zip>6351</zip>
        <country>Korea, Republic of</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Investigational Site 437</name>
      <address>
        <city>Seoul</city>
        <zip>7441</zip>
        <country>Korea, Republic of</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Investigational Site 438</name>
      <address>
        <city>Seoul</city>
        <zip>8308</zip>
        <country>Korea, Republic of</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Aguascalientes</city>
        <state>AGS</state>
        <zip>20230</zip>
        <country>Mexico</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Tijuana</city>
        <state>Baja California</state>
        <zip>22320</zip>
        <country>Mexico</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Investigational Site 325</name>
      <address>
        <city>Mexico City</city>
        <state>D.f.</state>
        <zip>14000</zip>
        <country>Mexico</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Investigational Site 329</name>
      <address>
        <city>Mexico City</city>
        <state>D.f.</state>
        <zip>14080</zip>
        <country>Mexico</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Investigational Site 352</name>
      <address>
        <city>Ecatepec</city>
        <state>Estado De Mexico</state>
        <zip>55076</zip>
        <country>Mexico</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Investigational Site 324</name>
      <address>
        <city>Guadalajara</city>
        <state>Jalisco</state>
        <zip>44280</zip>
        <country>Mexico</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Investigational Site 351</name>
      <address>
        <city>Cuernavaca</city>
        <state>Morelos</state>
        <zip>62290</zip>
        <country>Mexico</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Monterrey</city>
        <state>NL</state>
        <zip>64460</zip>
        <country>Mexico</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>San Luis Potosi</city>
        <state>SLP</state>
        <zip>78240</zip>
        <country>Mexico</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Investigational Site 363</name>
      <address>
        <city>Ciudad Victoria</city>
        <state>Tamaulipas</state>
        <country>Mexico</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Investigational Site 326</name>
      <address>
        <city>Durango</city>
        <zip>34000</zip>
        <country>Mexico</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Morelos</city>
        <country>Mexico</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>San Luis Potosi</city>
        <zip>78240</zip>
        <country>Mexico</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Investigational Site 354</name>
      <address>
        <city>Panama City</city>
        <country>Panama</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Investigational Site 364</name>
      <address>
        <city>Trujillo</city>
        <state>La Libertad</state>
        <zip>130101</zip>
        <country>Peru</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Investigational Site 332</name>
      <address>
        <city>Jesus Maria</city>
        <state>Lima</state>
        <zip>lima 11</zip>
        <country>Peru</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Lima Cercado</city>
        <state>Lima</state>
        <country>Peru</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Investigational Site 334</name>
      <address>
        <city>San Martín de Porres</city>
        <state>Lima</state>
        <zip>lima 31</zip>
        <country>Peru</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Surquillo</city>
        <state>Lima</state>
        <country>Peru</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Investigational Site 356</name>
      <address>
        <city>Lima</city>
        <zip>callao 2</zip>
        <country>Peru</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Investigational Site 355</name>
      <address>
        <city>Lima</city>
        <zip>lima 1</zip>
        <country>Peru</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Lima</city>
        <country>Peru</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Investigational Site 365</name>
      <address>
        <city>Piura</city>
        <zip>200101</zip>
        <country>Peru</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Alabang</city>
        <zip>1770</zip>
        <country>Philippines</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Dasmarinas</city>
        <zip>4114</zip>
        <country>Philippines</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Manila</city>
        <zip>1000</zip>
        <country>Philippines</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Manila</city>
        <zip>1004</zip>
        <country>Philippines</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Pasig City</city>
        <zip>1600</zip>
        <country>Philippines</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Quezon City</city>
        <zip>1100</zip>
        <country>Philippines</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Quezon City</city>
        <zip>1101</zip>
        <country>Philippines</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Investigational Site 284</name>
      <address>
        <city>Bydgoszcz</city>
        <zip>85-863</zip>
        <country>Poland</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Investigational Site 283</name>
      <address>
        <city>Nowy Duninów</city>
        <zip>09-505</zip>
        <country>Poland</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Investigational Site 171</name>
      <address>
        <city>Bayamon</city>
        <zip>00960</zip>
        <country>Puerto Rico</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Bayamon</city>
        <zip>00961</zip>
        <country>Puerto Rico</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Singapore</city>
        <zip>119074</zip>
        <country>Singapore</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Investigational Site 419</name>
      <address>
        <city>Singapore</city>
        <zip>119228</zip>
        <country>Singapore</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Singapore</city>
        <zip>169608</zip>
        <country>Singapore</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Investigational Site 428</name>
      <address>
        <city>Singapore</city>
        <zip>308433</zip>
        <country>Singapore</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Investigational Site 445</name>
      <address>
        <city>Singapore</city>
        <zip>768828</zip>
        <country>Singapore</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Investigational Site 294</name>
      <address>
        <city>Cordoba</city>
        <zip>14004</zip>
        <country>Spain</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Investigational Site 293</name>
      <address>
        <city>Santander</city>
        <zip>39008</zip>
        <country>Spain</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Investigational Site 292</name>
      <address>
        <city>Terrassa</city>
        <zip>08221</zip>
        <country>Spain</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Investigational Site 295</name>
      <address>
        <city>Vigo</city>
        <zip>36312</zip>
        <country>Spain</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Göthenburg</city>
        <state>SWE</state>
        <zip>41685</zip>
        <country>Sweden</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Stockholm</city>
        <zip>11157</zip>
        <country>Sweden</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Umea</city>
        <zip>90185</zip>
        <country>Sweden</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Kaohsiung</city>
        <zip>813</zip>
        <country>Taiwan</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Investigational Site 426</name>
      <address>
        <city>New Taipei City</city>
        <zip>22056</zip>
        <country>Taiwan</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>New Taipei City</city>
        <zip>23156</zip>
        <country>Taiwan</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Investigational Site 429</name>
      <address>
        <city>Taichung City</city>
        <zip>40201</zip>
        <country>Taiwan</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Investigational Site 421</name>
      <address>
        <city>Tainan</city>
        <zip>71004</zip>
        <country>Taiwan</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Investigational Site 425</name>
      <address>
        <city>Taipei</city>
        <zip>10002</zip>
        <country>Taiwan</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Tiachung</city>
        <zip>404</zip>
        <country>Taiwan</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Investigational Site 443</name>
      <address>
        <city>Bangkok</city>
        <zip>10330</zip>
        <country>Thailand</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Investigational Site 442</name>
      <address>
        <city>Bangkok</city>
        <zip>10400</zip>
        <country>Thailand</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Investigational Site 441</name>
      <address>
        <city>Khon Kaen</city>
        <zip>40002</zip>
        <country>Thailand</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Investigational Site 276</name>
      <address>
        <city>Blackpool</city>
        <zip>FY3 7EN</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Blackpool</city>
        <zip>FY3 8NR</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Investigational Site 277</name>
      <address>
        <city>Coventry</city>
        <zip>CV2 2DX</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Harrow</city>
        <zip>HA1 3UJ</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Investigational Site 281</name>
      <address>
        <city>Leeds</city>
        <zip>LS9 7TF</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Liverpool</city>
        <zip>L78XP</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Investigational Site 271</name>
      <address>
        <city>London</city>
        <zip>SW17 0RE</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Manchester</city>
        <zip>M8 5RB</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Middlesex</city>
        <zip>HA1 3UJ</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>North Shields</city>
        <zip>NE29 8NH</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Investigational Site 275</name>
      <address>
        <city>Penzance</city>
        <zip>TR19 7HX</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Stoke on Trent</city>
        <zip>SR53SY</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Australia</country>
    <country>Brazil</country>
    <country>Canada</country>
    <country>Colombia</country>
    <country>Costa Rica</country>
    <country>Denmark</country>
    <country>Dominican Republic</country>
    <country>Finland</country>
    <country>France</country>
    <country>Germany</country>
    <country>Guatemala</country>
    <country>Japan</country>
    <country>Korea, Republic of</country>
    <country>Mexico</country>
    <country>Panama</country>
    <country>Peru</country>
    <country>Philippines</country>
    <country>Poland</country>
    <country>Puerto Rico</country>
    <country>Singapore</country>
    <country>Spain</country>
    <country>Sweden</country>
    <country>Taiwan</country>
    <country>Thailand</country>
    <country>United Kingdom</country>
    <country>United States</country>
  </location_countries>
  <removed_countries>
    <country>Chile</country>
  </removed_countries>
  <verification_date>June 2019</verification_date>
  <study_first_submitted>June 20, 2013</study_first_submitted>
  <study_first_submitted_qc>June 24, 2013</study_first_submitted_qc>
  <study_first_posted type="Estimate">June 27, 2013</study_first_posted>
  <results_first_submitted>June 11, 2019</results_first_submitted>
  <results_first_submitted_qc>June 11, 2019</results_first_submitted_qc>
  <results_first_posted type="Actual">July 5, 2019</results_first_posted>
  <last_update_submitted>June 11, 2019</last_update_submitted>
  <last_update_submitted_qc>June 11, 2019</last_update_submitted_qc>
  <last_update_posted type="Actual">July 5, 2019</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Clostridium difficile Toxoid Vaccine</keyword>
  <keyword>Clostridium difficile infection</keyword>
  <keyword>Cdiffense</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Infection</mesh_term>
    <mesh_term>Communicable Diseases</mesh_term>
    <mesh_term>Clostridium Infections</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Yes</sharing_ipd>
    <ipd_description>Individual participant data (IPD) and supporting clinical documents are available for request at clinicalstudydatarequest.com. While making information available, Sanofi continues to protect the privacy of the participants in clinical trials and to remove commercially confidential information (CCI). Details on Data Sharing criteria and process for requesting access can be found at this web address: clinicalstudydatarequest.com</ipd_description>
  </patient_data>
  <provided_document_section>
    <provided_document>
      <document_type>Study Protocol</document_type>
      <document_has_protocol>Yes</document_has_protocol>
      <document_has_icf>No</document_has_icf>
      <document_has_sap>No</document_has_sap>
      <document_date>February 14, 2017</document_date>
      <document_url>https://ClinicalTrials.gov/ProvidedDocs/12/NCT01887912/Prot_000.pdf</document_url>
    </provided_document>
    <provided_document>
      <document_type>Statistical Analysis Plan</document_type>
      <document_has_protocol>No</document_has_protocol>
      <document_has_icf>No</document_has_icf>
      <document_has_sap>Yes</document_has_sap>
      <document_date>September 5, 2017</document_date>
      <document_url>https://ClinicalTrials.gov/ProvidedDocs/12/NCT01887912/SAP_001.pdf</document_url>
    </provided_document>
  </provided_document_section>

  <clinical_results>

    <participant_flow>
      <recruitment_details>Study participants were enrolled in the study from 30 July 2013 to 17 November 2017.</recruitment_details>
      <pre_assignment_details>A total of 9302 participants were enrolled and randomized in the study.</pre_assignment_details>
      <group_list>
        <group group_id="P1">
          <title>C. Difficile Vaccine Group</title>
          <description>Participants received 1 injection of 0.5 mL C. difficile toxoid vaccine at Days 0 (Injection 1), 7 (Injection 2), and 30 (Injection 3).</description>
        </group>
        <group group_id="P2">
          <title>Placebo Group</title>
          <description>Participants received 1 injection of 0.5 mL placebo matched to vaccine at Days 0 (Injection 1), 7 (Injection 2), and 30 (Injection 3).</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Overall Study</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="6201"/>
                <participants group_id="P2" count="3101"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>Safety Population</title>
              <participants_list>
                <participants group_id="P1" count="6113"/>
                <participants group_id="P2" count="3057"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="4809"/>
                <participants group_id="P2" count="2370"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="1392"/>
                <participants group_id="P2" count="731"/>
              </participants_list>
            </milestone>
          </milestone_list>
          <drop_withdraw_reason_list>
            <drop_withdraw_reason>
              <title>Serious adverse event</title>
              <participants_list>
                <participants group_id="P1" count="400"/>
                <participants group_id="P2" count="198"/>
              </participants_list>
            </drop_withdraw_reason>
            <drop_withdraw_reason>
              <title>Other Adverse Event</title>
              <participants_list>
                <participants group_id="P1" count="34"/>
                <participants group_id="P2" count="15"/>
              </participants_list>
            </drop_withdraw_reason>
            <drop_withdraw_reason>
              <title>Protocol Violation</title>
              <participants_list>
                <participants group_id="P1" count="67"/>
                <participants group_id="P2" count="37"/>
              </participants_list>
            </drop_withdraw_reason>
            <drop_withdraw_reason>
              <title>Lost to Follow-up</title>
              <participants_list>
                <participants group_id="P1" count="163"/>
                <participants group_id="P2" count="74"/>
              </participants_list>
            </drop_withdraw_reason>
            <drop_withdraw_reason>
              <title>Withdrawal by Subject</title>
              <participants_list>
                <participants group_id="P1" count="606"/>
                <participants group_id="P2" count="349"/>
              </participants_list>
            </drop_withdraw_reason>
            <drop_withdraw_reason>
              <title>Other</title>
              <participants_list>
                <participants group_id="P1" count="122"/>
                <participants group_id="P2" count="58"/>
              </participants_list>
            </drop_withdraw_reason>
          </drop_withdraw_reason_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <population>Analysis was performed on all randomized participants.</population>
      <group_list>
        <group group_id="B1">
          <title>C. Difficile Vaccine Group</title>
          <description>Participants received 1 injection of 0.5 mL C. difficile toxoid vaccine at Days 0 (Injection 1), 7 (Injection 2), and 30 (Injection 3).</description>
        </group>
        <group group_id="B2">
          <title>Placebo Group</title>
          <description>Participants received 1 injection of 0.5 mL placebo matched to vaccine at Days 0 (Injection 1), 7 (Injection 2), and 30 (Injection 3).</description>
        </group>
        <group group_id="B3">
          <title>Total</title>
          <description>Total of all reporting groups</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="6201"/>
            <count group_id="B2" value="3101"/>
            <count group_id="B3" value="9302"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age</title>
          <units>years</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="65.9" spread="8.86"/>
                    <measurement group_id="B2" value="65.8" spread="8.87"/>
                    <measurement group_id="B3" value="65.8" spread="8.86"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Sex: Female, Male</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>Female</title>
                  <measurement_list>
                    <measurement group_id="B1" value="2629"/>
                    <measurement group_id="B2" value="1294"/>
                    <measurement group_id="B3" value="3923"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Male</title>
                  <measurement_list>
                    <measurement group_id="B1" value="3572"/>
                    <measurement group_id="B2" value="1807"/>
                    <measurement group_id="B3" value="5379"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Ethnicity (NIH/OMB)</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>Hispanic or Latino</title>
                  <measurement_list>
                    <measurement group_id="B1" value="330"/>
                    <measurement group_id="B2" value="171"/>
                    <measurement group_id="B3" value="501"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Not Hispanic or Latino</title>
                  <measurement_list>
                    <measurement group_id="B1" value="2780"/>
                    <measurement group_id="B2" value="1390"/>
                    <measurement group_id="B3" value="4170"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Unknown or Not Reported</title>
                  <measurement_list>
                    <measurement group_id="B1" value="3091"/>
                    <measurement group_id="B2" value="1540"/>
                    <measurement group_id="B3" value="4631"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Race (NIH/OMB)</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>American Indian or Alaska Native</title>
                  <measurement_list>
                    <measurement group_id="B1" value="6"/>
                    <measurement group_id="B2" value="6"/>
                    <measurement group_id="B3" value="12"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Asian</title>
                  <measurement_list>
                    <measurement group_id="B1" value="795"/>
                    <measurement group_id="B2" value="398"/>
                    <measurement group_id="B3" value="1193"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Native Hawaiian or Other Pacific Islander</title>
                  <measurement_list>
                    <measurement group_id="B1" value="5"/>
                    <measurement group_id="B2" value="4"/>
                    <measurement group_id="B3" value="9"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Black or African American</title>
                  <measurement_list>
                    <measurement group_id="B1" value="206"/>
                    <measurement group_id="B2" value="102"/>
                    <measurement group_id="B3" value="308"/>
                  </measurement_list>
                </category>
                <category>
                  <title>White</title>
                  <measurement_list>
                    <measurement group_id="B1" value="2983"/>
                    <measurement group_id="B2" value="1487"/>
                    <measurement group_id="B3" value="4470"/>
                  </measurement_list>
                </category>
                <category>
                  <title>More than one race</title>
                  <measurement_list>
                    <measurement group_id="B1" value="8"/>
                    <measurement group_id="B2" value="5"/>
                    <measurement group_id="B3" value="13"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Unknown or Not Reported</title>
                  <measurement_list>
                    <measurement group_id="B1" value="2198"/>
                    <measurement group_id="B2" value="1099"/>
                    <measurement group_id="B3" value="3297"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>Number of Participants With Symptomatic Polymerase Chain Reaction (PCR)-Confirmed Primary C. Difficile Infection (CDI) Cases</title>
        <description>Symptomatic PCR-confirmed CDI cases were defined as the number of participants with combination of clinical and laboratory findings. Clinical components were: &gt;= 3 loose stools in &lt;= 24 hours, loose stools (defined as type 6 [fluffy pieces with ragged edges, mushy] or type 7 [watery, no solid pieces] according to the Bristol Stool Chart) lasting &gt;= 24 hours. Laboratory findings were: stool sample positive for C. difficile Toxin B by PCR at central laboratory or diagnosis of pseudomembranous colitis visualized at colonoscopy.</description>
        <time_frame>Up to 3 years post injection 1</time_frame>
        <population>Analysis was performed on modified intent-to-treat (mITT) population which included all participants who received at least 1 injection and were analyzed according to the group to which they were randomized.</population>
        <group_list>
          <group group_id="O1">
            <title>C. Difficile Vaccine Group</title>
            <description>Participants received 1 injection of 0.5 mL C. difficile toxoid vaccine at Days 0 (Injection 1), 7 (Injection 2), and 30 (Injection 3).</description>
          </group>
          <group group_id="O2">
            <title>Placebo Group</title>
            <description>Participants received 1 injection of 0.5 mL placebo matched to vaccine at Days 0 (Injection 1), 7 (Injection 2), and 30 (Injection 3).</description>
          </group>
        </group_list>
        <measure>
          <title>Number of Participants With Symptomatic Polymerase Chain Reaction (PCR)-Confirmed Primary C. Difficile Infection (CDI) Cases</title>
          <description>Symptomatic PCR-confirmed CDI cases were defined as the number of participants with combination of clinical and laboratory findings. Clinical components were: &gt;= 3 loose stools in &lt;= 24 hours, loose stools (defined as type 6 [fluffy pieces with ragged edges, mushy] or type 7 [watery, no solid pieces] according to the Bristol Stool Chart) lasting &gt;= 24 hours. Laboratory findings were: stool sample positive for C. difficile Toxin B by PCR at central laboratory or diagnosis of pseudomembranous colitis visualized at colonoscopy.</description>
          <population>Analysis was performed on modified intent-to-treat (mITT) population which included all participants who received at least 1 injection and were analyzed according to the group to which they were randomized.</population>
          <units>Participants</units>
          <param>Count of Participants</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="6173"/>
                <count group_id="O2" value="3085"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="34"/>
                    <measurement group_id="O2" value="16"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Number of Participants With Severe PCR-Confirmed Primary CDI Cases</title>
        <description>Severe CDI cases were defined as number of participants with at least one of the following symptoms: fever &gt;= 38.5 degree Celsius (°C), white blood cell count &gt;= 15,000 cells/mm^3, ileus, pseudomembranous colitis, serum albumin &lt;3 gram per deciliter, abdominal distension, abdominal tenderness, or admission to the intensive care unit within 7 days of CDI diagnosis.</description>
        <time_frame>Up to 3 years post injection 1</time_frame>
        <population>Analysis was performed on participants with protocol-defined (PCR confirmed) primary CDI cases.</population>
        <group_list>
          <group group_id="O1">
            <title>C. Difficile Vaccine Group</title>
            <description>Participants received 1 injection of 0.5 mL C. difficile toxoid vaccine at Days 0 (Injection 1), 7 (Injection 2), and 30 (Injection 3).</description>
          </group>
          <group group_id="O2">
            <title>Placebo Group</title>
            <description>Participants received 1 injection of 0.5 mL placebo matched to vaccine at Days 0 (Injection 1), 7 (Injection 2), and 30 (Injection 3).</description>
          </group>
        </group_list>
        <measure>
          <title>Number of Participants With Severe PCR-Confirmed Primary CDI Cases</title>
          <description>Severe CDI cases were defined as number of participants with at least one of the following symptoms: fever &gt;= 38.5 degree Celsius (°C), white blood cell count &gt;= 15,000 cells/mm^3, ileus, pseudomembranous colitis, serum albumin &lt;3 gram per deciliter, abdominal distension, abdominal tenderness, or admission to the intensive care unit within 7 days of CDI diagnosis.</description>
          <population>Analysis was performed on participants with protocol-defined (PCR confirmed) primary CDI cases.</population>
          <units>Participants</units>
          <param>Count of Participants</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="34"/>
                <count group_id="O2" value="16"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="9"/>
                    <measurement group_id="O2" value="6"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Number of Participants With Loose Stool Episodes</title>
        <description>Loose stools were defined as type 6 (fluffy pieces with ragged edges, mushy) or type 7 (watery, no solid pieces) according to the Bristol Stool Chart. In this outcome measure, participants with number of loose stool episodes (categorized as: loose stool episodes less than 3, 3 to 6, 7 to 10, 11 to 15 and greater than 15) were reported.</description>
        <time_frame>Up to 3 years post injection 1</time_frame>
        <population>Analysis was performed on participants with protocol-defined PCR confirmed CDI cases.</population>
        <group_list>
          <group group_id="O1">
            <title>C. Difficile Vaccine Group</title>
            <description>Participants received 1 injection of 0.5 mL C. difficile toxoid vaccine at Days 0 (Injection 1), 7 (Injection 2), and 30 (Injection 3).</description>
          </group>
          <group group_id="O2">
            <title>Placebo Group</title>
            <description>Participants received 1 injection of 0.5 mL placebo matched to vaccine at Days 0 (Injection 1), 7 (Injection 2), and 30 (Injection 3).</description>
          </group>
        </group_list>
        <measure>
          <title>Number of Participants With Loose Stool Episodes</title>
          <description>Loose stools were defined as type 6 (fluffy pieces with ragged edges, mushy) or type 7 (watery, no solid pieces) according to the Bristol Stool Chart. In this outcome measure, participants with number of loose stool episodes (categorized as: loose stool episodes less than 3, 3 to 6, 7 to 10, 11 to 15 and greater than 15) were reported.</description>
          <population>Analysis was performed on participants with protocol-defined PCR confirmed CDI cases.</population>
          <units>Participants</units>
          <param>Count of Participants</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="34"/>
                <count group_id="O2" value="16"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>&lt;3</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>3 to 6</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="7"/>
                    <measurement group_id="O2" value="4"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>7 to 10</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="7"/>
                    <measurement group_id="O2" value="2"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>11 to 15</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="7"/>
                    <measurement group_id="O2" value="4"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>&gt;15</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="13"/>
                    <measurement group_id="O2" value="6"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Number of Participants With Symptomatic PCR Confirmed CDI Cases: Per-Protocol Population</title>
        <description>Symptomatic PCR confirmed CDI cases were defined as the number of participants with combination of clinical and laboratory findings. Clinical components were: &gt;= 3 loose stools in &lt;= 24 hours, loose stools (defined as type 6 [fluffy pieces with ragged edges, mushy] or type 7 [watery, no solid pieces] according to the Bristol Stool Chart) lasting &gt;= 24 hours. Laboratory findings were: stool sample positive for C. difficile Toxin B by PCR at central laboratory or diagnosis of pseudomembranous colitis visualized at colonoscopy. Analysis was performed on per-protocol efficacy analysis set (PPEAS).</description>
        <time_frame>Up to 3 years post injection 1</time_frame>
        <population>PPEAS: participants who had at least 1 injection, no relevant protocol deviations (not meet inclusion criteria/ met exclusion criteria, not receive any vaccine/not received in proper time window, received different vaccine than randomized, preparation and / or administration of vaccine not done per protocol, received protocol-restricted therapy).</population>
        <group_list>
          <group group_id="O1">
            <title>C. Difficile Vaccine Group</title>
            <description>Participants received 1 injection of 0.5 mL C. difficile toxoid vaccine at Days 0 (Injection 1), 7 (Injection 2), and 30 (Injection 3).</description>
          </group>
          <group group_id="O2">
            <title>Placebo Group</title>
            <description>Participants received 1 injection of 0.5 mL placebo matched to vaccine at Days 0 (Injection 1), 7 (Injection 2), and 30 (Injection 3).</description>
          </group>
        </group_list>
        <measure>
          <title>Number of Participants With Symptomatic PCR Confirmed CDI Cases: Per-Protocol Population</title>
          <description>Symptomatic PCR confirmed CDI cases were defined as the number of participants with combination of clinical and laboratory findings. Clinical components were: &gt;= 3 loose stools in &lt;= 24 hours, loose stools (defined as type 6 [fluffy pieces with ragged edges, mushy] or type 7 [watery, no solid pieces] according to the Bristol Stool Chart) lasting &gt;= 24 hours. Laboratory findings were: stool sample positive for C. difficile Toxin B by PCR at central laboratory or diagnosis of pseudomembranous colitis visualized at colonoscopy. Analysis was performed on per-protocol efficacy analysis set (PPEAS).</description>
          <population>PPEAS: participants who had at least 1 injection, no relevant protocol deviations (not meet inclusion criteria/ met exclusion criteria, not receive any vaccine/not received in proper time window, received different vaccine than randomized, preparation and / or administration of vaccine not done per protocol, received protocol-restricted therapy).</population>
          <units>Participants</units>
          <param>Count of Participants</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="4786"/>
                <count group_id="O2" value="2378"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="23"/>
                    <measurement group_id="O2" value="13"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Serum Antibody Concentrations Against Toxins A and B Measured by Enzyme-Linked Immunosorbent Assay (ELISA)</title>
        <description>Serum antibody concentrations against toxins A and B were measured by ELISA and expressed as geometric mean concentration (GMC). The 2-sided 95% Confidence Interval (CI) of GMC was based on the Student t-distribution. Analysis was performed on Per Protocol Immunogenicity Analysis Set, which included participants who had at least 1 injection, no relevant protocol deviations (not met inclusion criteria/ met exclusion criteria, not received vaccine/ not received in proper time window, received different vaccine than randomized, preparation and/ or administration of vaccine not per protocol, protocol-restricted therapy, not provided post-dose serology sample/serology sample did not produced a valid test result).</description>
        <time_frame>Day 0, Day 14, Day 30, Day 60, Day 210, Day 390, Day 570, Day 750, Day 930, and Day 1110</time_frame>
        <population>Analysis was performed on Per Protocol Immunogenicity Analysis Set. Here, ‘number analyzed’ = participants with available data for each specified category.</population>
        <group_list>
          <group group_id="O1">
            <title>C. Difficile Vaccine Group</title>
            <description>Participants received 1 injection of 0.5 mL C. difficile toxoid vaccine at Days 0 (Injection 1), 7 (Injection 2), and 30 (Injection 3).</description>
          </group>
          <group group_id="O2">
            <title>Placebo Group</title>
            <description>Participants received 1 injection of 0.5 mL placebo matched to vaccine at Days 0 (Injection 1), 7 (Injection 2), and 30 (Injection 3).</description>
          </group>
        </group_list>
        <measure>
          <title>Serum Antibody Concentrations Against Toxins A and B Measured by Enzyme-Linked Immunosorbent Assay (ELISA)</title>
          <description>Serum antibody concentrations against toxins A and B were measured by ELISA and expressed as geometric mean concentration (GMC). The 2-sided 95% Confidence Interval (CI) of GMC was based on the Student t-distribution. Analysis was performed on Per Protocol Immunogenicity Analysis Set, which included participants who had at least 1 injection, no relevant protocol deviations (not met inclusion criteria/ met exclusion criteria, not received vaccine/ not received in proper time window, received different vaccine than randomized, preparation and/ or administration of vaccine not per protocol, protocol-restricted therapy, not provided post-dose serology sample/serology sample did not produced a valid test result).</description>
          <population>Analysis was performed on Per Protocol Immunogenicity Analysis Set. Here, ‘number analyzed’ = participants with available data for each specified category.</population>
          <units>ELISA units per milliliter (EU/mL)</units>
          <param>Geometric Mean</param>
          <dispersion>95% Confidence Interval</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="471"/>
                <count group_id="O2" value="236"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Toxin A ImunnoglobulinG (IgG): Day 0</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="468"/>
                    <count group_id="O2" value="230"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.957" lower_limit="0.897" upper_limit="1.02"/>
                    <measurement group_id="O2" value="0.999" lower_limit="0.912" upper_limit="1.09"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Toxin A IgG: Day 14</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="418"/>
                    <count group_id="O2" value="214"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="3.19" lower_limit="2.68" upper_limit="3.80"/>
                    <measurement group_id="O2" value="0.913" lower_limit="0.849" upper_limit="0.983"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Toxin A IgG: Day 30</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="456"/>
                    <count group_id="O2" value="230"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="12.2" lower_limit="10.4" upper_limit="14.3"/>
                    <measurement group_id="O2" value="0.959" lower_limit="0.889" upper_limit="1.03"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Toxin A IgG: Day 60</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="417"/>
                    <count group_id="O2" value="212"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="43.7" lower_limit="38.1" upper_limit="50.2"/>
                    <measurement group_id="O2" value="0.933" lower_limit="0.867" upper_limit="1.00"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Toxin A IgG: Day 210</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="355"/>
                    <count group_id="O2" value="182"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="12.0" lower_limit="10.5" upper_limit="13.8"/>
                    <measurement group_id="O2" value="0.944" lower_limit="0.865" upper_limit="1.03"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Toxin A IgG: Day 390</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="320"/>
                    <count group_id="O2" value="159"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="6.02" lower_limit="5.23" upper_limit="6.93"/>
                    <measurement group_id="O2" value="0.955" lower_limit="0.856" upper_limit="1.06"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Toxin A IgG: Day 570</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="277"/>
                    <count group_id="O2" value="145"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="4.50" lower_limit="3.86" upper_limit="5.25"/>
                    <measurement group_id="O2" value="0.908" lower_limit="0.834" upper_limit="0.989"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Toxin A IgG: Day 750</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="191"/>
                    <count group_id="O2" value="93"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="4.02" lower_limit="3.38" upper_limit="4.78"/>
                    <measurement group_id="O2" value="0.856" lower_limit="0.776" upper_limit="0.944"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Toxin A IgG: Day 930</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="108"/>
                    <count group_id="O2" value="66"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="3.83" lower_limit="3.02" upper_limit="4.85"/>
                    <measurement group_id="O2" value="0.902" lower_limit="0.796" upper_limit="1.02"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Toxin A IgG: Day 1110</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="59"/>
                    <count group_id="O2" value="36"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="3.75" lower_limit="2.64" upper_limit="5.34"/>
                    <measurement group_id="O2" value="1.09" lower_limit="0.786" upper_limit="1.50"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Toxin B IgG: Day 0</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="468"/>
                    <count group_id="O2" value="231"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1.40" lower_limit="1.24" upper_limit="1.57"/>
                    <measurement group_id="O2" value="1.49" lower_limit="1.24" upper_limit="1.79"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Toxin B IgG: Day 14</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="419"/>
                    <count group_id="O2" value="216"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="4.36" lower_limit="3.37" upper_limit="5.64"/>
                    <measurement group_id="O2" value="1.56" lower_limit="1.29" upper_limit="1.89"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Toxin B IgG: Day 30</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="455"/>
                    <count group_id="O2" value="231"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="10.0" lower_limit="7.85" upper_limit="12.8"/>
                    <measurement group_id="O2" value="1.46" lower_limit="1.21" upper_limit="1.75"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Toxin B IgG: Day 60</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="417"/>
                    <count group_id="O2" value="212"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="24.8" lower_limit="20.1" upper_limit="30.6"/>
                    <measurement group_id="O2" value="1.42" lower_limit="1.18" upper_limit="1.71"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Toxin B IgG: Day 210</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="354"/>
                    <count group_id="O2" value="182"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="6.62" lower_limit="5.36" upper_limit="8.19"/>
                    <measurement group_id="O2" value="1.31" lower_limit="1.07" upper_limit="1.61"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Toxin B IgG: Day 390</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="319"/>
                    <count group_id="O2" value="159"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="3.98" lower_limit="3.15" upper_limit="5.02"/>
                    <measurement group_id="O2" value="1.24" lower_limit="0.991" upper_limit="1.56"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Toxin B IgG: Day 570</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="277"/>
                    <count group_id="O2" value="145"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="3.37" lower_limit="2.63" upper_limit="4.32"/>
                    <measurement group_id="O2" value="1.15" lower_limit="0.905" upper_limit="1.47"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Toxin B IgG: Day 750</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="191"/>
                    <count group_id="O2" value="93"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="2.86" lower_limit="2.14" upper_limit="3.84"/>
                    <measurement group_id="O2" value="1.11" lower_limit="0.840" upper_limit="1.47"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Toxin B IgG: Day 930</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="108"/>
                    <count group_id="O2" value="66"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="2.42" lower_limit="1.65" upper_limit="3.55"/>
                    <measurement group_id="O2" value="1.13" lower_limit="0.812" upper_limit="1.58"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Toxin B IgG: Day 1110</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="59"/>
                    <count group_id="O2" value="36"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="3.46" lower_limit="2.06" upper_limit="5.81"/>
                    <measurement group_id="O2" value="0.966" lower_limit="0.592" upper_limit="1.58"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Percentage of Participants With &gt;= 2 and 4-Fold Rise in Serum Antibody Concentrations From Baseline Against Toxins A and B Measured by ELISA</title>
        <description>Percentage of Participants with &gt;= 2 and 4-fold rise in serum antibody concentrations against toxins A and B were measured by ELISA. The 2-sided 95% Cl of the percentage was based on Exact method calculations.</description>
        <time_frame>Day 60</time_frame>
        <population>Analysis was performed on Per Protocol Immunogenicity Analysis Set. Here, ‘overall number of participants analyzed’ = participants evaluable for this outcome measure and 'number analyzed' = participants with available data for each specified category.</population>
        <group_list>
          <group group_id="O1">
            <title>C. Difficile Vaccine Group</title>
            <description>Participants received 1 injection of 0.5 mL C. difficile toxoid vaccine at Days 0 (Injection 1), 7 (Injection 2), and 30 (Injection 3).</description>
          </group>
          <group group_id="O2">
            <title>Placebo Group</title>
            <description>Participants received 1 injection of 0.5 mL placebo matched to vaccine at Days 0 (Injection 1), 7 (Injection 2), and 30 (Injection 3).</description>
          </group>
        </group_list>
        <measure>
          <title>Percentage of Participants With &gt;= 2 and 4-Fold Rise in Serum Antibody Concentrations From Baseline Against Toxins A and B Measured by ELISA</title>
          <description>Percentage of Participants with &gt;= 2 and 4-fold rise in serum antibody concentrations against toxins A and B were measured by ELISA. The 2-sided 95% Cl of the percentage was based on Exact method calculations.</description>
          <population>Analysis was performed on Per Protocol Immunogenicity Analysis Set. Here, ‘overall number of participants analyzed’ = participants evaluable for this outcome measure and 'number analyzed' = participants with available data for each specified category.</population>
          <units>percentage of participants</units>
          <param>Number</param>
          <dispersion>95% Confidence Interval</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="436"/>
                <count group_id="O2" value="220"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Toxin A IgG: &gt;=2</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="433"/>
                    <count group_id="O2" value="217"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="93.3" lower_limit="90.5" upper_limit="95.5"/>
                    <measurement group_id="O2" value="0.9" lower_limit="0.1" upper_limit="3.3"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Toxin A IgG: &gt;=4</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="433"/>
                    <count group_id="O2" value="217"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="88.9" lower_limit="85.6" upper_limit="91.7"/>
                    <measurement group_id="O2" value="0.0" lower_limit="0.0" upper_limit="1.7"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Toxin B IgG: &gt;=2</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="433"/>
                    <count group_id="O2" value="218"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="82.2" lower_limit="78.3" upper_limit="85.7"/>
                    <measurement group_id="O2" value="4.6" lower_limit="2.2" upper_limit="8.3"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Toxin B IgG: &gt;=4</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="433"/>
                    <count group_id="O2" value="218"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="73.2" lower_limit="68.8" upper_limit="77.3"/>
                    <measurement group_id="O2" value="0.5" lower_limit="0.0" upper_limit="2.5"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Serum Antibody Concentrations Against Toxins A and B Measured by ELISA in Participants With CDI</title>
        <description>Serum antibody concentrations against toxins A and B were measured by ELISA and expressed as GMC. The 2-sided 95% CI GMC was based on the Student t-distribution. Symptomatic PCR-confirmed CDI cases were defined as the number of participants with combination of clinical and laboratory findings. Clinical components were: &gt;= 3 loose stools in &lt;= 24 hours, loose stools (defined as type 6 [fluffy pieces with ragged edges, mushy] or type 7 [watery, no solid pieces] according to the Bristol Stool Chart) lasting &gt;= 24 hours. Laboratory findings were: stool sample positive for C. difficile Toxin B by PCR at central laboratory or diagnosis of pseudomembranous colitis visualized at colonoscopy.</description>
        <time_frame>Day 0 and Day 60</time_frame>
        <population>Analysis was performed on participants with protocol-defined (PCR confirmed) primary CDI cases. Here, ‘number analyzed’ = participants with available data for each specified category.</population>
        <group_list>
          <group group_id="O1">
            <title>C. Difficile Vaccine Group</title>
            <description>Participants received 1 injection of 0.5 mL C. difficile toxoid vaccine at Days 0 (Injection 1), 7 (Injection 2), and 30 (Injection 3).</description>
          </group>
          <group group_id="O2">
            <title>Placebo Group</title>
            <description>Participants received 1 injection of 0.5 mL placebo matched to vaccine at Days 0 (Injection 1), 7 (Injection 2), and 30 (Injection 3).</description>
          </group>
        </group_list>
        <measure>
          <title>Serum Antibody Concentrations Against Toxins A and B Measured by ELISA in Participants With CDI</title>
          <description>Serum antibody concentrations against toxins A and B were measured by ELISA and expressed as GMC. The 2-sided 95% CI GMC was based on the Student t-distribution. Symptomatic PCR-confirmed CDI cases were defined as the number of participants with combination of clinical and laboratory findings. Clinical components were: &gt;= 3 loose stools in &lt;= 24 hours, loose stools (defined as type 6 [fluffy pieces with ragged edges, mushy] or type 7 [watery, no solid pieces] according to the Bristol Stool Chart) lasting &gt;= 24 hours. Laboratory findings were: stool sample positive for C. difficile Toxin B by PCR at central laboratory or diagnosis of pseudomembranous colitis visualized at colonoscopy.</description>
          <population>Analysis was performed on participants with protocol-defined (PCR confirmed) primary CDI cases. Here, ‘number analyzed’ = participants with available data for each specified category.</population>
          <units>EU/mL</units>
          <param>Geometric Mean</param>
          <dispersion>95% Confidence Interval</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="34"/>
                <count group_id="O2" value="16"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Toxin A IgG: Day 0</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="33"/>
                    <count group_id="O2" value="16"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1.15" lower_limit="0.821" upper_limit="1.62"/>
                    <measurement group_id="O2" value="1.04" lower_limit="0.661" upper_limit="1.64"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Toxin A IgG: Day 60</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="30"/>
                    <count group_id="O2" value="16"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="42.1" lower_limit="18.0" upper_limit="98.3"/>
                    <measurement group_id="O2" value="1.06" lower_limit="0.632" upper_limit="1.76"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Toxin B IgG: Day 0</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="33"/>
                    <count group_id="O2" value="16"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1.41" lower_limit="0.762" upper_limit="2.62"/>
                    <measurement group_id="O2" value="1.05" lower_limit="0.504" upper_limit="2.20"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Toxin B IgG: Day 60</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="30"/>
                    <count group_id="O2" value="16"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="19.3" lower_limit="6.65" upper_limit="56.2"/>
                    <measurement group_id="O2" value="1.13" lower_limit="0.609" upper_limit="2.11"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Serum Antibody Concentrations Against Toxins A and B Measured by Toxin Neutralization Assay (TNA)</title>
        <description>Serum antibody concentrations against toxins A and B were measured by TNA and expressed as geometric mean titer (GMT). The 2-sided 95% Cl of GMT was based on the Student t-distribution.</description>
        <time_frame>Day 0, Day 14, Day 30, Day 60, Day 210, Day 390, Day 570, Day 750, Day 930, and Day 1110</time_frame>
        <population>Analysis was performed on Per Protocol Immunogenicity Analysis Set. Here, 'number analyzed' = participants with available data for each specified category.</population>
        <group_list>
          <group group_id="O1">
            <title>C. Difficile Vaccine Group</title>
            <description>Participants received 1 injection of 0.5 mL C. difficile toxoid vaccine at Days 0 (Injection 1), 7 (Injection 2), and 30 (Injection 3).</description>
          </group>
          <group group_id="O2">
            <title>Placebo Group</title>
            <description>Participants received 1 injection of 0.5 mL placebo matched to vaccine at Days 0 (Injection 1), 7 (Injection 2), and 30 (Injection 3).</description>
          </group>
        </group_list>
        <measure>
          <title>Serum Antibody Concentrations Against Toxins A and B Measured by Toxin Neutralization Assay (TNA)</title>
          <description>Serum antibody concentrations against toxins A and B were measured by TNA and expressed as geometric mean titer (GMT). The 2-sided 95% Cl of GMT was based on the Student t-distribution.</description>
          <population>Analysis was performed on Per Protocol Immunogenicity Analysis Set. Here, 'number analyzed' = participants with available data for each specified category.</population>
          <units>Titer (1/dilution)</units>
          <param>Geometric Mean</param>
          <dispersion>95% Confidence Interval</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="471"/>
                <count group_id="O2" value="236"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Toxin A TNA: Day 0</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="466"/>
                    <count group_id="O2" value="231"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="9.86" lower_limit="9.22" upper_limit="10.5"/>
                    <measurement group_id="O2" value="10.1" lower_limit="9.12" upper_limit="11.2"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Toxin A TNA: Day 14</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="419"/>
                    <count group_id="O2" value="216"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="28.5" lower_limit="22.7" upper_limit="35.8"/>
                    <measurement group_id="O2" value="9.86" lower_limit="8.96" upper_limit="10.8"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Toxin A TNA: Day 30</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="456"/>
                    <count group_id="O2" value="231"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="50.5" lower_limit="40.9" upper_limit="62.3"/>
                    <measurement group_id="O2" value="9.97" lower_limit="9.09" upper_limit="10.9"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Toxin A TNA: Day 60</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="416"/>
                    <count group_id="O2" value="212"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="269" lower_limit="226" upper_limit="322"/>
                    <measurement group_id="O2" value="9.82" lower_limit="8.95" upper_limit="10.8"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Toxin A TNA: Day 210</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="354"/>
                    <count group_id="O2" value="181"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="269" lower_limit="228" upper_limit="317"/>
                    <measurement group_id="O2" value="10.3" lower_limit="9.09" upper_limit="11.7"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Toxin A TNA: Day 390</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="320"/>
                    <count group_id="O2" value="159"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="217" lower_limit="183" upper_limit="259"/>
                    <measurement group_id="O2" value="10.1" lower_limit="8.86" upper_limit="11.5"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Toxin A TNA: Day 570</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="277"/>
                    <count group_id="O2" value="145"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="184" lower_limit="153" upper_limit="223"/>
                    <measurement group_id="O2" value="9.86" lower_limit="8.76" upper_limit="11.1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Toxin A TNA: Day 750</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="191"/>
                    <count group_id="O2" value="93"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="186" lower_limit="148" upper_limit="234"/>
                    <measurement group_id="O2" value="10.2" lower_limit="8.66" upper_limit="12.0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Toxin A TNA: Day 930</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="108"/>
                    <count group_id="O2" value="66"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="173" lower_limit="125" upper_limit="240"/>
                    <measurement group_id="O2" value="10.7" lower_limit="8.57" upper_limit="13.4"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Toxin A TNA: Day 1110</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="59"/>
                    <count group_id="O2" value="36"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="212" lower_limit="137" upper_limit="329"/>
                    <measurement group_id="O2" value="10.2" lower_limit="8.03" upper_limit="12.9"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Toxin B TNA: Day 0</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="466"/>
                    <count group_id="O2" value="230"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="12.3" lower_limit="11.2" upper_limit="13.6"/>
                    <measurement group_id="O2" value="13.2" lower_limit="11.2" upper_limit="15.6"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Toxin B TNA: Day 14</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="419"/>
                    <count group_id="O2" value="216"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="32.7" lower_limit="25.3" upper_limit="42.2"/>
                    <measurement group_id="O2" value="13.3" lower_limit="11.3" upper_limit="15.7"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Toxin B TNA: Day 30</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="456"/>
                    <count group_id="O2" value="231"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="37.8" lower_limit="29.3" upper_limit="48.8"/>
                    <measurement group_id="O2" value="13.4" lower_limit="11.3" upper_limit="15.8"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Toxin B TNA: Day 60</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="416"/>
                    <count group_id="O2" value="212"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="43.9" lower_limit="34.0" upper_limit="56.6"/>
                    <measurement group_id="O2" value="14.3" lower_limit="11.9" upper_limit="17.2"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Toxin B TNA: Day 210</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="354"/>
                    <count group_id="O2" value="181"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="41.4" lower_limit="32.4" upper_limit="53.1"/>
                    <measurement group_id="O2" value="13.2" lower_limit="11.1" upper_limit="15.5"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Toxin B TNA: Day 390</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="319"/>
                    <count group_id="O2" value="159"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="38.4" lower_limit="30.0" upper_limit="49.0"/>
                    <measurement group_id="O2" value="13.5" lower_limit="11.3" upper_limit="16.1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Toxin B TNA: Day 570</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="277"/>
                    <count group_id="O2" value="145"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="35.7" lower_limit="27.7" upper_limit="46.0"/>
                    <measurement group_id="O2" value="13.7" lower_limit="11.3" upper_limit="16.8"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Toxin B TNA: Day 750</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="191"/>
                    <count group_id="O2" value="93"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="34.3" lower_limit="25.1" upper_limit="46.9"/>
                    <measurement group_id="O2" value="14.6" lower_limit="11.2" upper_limit="18.9"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Toxin B TNA: Day 930</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="108"/>
                    <count group_id="O2" value="66"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="31.0" lower_limit="21.1" upper_limit="45.6"/>
                    <measurement group_id="O2" value="17.0" lower_limit="12.3" upper_limit="23.5"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Toxin B TNA: Day 1110</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="59"/>
                    <count group_id="O2" value="36"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="46.8" lower_limit="26.1" upper_limit="84.1"/>
                    <measurement group_id="O2" value="14.0" lower_limit="9.05" upper_limit="21.7"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Percentage of Participants With &gt;= 2 and 4-Fold Rise in Serum Antibody Concentrations From Baseline Against Toxins A and B Measured by TNA</title>
        <description>Percentage of Participants with &gt;= 2 and 4-fold rise in serum antibody concentrations against toxins A and B were measured by TNA. The 2-sided 95% CI of the percentage was based on Exact method calculations.</description>
        <time_frame>Day 60</time_frame>
        <population>Analysis was performed on Per Protocol Immunogenicity Analysis Set. Here, &quot;overall number of participants analyzed&quot; signifies participants evaluable for this outcome measure and 'number analyzed' = participants with evaluable data for each specified category.</population>
        <group_list>
          <group group_id="O1">
            <title>C. Difficile Vaccine Group</title>
            <description>Participants received 1 injection of 0.5 mL C. difficile toxoid vaccine at Days 0 (Injection 1), 7 (Injection 2), and 30 (Injection 3).</description>
          </group>
          <group group_id="O2">
            <title>Placebo Group</title>
            <description>Participants received 1 injection of 0.5 mL placebo matched to vaccine at Days 0 (Injection 1), 7 (Injection 2), and 30 (Injection 3).</description>
          </group>
        </group_list>
        <measure>
          <title>Percentage of Participants With &gt;= 2 and 4-Fold Rise in Serum Antibody Concentrations From Baseline Against Toxins A and B Measured by TNA</title>
          <description>Percentage of Participants with &gt;= 2 and 4-fold rise in serum antibody concentrations against toxins A and B were measured by TNA. The 2-sided 95% CI of the percentage was based on Exact method calculations.</description>
          <population>Analysis was performed on Per Protocol Immunogenicity Analysis Set. Here, &quot;overall number of participants analyzed&quot; signifies participants evaluable for this outcome measure and 'number analyzed' = participants with evaluable data for each specified category.</population>
          <units>percentage of participants</units>
          <param>Number</param>
          <dispersion>95% Confidence Interval</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="436"/>
                <count group_id="O2" value="220"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Toxin A TNA: &gt;=2</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="431"/>
                    <count group_id="O2" value="218"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="85.6" lower_limit="81.9" upper_limit="88.8"/>
                    <measurement group_id="O2" value="0.5" lower_limit="0.0" upper_limit="2.5"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Toxin A TNA: &gt;=4</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="431"/>
                    <count group_id="O2" value="218"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="78.2" lower_limit="74.0" upper_limit="82.0"/>
                    <measurement group_id="O2" value="0.5" lower_limit="0.0" upper_limit="2.5"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Toxin B TNA: &gt;=2</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="431"/>
                    <count group_id="O2" value="217"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="30.9" lower_limit="26.5" upper_limit="35.5"/>
                    <measurement group_id="O2" value="2.8" lower_limit="1.0" upper_limit="5.9"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Toxin B TNA: &gt;=4</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="431"/>
                    <count group_id="O2" value="217"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="27.4" lower_limit="23.2" upper_limit="31.8"/>
                    <measurement group_id="O2" value="1.8" lower_limit="0.5" upper_limit="4.7"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Serum Antibody Concentrations Against Toxins A and B Measured by TNA in Participants With CDI</title>
        <description>Serum antibody concentrations against toxins A and B were measured by TNA and were expressed as GMT. The 2-sided 95% CI GMC was based on the Student t-distribution. Symptomatic PCR confirmed CDI cases were defined as the number of participants with combination of clinical and laboratory findings. Clinical components were: &gt;= 3 loose stools in &lt;= 24 hours, loose stools (defined as type 6 [fluffy pieces with ragged edges, mushy] or type 7 [watery, no solid pieces] according to the Bristol Stool Chart) lasting &gt;= 24 hours. Laboratory findings were: stool sample positive for C. difficile Toxin B by PCR at central laboratory or diagnosis of pseudomembranous colitis visualized at colonoscopy.</description>
        <time_frame>Day 0 and Day 60</time_frame>
        <population>Analysis was performed on participants with protocol-defined (PCR confirmed) primary CDI cases. Here, ‘number analyzed’ = participants with available data for each specified category.</population>
        <group_list>
          <group group_id="O1">
            <title>C. Difficile Vaccine Group</title>
            <description>Participants received 1 injection of 0.5 mL C. difficile toxoid vaccine at Days 0 (Injection 1), 7 (Injection 2), and 30 (Injection 3).</description>
          </group>
          <group group_id="O2">
            <title>Placebo Group</title>
            <description>Participants received 1 injection of 0.5 mL placebo matched to vaccine at Days 0 (Injection 1), 7 (Injection 2), and 30 (Injection 3).</description>
          </group>
        </group_list>
        <measure>
          <title>Serum Antibody Concentrations Against Toxins A and B Measured by TNA in Participants With CDI</title>
          <description>Serum antibody concentrations against toxins A and B were measured by TNA and were expressed as GMT. The 2-sided 95% CI GMC was based on the Student t-distribution. Symptomatic PCR confirmed CDI cases were defined as the number of participants with combination of clinical and laboratory findings. Clinical components were: &gt;= 3 loose stools in &lt;= 24 hours, loose stools (defined as type 6 [fluffy pieces with ragged edges, mushy] or type 7 [watery, no solid pieces] according to the Bristol Stool Chart) lasting &gt;= 24 hours. Laboratory findings were: stool sample positive for C. difficile Toxin B by PCR at central laboratory or diagnosis of pseudomembranous colitis visualized at colonoscopy.</description>
          <population>Analysis was performed on participants with protocol-defined (PCR confirmed) primary CDI cases. Here, ‘number analyzed’ = participants with available data for each specified category.</population>
          <units>Titer (1/dilution)</units>
          <param>Geometric Mean</param>
          <dispersion>95% Confidence Interval</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="34"/>
                <count group_id="O2" value="16"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Toxin A TNA: Day 0</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="33"/>
                    <count group_id="O2" value="16"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="12.4" lower_limit="8.59" upper_limit="17.9"/>
                    <measurement group_id="O2" value="12.0" lower_limit="6.27" upper_limit="23.0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Toxin A TNA: Day 60</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="30"/>
                    <count group_id="O2" value="16"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="176" lower_limit="83.4" upper_limit="371"/>
                    <measurement group_id="O2" value="10.7" lower_limit="5.77" upper_limit="19.7"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Toxin B TNA: Day 0</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="33"/>
                    <count group_id="O2" value="16"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="16.7" lower_limit="9.46" upper_limit="29.5"/>
                    <measurement group_id="O2" value="11.1" lower_limit="7.57" upper_limit="16.3"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Toxin B TNA: Day 60</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="30"/>
                    <count group_id="O2" value="16"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="53.0" lower_limit="18.3" upper_limit="153"/>
                    <measurement group_id="O2" value="13.1" lower_limit="8.11" upper_limit="21.0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Percentage of Participants Reporting Solicited Injection Site and Systemic Reactions</title>
        <description>Solicited injection site reactions: pain, erythema, and swelling. Pain: Grade 1: no interference with activity, Grade 2: some interference with activity, Grade 3: significant; prevents daily activity; Erythema and swelling: Grade 1: &gt;= 25 to &lt;=50 mm, Grade 2: &gt;51 to &lt;=100 mm, Grade 3: &gt;100 mm. Solicited systemic reactions: fever, headache, malaise, myalgia, and arthralgia. Fever: Grade 1: &gt;= 38.0°C to &lt;=38.4°C or &gt;= 100.4° Fahrenheit (F) to &lt;=101.1°F, Grade 2: &gt;=38.5°C to &lt;= 38.9°C or &gt;=101.2°F to &lt;=102.0°F, Grade 3: &gt;=39.0°C or &gt;=102.1°F. Headache, malaise, and myalgia: Grade 1: no interference with activity, Grade 2: some interference with activity, Grade 3: significant; prevents daily activity; Arthralgia: Grade 1: free range of motion but complains of pain or discomfort, Grade 2: decreased range of motion due to pain or discomfort, Grade 3: unwilling to move due to pain.</description>
        <time_frame>Day 0 to Day 6 after any vaccination</time_frame>
        <population>Analysis was performed on all participants who received vaccine and were evaluable for reactogenicity. Here, ‘number analyzed’ = participants with available data for each specified category.</population>
        <group_list>
          <group group_id="O1">
            <title>C. Difficile Vaccine Group</title>
            <description>Participants received 1 injection of 0.5 mL C. difficile toxoid vaccine at Days 0 (Injection 1), 7 (Injection 2), and 30 (Injection 3).</description>
          </group>
          <group group_id="O2">
            <title>Placebo Group</title>
            <description>Participants received 1 injection of 0.5 mL placebo matched to vaccine at Days 0 (Injection 1), 7 (Injection 2), and 30 (Injection 3).</description>
          </group>
        </group_list>
        <measure>
          <title>Percentage of Participants Reporting Solicited Injection Site and Systemic Reactions</title>
          <description>Solicited injection site reactions: pain, erythema, and swelling. Pain: Grade 1: no interference with activity, Grade 2: some interference with activity, Grade 3: significant; prevents daily activity; Erythema and swelling: Grade 1: &gt;= 25 to &lt;=50 mm, Grade 2: &gt;51 to &lt;=100 mm, Grade 3: &gt;100 mm. Solicited systemic reactions: fever, headache, malaise, myalgia, and arthralgia. Fever: Grade 1: &gt;= 38.0°C to &lt;=38.4°C or &gt;= 100.4° Fahrenheit (F) to &lt;=101.1°F, Grade 2: &gt;=38.5°C to &lt;= 38.9°C or &gt;=101.2°F to &lt;=102.0°F, Grade 3: &gt;=39.0°C or &gt;=102.1°F. Headache, malaise, and myalgia: Grade 1: no interference with activity, Grade 2: some interference with activity, Grade 3: significant; prevents daily activity; Arthralgia: Grade 1: free range of motion but complains of pain or discomfort, Grade 2: decreased range of motion due to pain or discomfort, Grade 3: unwilling to move due to pain.</description>
          <population>Analysis was performed on all participants who received vaccine and were evaluable for reactogenicity. Here, ‘number analyzed’ = participants with available data for each specified category.</population>
          <units>percentage of participants</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="1227"/>
                <count group_id="O2" value="608"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Injection site Pain</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="1199"/>
                    <count group_id="O2" value="586"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="38.6"/>
                    <measurement group_id="O2" value="13.5"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Injection site Erythema</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="1196"/>
                    <count group_id="O2" value="587"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="4.2"/>
                    <measurement group_id="O2" value="0.0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Injection site Swelling</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="1197"/>
                    <count group_id="O2" value="587"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="3.8"/>
                    <measurement group_id="O2" value="0.3"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Fever</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="1173"/>
                    <count group_id="O2" value="577"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="4.8"/>
                    <measurement group_id="O2" value="5.7"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Headache</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="1196"/>
                    <count group_id="O2" value="586"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="25.3"/>
                    <measurement group_id="O2" value="22.5"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Malaise</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="1196"/>
                    <count group_id="O2" value="586"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="23.9"/>
                    <measurement group_id="O2" value="19.6"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Myalgia</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="1196"/>
                    <count group_id="O2" value="586"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="26.6"/>
                    <measurement group_id="O2" value="21.2"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Arthralgia</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="1196"/>
                    <count group_id="O2" value="586"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="19.5"/>
                    <measurement group_id="O2" value="16.7"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
    </outcome_list>

    <reported_events>
      <time_frame>Adverse events data was collected throughout the study (up to 3 years).</time_frame>
      <desc>Safety Analysis Set included all participants who received at least one study or control vaccine and were analyzed according to the vaccine received. Solicited reaction(SR) was an adverse event (AE) that was prelisted (i.e.,solicited) in the electronic case report form (eCRF) and considered to be related to vaccination. An unsolicited AE was an observed AE that did not fulfill the conditions prelisted (i.e.,solicited) in the eCRF in terms of symptom and/or onset post-vaccination.</desc>
      <group_list>
        <group group_id="E1">
          <title>C. Difficile Vaccine Group</title>
          <description>Participants received 1 injection of 0.5 mL C. difficile toxoid vaccine at Days 0 (Injection 1), 7 (Injection 2), and 30 (Injection 3).</description>
        </group>
        <group group_id="E2">
          <title>Placebo Group</title>
          <description>Participants received 1 injection of 0.5 mL placebo matched to vaccine at Days 0 (Injection 1), 7 (Injection 2), and 30 (Injection 3).</description>
        </group>
      </group_list>
      <serious_events>
        <default_vocab>MedDra 16.0</default_vocab>
        <default_assessment>Systematic Assessment</default_assessment>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, all-cause mortality</sub_title>
                <counts group_id="E1" subjects_affected="255" subjects_at_risk="6113"/>
                <counts group_id="E2" subjects_affected="127" subjects_at_risk="3057"/>
              </event>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="1662" subjects_at_risk="6113"/>
                <counts group_id="E2" subjects_affected="851" subjects_at_risk="3057"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Blood and lymphatic system disorders</title>
            <event_list>
              <event>
                <sub_title>Anaemia</sub_title>
                <counts group_id="E1" events="20" subjects_affected="19" subjects_at_risk="6113"/>
                <counts group_id="E2" events="13" subjects_affected="11" subjects_at_risk="3057"/>
              </event>
              <event>
                <sub_title>Antiphospholipid Syndrome</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="6113"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3057"/>
              </event>
              <event>
                <sub_title>Coagulopathy</sub_title>
                <counts group_id="E1" events="4" subjects_affected="4" subjects_at_risk="6113"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3057"/>
              </event>
              <event>
                <sub_title>Haemolytic Anaemia</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="6113"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3057"/>
              </event>
              <event>
                <sub_title>Haemorrhagic Anaemia</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="6113"/>
                <counts group_id="E2" events="5" subjects_affected="5" subjects_at_risk="3057"/>
              </event>
              <event>
                <sub_title>Iron Deficiency Anaemia</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="6113"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3057"/>
              </event>
              <event>
                <sub_title>Microcytic Anaemia</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="6113"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3057"/>
              </event>
              <event>
                <sub_title>Nephrogenic Anaemia</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="6113"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3057"/>
              </event>
              <event>
                <sub_title>Normochromic Normocytic Anaemia</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="6113"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3057"/>
              </event>
              <event>
                <sub_title>Thrombocytosis</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="6113"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3057"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Cardiac disorders</title>
            <event_list>
              <event>
                <sub_title>Acute Coronary Syndrome</sub_title>
                <counts group_id="E1" events="15" subjects_affected="13" subjects_at_risk="6113"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="3057"/>
              </event>
              <event>
                <sub_title>Acute Myocardial Infarction</sub_title>
                <counts group_id="E1" events="59" subjects_affected="56" subjects_at_risk="6113"/>
                <counts group_id="E2" events="24" subjects_affected="22" subjects_at_risk="3057"/>
              </event>
              <event>
                <sub_title>Angina Pectoris</sub_title>
                <counts group_id="E1" events="20" subjects_affected="19" subjects_at_risk="6113"/>
                <counts group_id="E2" events="10" subjects_affected="10" subjects_at_risk="3057"/>
              </event>
              <event>
                <sub_title>Angina Unstable</sub_title>
                <counts group_id="E1" events="32" subjects_affected="27" subjects_at_risk="6113"/>
                <counts group_id="E2" events="15" subjects_affected="9" subjects_at_risk="3057"/>
              </event>
              <event>
                <sub_title>Aortic Valve Incompetence</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="6113"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3057"/>
              </event>
              <event>
                <sub_title>Aortic Valve Stenosis</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="6113"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3057"/>
              </event>
              <event>
                <sub_title>Arrhythmia</sub_title>
                <counts group_id="E1" events="9" subjects_affected="9" subjects_at_risk="6113"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="3057"/>
              </event>
              <event>
                <sub_title>Arrhythmia Supraventricular</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="6113"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3057"/>
              </event>
              <event>
                <sub_title>Arteriosclerosis Coronary Artery</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="6113"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3057"/>
              </event>
              <event>
                <sub_title>Atrial Fibrillation</sub_title>
                <counts group_id="E1" events="53" subjects_affected="42" subjects_at_risk="6113"/>
                <counts group_id="E2" events="15" subjects_affected="14" subjects_at_risk="3057"/>
              </event>
              <event>
                <sub_title>Atrial Flutter</sub_title>
                <counts group_id="E1" events="3" subjects_affected="3" subjects_at_risk="6113"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="3057"/>
              </event>
              <event>
                <sub_title>Atrial Tachycardia</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="6113"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3057"/>
              </event>
              <event>
                <sub_title>Atrial Thrombosis</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="6113"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3057"/>
              </event>
              <event>
                <sub_title>Atrioventricular Block</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="6113"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3057"/>
              </event>
              <event>
                <sub_title>Atrioventricular Block Complete</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="6113"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="3057"/>
              </event>
              <event>
                <sub_title>Bradyarrhythmia</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="6113"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3057"/>
              </event>
              <event>
                <sub_title>Bradycardia</sub_title>
                <counts group_id="E1" events="6" subjects_affected="5" subjects_at_risk="6113"/>
                <counts group_id="E2" events="5" subjects_affected="5" subjects_at_risk="3057"/>
              </event>
              <event>
                <sub_title>Bundle Branch Block Left</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="6113"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3057"/>
              </event>
              <event>
                <sub_title>Cardiac Arrest</sub_title>
                <counts group_id="E1" events="11" subjects_affected="10" subjects_at_risk="6113"/>
                <counts group_id="E2" events="8" subjects_affected="8" subjects_at_risk="3057"/>
              </event>
              <event>
                <sub_title>Cardiac Disorder</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="6113"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3057"/>
              </event>
              <event>
                <sub_title>Cardiac Failure</sub_title>
                <counts group_id="E1" events="40" subjects_affected="34" subjects_at_risk="6113"/>
                <counts group_id="E2" events="36" subjects_affected="16" subjects_at_risk="3057"/>
              </event>
              <event>
                <sub_title>Cardiac Failure Acute</sub_title>
                <counts group_id="E1" events="22" subjects_affected="16" subjects_at_risk="6113"/>
                <counts group_id="E2" events="7" subjects_affected="6" subjects_at_risk="3057"/>
              </event>
              <event>
                <sub_title>Cardiac Failure Chronic</sub_title>
                <counts group_id="E1" events="5" subjects_affected="3" subjects_at_risk="6113"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3057"/>
              </event>
              <event>
                <sub_title>Cardiac Failure Congestive</sub_title>
                <counts group_id="E1" events="102" subjects_affected="69" subjects_at_risk="6113"/>
                <counts group_id="E2" events="37" subjects_affected="29" subjects_at_risk="3057"/>
              </event>
              <event>
                <sub_title>Cardiac Tamponade</sub_title>
                <counts group_id="E1" events="6" subjects_affected="6" subjects_at_risk="6113"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="3057"/>
              </event>
              <event>
                <sub_title>Cardiac Valve Disease</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="6113"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3057"/>
              </event>
              <event>
                <sub_title>Cardio-Respiratory Arrest</sub_title>
                <counts group_id="E1" events="11" subjects_affected="10" subjects_at_risk="6113"/>
                <counts group_id="E2" events="3" subjects_affected="3" subjects_at_risk="3057"/>
              </event>
              <event>
                <sub_title>Cardiogenic Shock</sub_title>
                <counts group_id="E1" events="9" subjects_affected="8" subjects_at_risk="6113"/>
                <counts group_id="E2" events="5" subjects_affected="5" subjects_at_risk="3057"/>
              </event>
              <event>
                <sub_title>Cardiomyopathy</sub_title>
                <counts group_id="E1" events="6" subjects_affected="5" subjects_at_risk="6113"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3057"/>
              </event>
              <event>
                <sub_title>Cardiopulmonary Failure</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="6113"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3057"/>
              </event>
              <event>
                <sub_title>Cardiorenal Syndrome</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="6113"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3057"/>
              </event>
              <event>
                <sub_title>Cor Pulmonale</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="6113"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3057"/>
              </event>
              <event>
                <sub_title>Coronary Artery Disease</sub_title>
                <counts group_id="E1" events="23" subjects_affected="22" subjects_at_risk="6113"/>
                <counts group_id="E2" events="7" subjects_affected="7" subjects_at_risk="3057"/>
              </event>
              <event>
                <sub_title>Coronary Artery Occlusion</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="6113"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3057"/>
              </event>
              <event>
                <sub_title>Coronary Artery Stenosis</sub_title>
                <counts group_id="E1" events="8" subjects_affected="7" subjects_at_risk="6113"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="3057"/>
              </event>
              <event>
                <sub_title>Coronary Artery Thrombosis</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="6113"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3057"/>
              </event>
              <event>
                <sub_title>Heart Valve Incompetence</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="6113"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3057"/>
              </event>
              <event>
                <sub_title>Hypertensive Heart Disease</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="6113"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3057"/>
              </event>
              <event>
                <sub_title>Intracardiac Thrombus</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="6113"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="3057"/>
              </event>
              <event>
                <sub_title>Ischaemic Cardiomyopathy</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="6113"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="3057"/>
              </event>
              <event>
                <sub_title>Left Ventricular Failure</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="6113"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3057"/>
              </event>
              <event>
                <sub_title>Mitral Valve Incompetence</sub_title>
                <counts group_id="E1" events="3" subjects_affected="3" subjects_at_risk="6113"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3057"/>
              </event>
              <event>
                <sub_title>Myocardial Infarction</sub_title>
                <counts group_id="E1" events="27" subjects_affected="27" subjects_at_risk="6113"/>
                <counts group_id="E2" events="16" subjects_affected="16" subjects_at_risk="3057"/>
              </event>
              <event>
                <sub_title>Myocardial Ischaemia</sub_title>
                <counts group_id="E1" events="8" subjects_affected="8" subjects_at_risk="6113"/>
                <counts group_id="E2" events="3" subjects_affected="3" subjects_at_risk="3057"/>
              </event>
              <event>
                <sub_title>Palpitations</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="6113"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3057"/>
              </event>
              <event>
                <sub_title>Pericardial Effusion</sub_title>
                <counts group_id="E1" events="5" subjects_affected="5" subjects_at_risk="6113"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3057"/>
              </event>
              <event>
                <sub_title>Pericarditis</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="6113"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="3057"/>
              </event>
              <event>
                <sub_title>Prinzmetal Angina</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="6113"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3057"/>
              </event>
              <event>
                <sub_title>Pulseless Electrical Activity</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="6113"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3057"/>
              </event>
              <event>
                <sub_title>Reperfusion Arrhythmia</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="6113"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3057"/>
              </event>
              <event>
                <sub_title>Right Ventricular Failure</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="6113"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3057"/>
              </event>
              <event>
                <sub_title>Sick Sinus Syndrome</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="6113"/>
                <counts group_id="E2" events="3" subjects_affected="3" subjects_at_risk="3057"/>
              </event>
              <event>
                <sub_title>Sinoatrial Block</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="6113"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3057"/>
              </event>
              <event>
                <sub_title>Sinus Bradycardia</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="6113"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3057"/>
              </event>
              <event>
                <sub_title>Stress Cardiomyopathy</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="6113"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3057"/>
              </event>
              <event>
                <sub_title>Supraventricular Tachyarrhythmia</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="6113"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3057"/>
              </event>
              <event>
                <sub_title>Supraventricular Tachycardia</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="6113"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3057"/>
              </event>
              <event>
                <sub_title>Tachyarrhythmia</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="6113"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3057"/>
              </event>
              <event>
                <sub_title>Tachycardia</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="6113"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="3057"/>
              </event>
              <event>
                <sub_title>Tricuspid Valve Incompetence</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="6113"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3057"/>
              </event>
              <event>
                <sub_title>Ventricle Rupture</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="6113"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3057"/>
              </event>
              <event>
                <sub_title>Ventricular Arrhythmia</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="6113"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3057"/>
              </event>
              <event>
                <sub_title>Ventricular Fibrillation</sub_title>
                <counts group_id="E1" events="3" subjects_affected="3" subjects_at_risk="6113"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3057"/>
              </event>
              <event>
                <sub_title>Ventricular Tachycardia</sub_title>
                <counts group_id="E1" events="5" subjects_affected="5" subjects_at_risk="6113"/>
                <counts group_id="E2" events="4" subjects_affected="4" subjects_at_risk="3057"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Congenital, familial and genetic disorders</title>
            <event_list>
              <event>
                <sub_title>Anophthalmos</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="6113"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3057"/>
              </event>
              <event>
                <sub_title>Cardiac Septal Defect</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="6113"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3057"/>
              </event>
              <event>
                <sub_title>Ectopic Ureter</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="6113"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3057"/>
              </event>
              <event>
                <sub_title>Hydrocele</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="6113"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3057"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Ear and labyrinth disorders</title>
            <event_list>
              <event>
                <sub_title>Deafness Neurosensory</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="6113"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3057"/>
              </event>
              <event>
                <sub_title>Meniere's Disease</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="6113"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3057"/>
              </event>
              <event>
                <sub_title>Sudden Hearing Loss</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="6113"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3057"/>
              </event>
              <event>
                <sub_title>Vertigo</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="6113"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3057"/>
              </event>
              <event>
                <sub_title>Vertigo Positional</sub_title>
                <counts group_id="E1" events="4" subjects_affected="4" subjects_at_risk="6113"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3057"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Endocrine disorders</title>
            <event_list>
              <event>
                <sub_title>Adrenal Insufficiency</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="6113"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3057"/>
              </event>
              <event>
                <sub_title>Goitre</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="6113"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3057"/>
              </event>
              <event>
                <sub_title>Hyperparathyroidism</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="6113"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3057"/>
              </event>
              <event>
                <sub_title>Hyperparathyroidism Primary</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="6113"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3057"/>
              </event>
              <event>
                <sub_title>Thyroid Mass</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="6113"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3057"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Eye disorders</title>
            <event_list>
              <event>
                <sub_title>Amaurosis</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="6113"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3057"/>
              </event>
              <event>
                <sub_title>Amaurosis Fugax</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="6113"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3057"/>
              </event>
              <event>
                <sub_title>Aphakia</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="6113"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3057"/>
              </event>
              <event>
                <sub_title>Cataract</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="6113"/>
                <counts group_id="E2" events="3" subjects_affected="2" subjects_at_risk="3057"/>
              </event>
              <event>
                <sub_title>Conjunctivochalasis</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="6113"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3057"/>
              </event>
              <event>
                <sub_title>Eyelid Ptosis</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="6113"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3057"/>
              </event>
              <event>
                <sub_title>Glaucoma</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="6113"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3057"/>
              </event>
              <event>
                <sub_title>Phacolytic Glaucoma</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="6113"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3057"/>
              </event>
              <event>
                <sub_title>Pterygium</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="6113"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3057"/>
              </event>
              <event>
                <sub_title>Retinal Detachment</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="6113"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3057"/>
              </event>
              <event>
                <sub_title>Retinal Vein Occlusion</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="6113"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3057"/>
              </event>
              <event>
                <sub_title>Vitreous Haemorrhage</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="6113"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3057"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Gastrointestinal disorders</title>
            <event_list>
              <event>
                <sub_title>Abdominal Adhesions</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="6113"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3057"/>
              </event>
              <event>
                <sub_title>Abdominal Hernia</sub_title>
                <counts group_id="E1" events="3" subjects_affected="3" subjects_at_risk="6113"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3057"/>
              </event>
              <event>
                <sub_title>Abdominal Pain</sub_title>
                <counts group_id="E1" events="14" subjects_affected="14" subjects_at_risk="6113"/>
                <counts group_id="E2" events="15" subjects_affected="11" subjects_at_risk="3057"/>
              </event>
              <event>
                <sub_title>Abdominal Pain Lower</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="6113"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3057"/>
              </event>
              <event>
                <sub_title>Abdominal Pain Upper</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="6113"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="3057"/>
              </event>
              <event>
                <sub_title>Abdominal Wall Haematoma</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="6113"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3057"/>
              </event>
              <event>
                <sub_title>Anal Fissure</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="6113"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3057"/>
              </event>
              <event>
                <sub_title>Anal Fistula</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="6113"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3057"/>
              </event>
              <event>
                <sub_title>Ascites</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="6113"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3057"/>
              </event>
              <event>
                <sub_title>Change Of Bowel Habit</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="6113"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3057"/>
              </event>
              <event>
                <sub_title>Colitis</sub_title>
                <counts group_id="E1" events="5" subjects_affected="5" subjects_at_risk="6113"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3057"/>
              </event>
              <event>
                <sub_title>Colitis Ischaemic</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="6113"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="3057"/>
              </event>
              <event>
                <sub_title>Colitis Microscopic</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="6113"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3057"/>
              </event>
              <event>
                <sub_title>Colonic Pseudo-Obstruction</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="6113"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3057"/>
              </event>
              <event>
                <sub_title>Colonic Stenosis</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="6113"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3057"/>
              </event>
              <event>
                <sub_title>Constipation</sub_title>
                <counts group_id="E1" events="9" subjects_affected="9" subjects_at_risk="6113"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="3057"/>
              </event>
              <event>
                <sub_title>Crohn's Disease</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="6113"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3057"/>
              </event>
              <event>
                <sub_title>Dental Pulp Disorder</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="6113"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3057"/>
              </event>
              <event>
                <sub_title>Diabetic Gastroparesis</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="6113"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3057"/>
              </event>
              <event>
                <sub_title>Diaphragmatic Hernia</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="6113"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3057"/>
              </event>
              <event>
                <sub_title>Diarrhoea</sub_title>
                <counts group_id="E1" events="8" subjects_affected="8" subjects_at_risk="6113"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="3057"/>
              </event>
              <event>
                <sub_title>Diverticular Perforation</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="6113"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3057"/>
              </event>
              <event>
                <sub_title>Diverticulum</sub_title>
                <counts group_id="E1" events="5" subjects_affected="4" subjects_at_risk="6113"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3057"/>
              </event>
              <event>
                <sub_title>Duodenal Ulcer</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="6113"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3057"/>
              </event>
              <event>
                <sub_title>Duodenal Ulcer Haemorrhage</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="6113"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3057"/>
              </event>
              <event>
                <sub_title>Dyspepsia</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="6113"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3057"/>
              </event>
              <event>
                <sub_title>Enterovesical Fistula</sub_title>
                <counts group_id="E1" events="2" subjects_affected="1" subjects_at_risk="6113"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3057"/>
              </event>
              <event>
                <sub_title>Erosive Duodenitis</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="6113"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3057"/>
              </event>
              <event>
                <sub_title>Erosive Oesophagitis</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="6113"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3057"/>
              </event>
              <event>
                <sub_title>Faecaloma</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="6113"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3057"/>
              </event>
              <event>
                <sub_title>Food Poisoning</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="6113"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3057"/>
              </event>
              <event>
                <sub_title>Gastric Disorder</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="6113"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3057"/>
              </event>
              <event>
                <sub_title>Gastric Haemorrhage</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="6113"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="3057"/>
              </event>
              <event>
                <sub_title>Gastric Ulcer</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="6113"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="3057"/>
              </event>
              <event>
                <sub_title>Gastric Ulcer Haemorrhage</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="6113"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3057"/>
              </event>
              <event>
                <sub_title>Gastric Ulcer Perforation</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="6113"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3057"/>
              </event>
              <event>
                <sub_title>Gastritis</sub_title>
                <counts group_id="E1" events="8" subjects_affected="8" subjects_at_risk="6113"/>
                <counts group_id="E2" events="5" subjects_affected="4" subjects_at_risk="3057"/>
              </event>
              <event>
                <sub_title>Gastritis Erosive</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="6113"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3057"/>
              </event>
              <event>
                <sub_title>Gastritis Haemorrhagic</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="6113"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3057"/>
              </event>
              <event>
                <sub_title>Gastroduodenal Ulcer</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="6113"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3057"/>
              </event>
              <event>
                <sub_title>Gastrointestinal Amyloidosis</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="6113"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3057"/>
              </event>
              <event>
                <sub_title>Gastrointestinal Haemorrhage</sub_title>
                <counts group_id="E1" events="13" subjects_affected="13" subjects_at_risk="6113"/>
                <counts group_id="E2" events="6" subjects_affected="6" subjects_at_risk="3057"/>
              </event>
              <event>
                <sub_title>Gastrointestinal Hypomotility</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="6113"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3057"/>
              </event>
              <event>
                <sub_title>Gastrointestinal Obstruction</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="6113"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3057"/>
              </event>
              <event>
                <sub_title>Gastrooesophageal Reflux Disease</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="6113"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3057"/>
              </event>
              <event>
                <sub_title>Haematemesis</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="6113"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3057"/>
              </event>
              <event>
                <sub_title>Haemorrhoids</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="6113"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3057"/>
              </event>
              <event>
                <sub_title>Hernial Eventration</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="6113"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3057"/>
              </event>
              <event>
                <sub_title>Hiatus Hernia</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="6113"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3057"/>
              </event>
              <event>
                <sub_title>Ileal Stenosis</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="6113"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3057"/>
              </event>
              <event>
                <sub_title>Ileus</sub_title>
                <counts group_id="E1" events="6" subjects_affected="6" subjects_at_risk="6113"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="3057"/>
              </event>
              <event>
                <sub_title>Ileus Paralytic</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="6113"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3057"/>
              </event>
              <event>
                <sub_title>Impaired Gastric Emptying</sub_title>
                <counts group_id="E1" events="5" subjects_affected="1" subjects_at_risk="6113"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3057"/>
              </event>
              <event>
                <sub_title>Inguinal Hernia</sub_title>
                <counts group_id="E1" events="4" subjects_affected="4" subjects_at_risk="6113"/>
                <counts group_id="E2" events="3" subjects_affected="3" subjects_at_risk="3057"/>
              </event>
              <event>
                <sub_title>Inguinal Hernia, Obstructive</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="6113"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3057"/>
              </event>
              <event>
                <sub_title>Intestinal Haemorrhage</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="6113"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3057"/>
              </event>
              <event>
                <sub_title>Intestinal Obstruction</sub_title>
                <counts group_id="E1" events="7" subjects_affected="6" subjects_at_risk="6113"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3057"/>
              </event>
              <event>
                <sub_title>Intestinal Perforation</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="6113"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3057"/>
              </event>
              <event>
                <sub_title>Intra-Abdominal Haemorrhage</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="6113"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3057"/>
              </event>
              <event>
                <sub_title>Large Intestinal Obstruction</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="6113"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3057"/>
              </event>
              <event>
                <sub_title>Large Intestine Polyp</sub_title>
                <counts group_id="E1" events="5" subjects_affected="5" subjects_at_risk="6113"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3057"/>
              </event>
              <event>
                <sub_title>Lower Gastrointestinal Haemorrhage</sub_title>
                <counts group_id="E1" events="4" subjects_affected="4" subjects_at_risk="6113"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3057"/>
              </event>
              <event>
                <sub_title>Melaena</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="6113"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="3057"/>
              </event>
              <event>
                <sub_title>Mesenteric Artery Thrombosis</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="6113"/>
                <counts group_id="E2" events="2" subjects_affected="1" subjects_at_risk="3057"/>
              </event>
              <event>
                <sub_title>Mesenteric Vein Thrombosis</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="6113"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3057"/>
              </event>
              <event>
                <sub_title>Nausea</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="6113"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3057"/>
              </event>
              <event>
                <sub_title>Oesophageal Obstruction</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="6113"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3057"/>
              </event>
              <event>
                <sub_title>Oesophageal Stenosis</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="6113"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3057"/>
              </event>
              <event>
                <sub_title>Oesophageal Varices Haemorrhage</sub_title>
                <counts group_id="E1" events="3" subjects_affected="2" subjects_at_risk="6113"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3057"/>
              </event>
              <event>
                <sub_title>Oesophagitis</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="6113"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3057"/>
              </event>
              <event>
                <sub_title>Oral Disorder</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="6113"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3057"/>
              </event>
              <event>
                <sub_title>Pancreatic Pseudocyst</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="6113"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3057"/>
              </event>
              <event>
                <sub_title>Pancreatitis</sub_title>
                <counts group_id="E1" events="7" subjects_affected="6" subjects_at_risk="6113"/>
                <counts group_id="E2" events="3" subjects_affected="3" subjects_at_risk="3057"/>
              </event>
              <event>
                <sub_title>Pancreatitis Acute</sub_title>
                <counts group_id="E1" events="5" subjects_affected="4" subjects_at_risk="6113"/>
                <counts group_id="E2" events="6" subjects_affected="6" subjects_at_risk="3057"/>
              </event>
              <event>
                <sub_title>Pancreatitis Chronic</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="6113"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3057"/>
              </event>
              <event>
                <sub_title>Pancreatitis Relapsing</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="6113"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3057"/>
              </event>
              <event>
                <sub_title>Peptic Ulcer</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="6113"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="3057"/>
              </event>
              <event>
                <sub_title>Periodontal Disease</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="6113"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3057"/>
              </event>
              <event>
                <sub_title>Peritoneal Adhesions</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="6113"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3057"/>
              </event>
              <event>
                <sub_title>Peritoneal Haemorrhage</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="6113"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3057"/>
              </event>
              <event>
                <sub_title>Proctalgia</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="6113"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3057"/>
              </event>
              <event>
                <sub_title>Rectal Haemorrhage</sub_title>
                <counts group_id="E1" events="4" subjects_affected="4" subjects_at_risk="6113"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="3057"/>
              </event>
              <event>
                <sub_title>Rectal Prolapse</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="6113"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3057"/>
              </event>
              <event>
                <sub_title>Small Intestinal Obstruction</sub_title>
                <counts group_id="E1" events="5" subjects_affected="5" subjects_at_risk="6113"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="3057"/>
              </event>
              <event>
                <sub_title>Spigelian Hernia</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="6113"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3057"/>
              </event>
              <event>
                <sub_title>Subileus</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="6113"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3057"/>
              </event>
              <event>
                <sub_title>Thrombosis Mesenteric Vessel</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="6113"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3057"/>
              </event>
              <event>
                <sub_title>Umbilical Hernia</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="6113"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3057"/>
              </event>
              <event>
                <sub_title>Umbilical Hernia, Obstructive</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="6113"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3057"/>
              </event>
              <event>
                <sub_title>Upper Gastrointestinal Haemorrhage</sub_title>
                <counts group_id="E1" events="5" subjects_affected="5" subjects_at_risk="6113"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="3057"/>
              </event>
              <event>
                <sub_title>Varices Oesophageal</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="6113"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3057"/>
              </event>
              <event>
                <sub_title>Volvulus</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="6113"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3057"/>
              </event>
              <event>
                <sub_title>Vomiting</sub_title>
                <counts group_id="E1" events="4" subjects_affected="4" subjects_at_risk="6113"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="3057"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>General disorders</title>
            <event_list>
              <event>
                <sub_title>Asthenia</sub_title>
                <counts group_id="E1" events="4" subjects_affected="4" subjects_at_risk="6113"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="3057"/>
              </event>
              <event>
                <sub_title>Catheter Site Haemorrhage</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="6113"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3057"/>
              </event>
              <event>
                <sub_title>Chest Discomfort</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="6113"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3057"/>
              </event>
              <event>
                <sub_title>Chest Pain</sub_title>
                <counts group_id="E1" events="56" subjects_affected="50" subjects_at_risk="6113"/>
                <counts group_id="E2" events="27" subjects_affected="19" subjects_at_risk="3057"/>
              </event>
              <event>
                <sub_title>Death</sub_title>
                <counts group_id="E1" events="8" subjects_affected="8" subjects_at_risk="6113"/>
                <counts group_id="E2" events="6" subjects_affected="6" subjects_at_risk="3057"/>
              </event>
              <event>
                <sub_title>Device Dislocation</sub_title>
                <counts group_id="E1" events="9" subjects_affected="9" subjects_at_risk="6113"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3057"/>
              </event>
              <event>
                <sub_title>Device Failure</sub_title>
                <counts group_id="E1" events="3" subjects_affected="3" subjects_at_risk="6113"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="3057"/>
              </event>
              <event>
                <sub_title>Device Issue</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="6113"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3057"/>
              </event>
              <event>
                <sub_title>Device Leakage</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="6113"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3057"/>
              </event>
              <event>
                <sub_title>Device Malfunction</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="6113"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3057"/>
              </event>
              <event>
                <sub_title>Device Occlusion</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="6113"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3057"/>
              </event>
              <event>
                <sub_title>Drug Interaction</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="6113"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3057"/>
              </event>
              <event>
                <sub_title>Fatigue</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="6113"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3057"/>
              </event>
              <event>
                <sub_title>General Physical Health Deterioration</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="6113"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3057"/>
              </event>
              <event>
                <sub_title>General Symptom</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="6113"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3057"/>
              </event>
              <event>
                <sub_title>Generalised Oedema</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="6113"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3057"/>
              </event>
              <event>
                <sub_title>Hernia Obstructive</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="6113"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3057"/>
              </event>
              <event>
                <sub_title>Hyperthermia</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="6113"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3057"/>
              </event>
              <event>
                <sub_title>Impaired Healing</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="6113"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3057"/>
              </event>
              <event>
                <sub_title>Implant Site Haematoma</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="6113"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3057"/>
              </event>
              <event>
                <sub_title>Inflammation</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="6113"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3057"/>
              </event>
              <event>
                <sub_title>Malaise</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="6113"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3057"/>
              </event>
              <event>
                <sub_title>Medical Device Complication</sub_title>
                <counts group_id="E1" events="8" subjects_affected="7" subjects_at_risk="6113"/>
                <counts group_id="E2" events="4" subjects_affected="4" subjects_at_risk="3057"/>
              </event>
              <event>
                <sub_title>Multi-Organ Failure</sub_title>
                <counts group_id="E1" events="4" subjects_affected="4" subjects_at_risk="6113"/>
                <counts group_id="E2" events="3" subjects_affected="3" subjects_at_risk="3057"/>
              </event>
              <event>
                <sub_title>Non-Cardiac Chest Pain</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="6113"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="3057"/>
              </event>
              <event>
                <sub_title>Oedema</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="6113"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3057"/>
              </event>
              <event>
                <sub_title>Oedema Peripheral</sub_title>
                <counts group_id="E1" events="3" subjects_affected="3" subjects_at_risk="6113"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3057"/>
              </event>
              <event>
                <sub_title>Pain</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="6113"/>
                <counts group_id="E2" events="3" subjects_affected="3" subjects_at_risk="3057"/>
              </event>
              <event>
                <sub_title>Patient-Device Incompatibility</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="6113"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3057"/>
              </event>
              <event>
                <sub_title>Perforated Ulcer</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="6113"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3057"/>
              </event>
              <event>
                <sub_title>Polyp</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="6113"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3057"/>
              </event>
              <event>
                <sub_title>Pyrexia</sub_title>
                <counts group_id="E1" events="5" subjects_affected="5" subjects_at_risk="6113"/>
                <counts group_id="E2" events="3" subjects_affected="3" subjects_at_risk="3057"/>
              </event>
              <event>
                <sub_title>Spinal Pain</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="6113"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3057"/>
              </event>
              <event>
                <sub_title>Stent-Graft Endoleak</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="6113"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3057"/>
              </event>
              <event>
                <sub_title>Sudden Cardiac Death</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="6113"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3057"/>
              </event>
              <event>
                <sub_title>Sudden Death</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="6113"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3057"/>
              </event>
              <event>
                <sub_title>Surgical Failure</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="6113"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3057"/>
              </event>
              <event>
                <sub_title>Systemic Inflammatory Response Syndrome</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="6113"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="3057"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Hepatobiliary disorders</title>
            <event_list>
              <event>
                <sub_title>Bile Duct Obstruction</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="6113"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3057"/>
              </event>
              <event>
                <sub_title>Bile Duct Stenosis</sub_title>
                <counts group_id="E1" events="2" subjects_affected="1" subjects_at_risk="6113"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3057"/>
              </event>
              <event>
                <sub_title>Bile Duct Stone</sub_title>
                <counts group_id="E1" events="3" subjects_affected="3" subjects_at_risk="6113"/>
                <counts group_id="E2" events="3" subjects_affected="3" subjects_at_risk="3057"/>
              </event>
              <event>
                <sub_title>Cholangitis</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="6113"/>
                <counts group_id="E2" events="3" subjects_affected="3" subjects_at_risk="3057"/>
              </event>
              <event>
                <sub_title>Cholangitis Acute</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="6113"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3057"/>
              </event>
              <event>
                <sub_title>Cholecystitis</sub_title>
                <counts group_id="E1" events="7" subjects_affected="7" subjects_at_risk="6113"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3057"/>
              </event>
              <event>
                <sub_title>Cholecystitis Acute</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="6113"/>
                <counts group_id="E2" events="7" subjects_affected="7" subjects_at_risk="3057"/>
              </event>
              <event>
                <sub_title>Cholecystitis Chronic</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="6113"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3057"/>
              </event>
              <event>
                <sub_title>Cholelithiasis</sub_title>
                <counts group_id="E1" events="7" subjects_affected="7" subjects_at_risk="6113"/>
                <counts group_id="E2" events="6" subjects_affected="6" subjects_at_risk="3057"/>
              </event>
              <event>
                <sub_title>Cirrhosis Alcoholic</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="6113"/>
                <counts group_id="E2" events="2" subjects_affected="1" subjects_at_risk="3057"/>
              </event>
              <event>
                <sub_title>Gallbladder Polyp</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="6113"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3057"/>
              </event>
              <event>
                <sub_title>Hepatic Cirrhosis</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="6113"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3057"/>
              </event>
              <event>
                <sub_title>Hepatic Cyst</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="6113"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3057"/>
              </event>
              <event>
                <sub_title>Hepatic Failure</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="6113"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3057"/>
              </event>
              <event>
                <sub_title>Hepatitis</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="6113"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3057"/>
              </event>
              <event>
                <sub_title>Hepatitis Acute</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="6113"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3057"/>
              </event>
              <event>
                <sub_title>Hepatorenal Syndrome</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="6113"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3057"/>
              </event>
              <event>
                <sub_title>Hydrocholecystis</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="6113"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3057"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Immune system disorders</title>
            <event_list>
              <event>
                <sub_title>Anaphylactic Reaction</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="6113"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3057"/>
              </event>
              <event>
                <sub_title>Anaphylactic Shock</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="6113"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3057"/>
              </event>
              <event>
                <sub_title>Device Allergy</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="6113"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3057"/>
              </event>
              <event>
                <sub_title>Food Allergy</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="6113"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3057"/>
              </event>
              <event>
                <sub_title>Secondary Immunodeficiency</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="6113"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3057"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Infections and infestations</title>
            <event_list>
              <event>
                <sub_title>Abdominal Hernia Gangrenous</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="6113"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3057"/>
              </event>
              <event>
                <sub_title>Abdominal Infection</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="6113"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3057"/>
              </event>
              <event>
                <sub_title>Abdominal Sepsis</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="6113"/>
                <counts group_id="E2" events="3" subjects_affected="3" subjects_at_risk="3057"/>
              </event>
              <event>
                <sub_title>Abdominal Wall Abscess</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="6113"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3057"/>
              </event>
              <event>
                <sub_title>Abscess</sub_title>
                <counts group_id="E1" events="5" subjects_affected="4" subjects_at_risk="6113"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3057"/>
              </event>
              <event>
                <sub_title>Abscess Limb</sub_title>
                <counts group_id="E1" events="4" subjects_affected="4" subjects_at_risk="6113"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="3057"/>
              </event>
              <event>
                <sub_title>Anal Abscess</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="6113"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3057"/>
              </event>
              <event>
                <sub_title>Appendicitis</sub_title>
                <counts group_id="E1" events="5" subjects_affected="5" subjects_at_risk="6113"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="3057"/>
              </event>
              <event>
                <sub_title>Appendicitis Perforated</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="6113"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3057"/>
              </event>
              <event>
                <sub_title>Arteriovenous Graft Site Abscess</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="6113"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3057"/>
              </event>
              <event>
                <sub_title>Arthritis Bacterial</sub_title>
                <counts group_id="E1" events="11" subjects_affected="11" subjects_at_risk="6113"/>
                <counts group_id="E2" events="3" subjects_affected="3" subjects_at_risk="3057"/>
              </event>
              <event>
                <sub_title>Arthritis Infective</sub_title>
                <counts group_id="E1" events="9" subjects_affected="8" subjects_at_risk="6113"/>
                <counts group_id="E2" events="4" subjects_affected="3" subjects_at_risk="3057"/>
              </event>
              <event>
                <sub_title>Asymptomatic Bacteriuria</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="6113"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3057"/>
              </event>
              <event>
                <sub_title>Atypical Mycobacterial Infection</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="6113"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3057"/>
              </event>
              <event>
                <sub_title>Bacteraemia</sub_title>
                <counts group_id="E1" events="9" subjects_affected="8" subjects_at_risk="6113"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="3057"/>
              </event>
              <event>
                <sub_title>Bacterial Infection</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="6113"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3057"/>
              </event>
              <event>
                <sub_title>Bacterial Sepsis</sub_title>
                <counts group_id="E1" events="4" subjects_affected="4" subjects_at_risk="6113"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3057"/>
              </event>
              <event>
                <sub_title>Bacterial Tracheitis</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="6113"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3057"/>
              </event>
              <event>
                <sub_title>Beta Haemolytic Streptococcal Infection</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="6113"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3057"/>
              </event>
              <event>
                <sub_title>Biliary Sepsis</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="6113"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3057"/>
              </event>
              <event>
                <sub_title>Breast Abscess</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="6113"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3057"/>
              </event>
              <event>
                <sub_title>Breast Cellulitis</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="6113"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3057"/>
              </event>
              <event>
                <sub_title>Bronchitis</sub_title>
                <counts group_id="E1" events="11" subjects_affected="11" subjects_at_risk="6113"/>
                <counts group_id="E2" events="3" subjects_affected="3" subjects_at_risk="3057"/>
              </event>
              <event>
                <sub_title>Bronchopneumonia</sub_title>
                <counts group_id="E1" events="3" subjects_affected="3" subjects_at_risk="6113"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3057"/>
              </event>
              <event>
                <sub_title>Bursitis Infective</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="6113"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3057"/>
              </event>
              <event>
                <sub_title>Candida Sepsis</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="6113"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3057"/>
              </event>
              <event>
                <sub_title>Cellulitis</sub_title>
                <counts group_id="E1" events="78" subjects_affected="63" subjects_at_risk="6113"/>
                <counts group_id="E2" events="41" subjects_affected="36" subjects_at_risk="3057"/>
              </event>
              <event>
                <sub_title>Chronic Hepatitis C</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="6113"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3057"/>
              </event>
              <event>
                <sub_title>Clostridium Difficile Colitis</sub_title>
                <counts group_id="E1" events="3" subjects_affected="3" subjects_at_risk="6113"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3057"/>
              </event>
              <event>
                <sub_title>Clostridium Difficile Infection</sub_title>
                <counts group_id="E1" events="3" subjects_affected="3" subjects_at_risk="6113"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3057"/>
              </event>
              <event>
                <sub_title>Dengue Fever</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="6113"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="3057"/>
              </event>
              <event>
                <sub_title>Dermo-Hypodermitis</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="6113"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3057"/>
              </event>
              <event>
                <sub_title>Device Related Infection</sub_title>
                <counts group_id="E1" events="22" subjects_affected="18" subjects_at_risk="6113"/>
                <counts group_id="E2" events="14" subjects_affected="12" subjects_at_risk="3057"/>
              </event>
              <event>
                <sub_title>Diabetic Foot Infection</sub_title>
                <counts group_id="E1" events="30" subjects_affected="26" subjects_at_risk="6113"/>
                <counts group_id="E2" events="9" subjects_affected="9" subjects_at_risk="3057"/>
              </event>
              <event>
                <sub_title>Diabetic Gangrene</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="6113"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3057"/>
              </event>
              <event>
                <sub_title>Diarrhoea Infectious</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="6113"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3057"/>
              </event>
              <event>
                <sub_title>Disseminated Tuberculosis</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="6113"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3057"/>
              </event>
              <event>
                <sub_title>Diverticulitis</sub_title>
                <counts group_id="E1" events="4" subjects_affected="4" subjects_at_risk="6113"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="3057"/>
              </event>
              <event>
                <sub_title>Empyema</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="6113"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="3057"/>
              </event>
              <event>
                <sub_title>Endocarditis</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="6113"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3057"/>
              </event>
              <event>
                <sub_title>Endocarditis Bacterial</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="6113"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3057"/>
              </event>
              <event>
                <sub_title>Enterobacter Pneumonia</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="6113"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3057"/>
              </event>
              <event>
                <sub_title>Enterocolitis Bacterial</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="6113"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3057"/>
              </event>
              <event>
                <sub_title>Enterocolitis Infectious</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="6113"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3057"/>
              </event>
              <event>
                <sub_title>Erysipelas</sub_title>
                <counts group_id="E1" events="3" subjects_affected="3" subjects_at_risk="6113"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3057"/>
              </event>
              <event>
                <sub_title>Escherichia Bacteraemia</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="6113"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3057"/>
              </event>
              <event>
                <sub_title>Escherichia Sepsis</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="6113"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3057"/>
              </event>
              <event>
                <sub_title>Escherichia Urinary Tract Infection</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="6113"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3057"/>
              </event>
              <event>
                <sub_title>Gangrene</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="6113"/>
                <counts group_id="E2" events="3" subjects_affected="1" subjects_at_risk="3057"/>
              </event>
              <event>
                <sub_title>Gastric Infection</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="6113"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3057"/>
              </event>
              <event>
                <sub_title>Gastroenteritis</sub_title>
                <counts group_id="E1" events="10" subjects_affected="10" subjects_at_risk="6113"/>
                <counts group_id="E2" events="6" subjects_affected="6" subjects_at_risk="3057"/>
              </event>
              <event>
                <sub_title>Gastroenteritis Viral</sub_title>
                <counts group_id="E1" events="3" subjects_affected="3" subjects_at_risk="6113"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3057"/>
              </event>
              <event>
                <sub_title>Genital Herpes</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="6113"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3057"/>
              </event>
              <event>
                <sub_title>Graft Infection</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="6113"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3057"/>
              </event>
              <event>
                <sub_title>Groin Abscess</sub_title>
                <counts group_id="E1" events="3" subjects_affected="3" subjects_at_risk="6113"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3057"/>
              </event>
              <event>
                <sub_title>Haematoma Infection</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="6113"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3057"/>
              </event>
              <event>
                <sub_title>Hepatic Cyst Infection</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="6113"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3057"/>
              </event>
              <event>
                <sub_title>Herpes Virus Infection</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="6113"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3057"/>
              </event>
              <event>
                <sub_title>Herpes Zoster</sub_title>
                <counts group_id="E1" events="3" subjects_affected="3" subjects_at_risk="6113"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3057"/>
              </event>
              <event>
                <sub_title>Implant Site Infection</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="6113"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3057"/>
              </event>
              <event>
                <sub_title>Incision Site Infection</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="6113"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3057"/>
              </event>
              <event>
                <sub_title>Infected Skin Ulcer</sub_title>
                <counts group_id="E1" events="3" subjects_affected="2" subjects_at_risk="6113"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="3057"/>
              </event>
              <event>
                <sub_title>Infection</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="6113"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3057"/>
              </event>
              <event>
                <sub_title>Infection In An Immunocompromised Host</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="6113"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3057"/>
              </event>
              <event>
                <sub_title>Infective Exacerbation Of Bronchiectasis</sub_title>
                <counts group_id="E1" events="6" subjects_affected="2" subjects_at_risk="6113"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3057"/>
              </event>
              <event>
                <sub_title>Infective Exacerbation Of Chronic Obstructive Airways Disease</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="6113"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3057"/>
              </event>
              <event>
                <sub_title>Infective Spondylitis</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="6113"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3057"/>
              </event>
              <event>
                <sub_title>Influenza</sub_title>
                <counts group_id="E1" events="5" subjects_affected="5" subjects_at_risk="6113"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="3057"/>
              </event>
              <event>
                <sub_title>Intervertebral Discitis</sub_title>
                <counts group_id="E1" events="3" subjects_affected="3" subjects_at_risk="6113"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3057"/>
              </event>
              <event>
                <sub_title>Joint Abscess</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="6113"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3057"/>
              </event>
              <event>
                <sub_title>Kidney Infection</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="6113"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3057"/>
              </event>
              <event>
                <sub_title>Liver Abscess</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="6113"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3057"/>
              </event>
              <event>
                <sub_title>Lobar Pneumonia</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="6113"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3057"/>
              </event>
              <event>
                <sub_title>Localised Infection</sub_title>
                <counts group_id="E1" events="4" subjects_affected="4" subjects_at_risk="6113"/>
                <counts group_id="E2" events="5" subjects_affected="4" subjects_at_risk="3057"/>
              </event>
              <event>
                <sub_title>Lower Respiratory Tract Infection</sub_title>
                <counts group_id="E1" events="7" subjects_affected="7" subjects_at_risk="6113"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="3057"/>
              </event>
              <event>
                <sub_title>Lower Respiratory Tract Infection Viral</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="6113"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3057"/>
              </event>
              <event>
                <sub_title>Lung Infection</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="6113"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3057"/>
              </event>
              <event>
                <sub_title>Mediastinitis</sub_title>
                <counts group_id="E1" events="4" subjects_affected="4" subjects_at_risk="6113"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="3057"/>
              </event>
              <event>
                <sub_title>Meningitis</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="6113"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3057"/>
              </event>
              <event>
                <sub_title>Mumps</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="6113"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3057"/>
              </event>
              <event>
                <sub_title>Mycobacterium Avium Complex Infection</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="6113"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3057"/>
              </event>
              <event>
                <sub_title>Nail Infection</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="6113"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3057"/>
              </event>
              <event>
                <sub_title>Neurological Infection</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="6113"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3057"/>
              </event>
              <event>
                <sub_title>Neurosyphilis</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="6113"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3057"/>
              </event>
              <event>
                <sub_title>Orchitis</sub_title>
                <counts group_id="E1" events="6" subjects_affected="6" subjects_at_risk="6113"/>
                <counts group_id="E2" events="2" subjects_affected="1" subjects_at_risk="3057"/>
              </event>
              <event>
                <sub_title>Osteomyelitis</sub_title>
                <counts group_id="E1" events="29" subjects_affected="27" subjects_at_risk="6113"/>
                <counts group_id="E2" events="16" subjects_affected="11" subjects_at_risk="3057"/>
              </event>
              <event>
                <sub_title>Osteomyelitis Acute</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="6113"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3057"/>
              </event>
              <event>
                <sub_title>Osteomyelitis Chronic</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="6113"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="3057"/>
              </event>
              <event>
                <sub_title>Otitis Externa</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="6113"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3057"/>
              </event>
              <event>
                <sub_title>Paraspinal Abscess</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="6113"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3057"/>
              </event>
              <event>
                <sub_title>Paronychia</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="6113"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3057"/>
              </event>
              <event>
                <sub_title>Perihepatic Abscess</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="6113"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3057"/>
              </event>
              <event>
                <sub_title>Perineal Abscess</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="6113"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3057"/>
              </event>
              <event>
                <sub_title>Periodontitis</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="6113"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3057"/>
              </event>
              <event>
                <sub_title>Peritonitis</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="6113"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3057"/>
              </event>
              <event>
                <sub_title>Peritonsillar Abscess</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="6113"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3057"/>
              </event>
              <event>
                <sub_title>Pneumonia</sub_title>
                <counts group_id="E1" events="122" subjects_affected="107" subjects_at_risk="6113"/>
                <counts group_id="E2" events="84" subjects_affected="67" subjects_at_risk="3057"/>
              </event>
              <event>
                <sub_title>Pneumonia Bacterial</sub_title>
                <counts group_id="E1" events="9" subjects_affected="5" subjects_at_risk="6113"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="3057"/>
              </event>
              <event>
                <sub_title>Pneumonia Necrotising</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="6113"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3057"/>
              </event>
              <event>
                <sub_title>Pneumonia Pneumococcal</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="6113"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3057"/>
              </event>
              <event>
                <sub_title>Pneumonia Staphylococcal</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="6113"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3057"/>
              </event>
              <event>
                <sub_title>Poliomyelitis</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="6113"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3057"/>
              </event>
              <event>
                <sub_title>Post Procedural Cellulitis</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="6113"/>
                <counts group_id="E2" events="2" subjects_affected="1" subjects_at_risk="3057"/>
              </event>
              <event>
                <sub_title>Post Procedural Infection</sub_title>
                <counts group_id="E1" events="7" subjects_affected="7" subjects_at_risk="6113"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3057"/>
              </event>
              <event>
                <sub_title>Post Procedural Pneumonia</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="6113"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3057"/>
              </event>
              <event>
                <sub_title>Post Procedural Sepsis</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="6113"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3057"/>
              </event>
              <event>
                <sub_title>Postoperative Wound Infection</sub_title>
                <counts group_id="E1" events="30" subjects_affected="28" subjects_at_risk="6113"/>
                <counts group_id="E2" events="15" subjects_affected="15" subjects_at_risk="3057"/>
              </event>
              <event>
                <sub_title>Prostatic Abscess</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="6113"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3057"/>
              </event>
              <event>
                <sub_title>Psoas Abscess</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="6113"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="3057"/>
              </event>
              <event>
                <sub_title>Pulmonary Sepsis</sub_title>
                <counts group_id="E1" events="2" subjects_affected="1" subjects_at_risk="6113"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="3057"/>
              </event>
              <event>
                <sub_title>Pulmonary Tuberculosis</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="6113"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3057"/>
              </event>
              <event>
                <sub_title>Pyelonephritis</sub_title>
                <counts group_id="E1" events="5" subjects_affected="5" subjects_at_risk="6113"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="3057"/>
              </event>
              <event>
                <sub_title>Pyelonephritis Acute</sub_title>
                <counts group_id="E1" events="8" subjects_affected="7" subjects_at_risk="6113"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3057"/>
              </event>
              <event>
                <sub_title>Renal Abscess</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="6113"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3057"/>
              </event>
              <event>
                <sub_title>Respiratory Tract Infection</sub_title>
                <counts group_id="E1" events="8" subjects_affected="7" subjects_at_risk="6113"/>
                <counts group_id="E2" events="6" subjects_affected="4" subjects_at_risk="3057"/>
              </event>
              <event>
                <sub_title>Scrotal Abscess</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="6113"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3057"/>
              </event>
              <event>
                <sub_title>Sepsis</sub_title>
                <counts group_id="E1" events="38" subjects_affected="34" subjects_at_risk="6113"/>
                <counts group_id="E2" events="18" subjects_affected="18" subjects_at_risk="3057"/>
              </event>
              <event>
                <sub_title>Septic Arthritis Staphylococcal</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="6113"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3057"/>
              </event>
              <event>
                <sub_title>Septic Shock</sub_title>
                <counts group_id="E1" events="27" subjects_affected="26" subjects_at_risk="6113"/>
                <counts group_id="E2" events="13" subjects_affected="13" subjects_at_risk="3057"/>
              </event>
              <event>
                <sub_title>Sinusitis Bacterial</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="6113"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3057"/>
              </event>
              <event>
                <sub_title>Skin Bacterial Infection</sub_title>
                <counts group_id="E1" events="4" subjects_affected="3" subjects_at_risk="6113"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3057"/>
              </event>
              <event>
                <sub_title>Skin Infection</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="6113"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="3057"/>
              </event>
              <event>
                <sub_title>Soft Tissue Infection</sub_title>
                <counts group_id="E1" events="3" subjects_affected="3" subjects_at_risk="6113"/>
                <counts group_id="E2" events="4" subjects_affected="4" subjects_at_risk="3057"/>
              </event>
              <event>
                <sub_title>Staphylococcal Bacteraemia</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="6113"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3057"/>
              </event>
              <event>
                <sub_title>Staphylococcal Infection</sub_title>
                <counts group_id="E1" events="4" subjects_affected="4" subjects_at_risk="6113"/>
                <counts group_id="E2" events="3" subjects_affected="3" subjects_at_risk="3057"/>
              </event>
              <event>
                <sub_title>Staphylococcal Osteomyelitis</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="6113"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="3057"/>
              </event>
              <event>
                <sub_title>Staphylococcal Sepsis</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="6113"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3057"/>
              </event>
              <event>
                <sub_title>Subcutaneous Abscess</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="6113"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="3057"/>
              </event>
              <event>
                <sub_title>Tracheitis</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="6113"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3057"/>
              </event>
              <event>
                <sub_title>Tracheobronchitis</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="6113"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3057"/>
              </event>
              <event>
                <sub_title>Tuberculosis</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="6113"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3057"/>
              </event>
              <event>
                <sub_title>Upper Respiratory Tract Infection</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="6113"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3057"/>
              </event>
              <event>
                <sub_title>Urinary Bladder Abscess</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="6113"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3057"/>
              </event>
              <event>
                <sub_title>Urinary Tract Infection</sub_title>
                <counts group_id="E1" events="116" subjects_affected="91" subjects_at_risk="6113"/>
                <counts group_id="E2" events="47" subjects_affected="38" subjects_at_risk="3057"/>
              </event>
              <event>
                <sub_title>Urinary Tract Infection Bacterial</sub_title>
                <counts group_id="E1" events="3" subjects_affected="3" subjects_at_risk="6113"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3057"/>
              </event>
              <event>
                <sub_title>Urinary Tract Infection Pseudomonal</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="6113"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3057"/>
              </event>
              <event>
                <sub_title>Urosepsis</sub_title>
                <counts group_id="E1" events="12" subjects_affected="11" subjects_at_risk="6113"/>
                <counts group_id="E2" events="6" subjects_affected="6" subjects_at_risk="3057"/>
              </event>
              <event>
                <sub_title>Viral Infection</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="6113"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3057"/>
              </event>
              <event>
                <sub_title>Viral Upper Respiratory Tract Infection</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="6113"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3057"/>
              </event>
              <event>
                <sub_title>Wound Infection</sub_title>
                <counts group_id="E1" events="5" subjects_affected="5" subjects_at_risk="6113"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3057"/>
              </event>
              <event>
                <sub_title>Wound Infection Bacterial</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="6113"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3057"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Injury, poisoning and procedural complications</title>
            <event_list>
              <event>
                <sub_title>Abdominal Wound Dehiscence</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="6113"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3057"/>
              </event>
              <event>
                <sub_title>Accidental Overdose</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="6113"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3057"/>
              </event>
              <event>
                <sub_title>Alcohol Poisoning</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="6113"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="3057"/>
              </event>
              <event>
                <sub_title>Anaemia Postoperative</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="6113"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3057"/>
              </event>
              <event>
                <sub_title>Animal Bite</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="6113"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3057"/>
              </event>
              <event>
                <sub_title>Ankle Fracture</sub_title>
                <counts group_id="E1" events="4" subjects_affected="4" subjects_at_risk="6113"/>
                <counts group_id="E2" events="4" subjects_affected="4" subjects_at_risk="3057"/>
              </event>
              <event>
                <sub_title>Arterial Injury</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="6113"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3057"/>
              </event>
              <event>
                <sub_title>Bladder Injury</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="6113"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3057"/>
              </event>
              <event>
                <sub_title>Bone Fissure</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="6113"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3057"/>
              </event>
              <event>
                <sub_title>Cardiac Procedure Complication</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="6113"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3057"/>
              </event>
              <event>
                <sub_title>Cervical Vertebral Fracture</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="6113"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3057"/>
              </event>
              <event>
                <sub_title>Chemical Poisoning</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="6113"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3057"/>
              </event>
              <event>
                <sub_title>Concussion</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="6113"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3057"/>
              </event>
              <event>
                <sub_title>Contusion</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="6113"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3057"/>
              </event>
              <event>
                <sub_title>Coronary Artery Restenosis</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="6113"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3057"/>
              </event>
              <event>
                <sub_title>Craniocerebral Injury</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="6113"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3057"/>
              </event>
              <event>
                <sub_title>Dislocation Of Vertebra</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="6113"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3057"/>
              </event>
              <event>
                <sub_title>Dural Tear</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="6113"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3057"/>
              </event>
              <event>
                <sub_title>Exposure To Toxic Agent</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="6113"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3057"/>
              </event>
              <event>
                <sub_title>Extradural Haematoma</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="6113"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3057"/>
              </event>
              <event>
                <sub_title>Facial Bones Fracture</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="6113"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3057"/>
              </event>
              <event>
                <sub_title>Fall</sub_title>
                <counts group_id="E1" events="18" subjects_affected="17" subjects_at_risk="6113"/>
                <counts group_id="E2" events="7" subjects_affected="7" subjects_at_risk="3057"/>
              </event>
              <event>
                <sub_title>Fat Embolism</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="6113"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3057"/>
              </event>
              <event>
                <sub_title>Femoral Neck Fracture</sub_title>
                <counts group_id="E1" events="5" subjects_affected="5" subjects_at_risk="6113"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="3057"/>
              </event>
              <event>
                <sub_title>Femur Fracture</sub_title>
                <counts group_id="E1" events="12" subjects_affected="11" subjects_at_risk="6113"/>
                <counts group_id="E2" events="4" subjects_affected="4" subjects_at_risk="3057"/>
              </event>
              <event>
                <sub_title>Foot Fracture</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="6113"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3057"/>
              </event>
              <event>
                <sub_title>Forearm Fracture</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="6113"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3057"/>
              </event>
              <event>
                <sub_title>Head Injury</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="6113"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3057"/>
              </event>
              <event>
                <sub_title>Heat Exhaustion</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="6113"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3057"/>
              </event>
              <event>
                <sub_title>Heat Stroke</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="6113"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3057"/>
              </event>
              <event>
                <sub_title>Hip Fracture</sub_title>
                <counts group_id="E1" events="8" subjects_affected="8" subjects_at_risk="6113"/>
                <counts group_id="E2" events="7" subjects_affected="6" subjects_at_risk="3057"/>
              </event>
              <event>
                <sub_title>Humerus Fracture</sub_title>
                <counts group_id="E1" events="4" subjects_affected="4" subjects_at_risk="6113"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3057"/>
              </event>
              <event>
                <sub_title>Incisional Hernia</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="6113"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3057"/>
              </event>
              <event>
                <sub_title>Joint Dislocation</sub_title>
                <counts group_id="E1" events="16" subjects_affected="12" subjects_at_risk="6113"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3057"/>
              </event>
              <event>
                <sub_title>Joint Dislocation Postoperative</sub_title>
                <counts group_id="E1" events="5" subjects_affected="4" subjects_at_risk="6113"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3057"/>
              </event>
              <event>
                <sub_title>Joint Injury</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="6113"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3057"/>
              </event>
              <event>
                <sub_title>Laceration</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="6113"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3057"/>
              </event>
              <event>
                <sub_title>Ligament Injury</sub_title>
                <counts group_id="E1" events="3" subjects_affected="2" subjects_at_risk="6113"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3057"/>
              </event>
              <event>
                <sub_title>Ligament Rupture</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="6113"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3057"/>
              </event>
              <event>
                <sub_title>Ligament Sprain</sub_title>
                <counts group_id="E1" events="4" subjects_affected="4" subjects_at_risk="6113"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3057"/>
              </event>
              <event>
                <sub_title>Limb Injury</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="6113"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3057"/>
              </event>
              <event>
                <sub_title>Lower Limb Fracture</sub_title>
                <counts group_id="E1" events="3" subjects_affected="3" subjects_at_risk="6113"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="3057"/>
              </event>
              <event>
                <sub_title>Mechanical Ventilation Complication</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="6113"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3057"/>
              </event>
              <event>
                <sub_title>Meniscus Injury</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="6113"/>
                <counts group_id="E2" events="6" subjects_affected="5" subjects_at_risk="3057"/>
              </event>
              <event>
                <sub_title>Multiple Fractures</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="6113"/>
                <counts group_id="E2" events="3" subjects_affected="3" subjects_at_risk="3057"/>
              </event>
              <event>
                <sub_title>Multiple Injuries</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="6113"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3057"/>
              </event>
              <event>
                <sub_title>Muscle Rupture</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="6113"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3057"/>
              </event>
              <event>
                <sub_title>Muscle Strain</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="6113"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3057"/>
              </event>
              <event>
                <sub_title>Overdose</sub_title>
                <counts group_id="E1" events="4" subjects_affected="4" subjects_at_risk="6113"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3057"/>
              </event>
              <event>
                <sub_title>Patella Fracture</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="6113"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3057"/>
              </event>
              <event>
                <sub_title>Pelvic Fracture</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="6113"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="3057"/>
              </event>
              <event>
                <sub_title>Periprosthetic Fracture</sub_title>
                <counts group_id="E1" events="7" subjects_affected="6" subjects_at_risk="6113"/>
                <counts group_id="E2" events="6" subjects_affected="5" subjects_at_risk="3057"/>
              </event>
              <event>
                <sub_title>Pneumothorax Traumatic</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="6113"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3057"/>
              </event>
              <event>
                <sub_title>Post Concussion Syndrome</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="6113"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3057"/>
              </event>
              <event>
                <sub_title>Post Procedural Complication</sub_title>
                <counts group_id="E1" events="18" subjects_affected="18" subjects_at_risk="6113"/>
                <counts group_id="E2" events="13" subjects_affected="11" subjects_at_risk="3057"/>
              </event>
              <event>
                <sub_title>Post Procedural Discharge</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="6113"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3057"/>
              </event>
              <event>
                <sub_title>Post Procedural Haematoma</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="6113"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3057"/>
              </event>
              <event>
                <sub_title>Post Procedural Haematuria</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="6113"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3057"/>
              </event>
              <event>
                <sub_title>Post Procedural Haemorrhage</sub_title>
                <counts group_id="E1" events="3" subjects_affected="3" subjects_at_risk="6113"/>
                <counts group_id="E2" events="3" subjects_affected="3" subjects_at_risk="3057"/>
              </event>
              <event>
                <sub_title>Post Procedural Swelling</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="6113"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3057"/>
              </event>
              <event>
                <sub_title>Postoperative Fever</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="6113"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3057"/>
              </event>
              <event>
                <sub_title>Postoperative Ileus</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="6113"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3057"/>
              </event>
              <event>
                <sub_title>Postoperative Respiratory Failure</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="6113"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3057"/>
              </event>
              <event>
                <sub_title>Postoperative Thoracic Procedure Complication</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="6113"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3057"/>
              </event>
              <event>
                <sub_title>Postoperative Wound Complication</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="6113"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3057"/>
              </event>
              <event>
                <sub_title>Procedural Haemorrhage</sub_title>
                <counts group_id="E1" events="5" subjects_affected="4" subjects_at_risk="6113"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3057"/>
              </event>
              <event>
                <sub_title>Procedural Hypotension</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="6113"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3057"/>
              </event>
              <event>
                <sub_title>Procedural Nausea</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="6113"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3057"/>
              </event>
              <event>
                <sub_title>Procedural Pain</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="6113"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3057"/>
              </event>
              <event>
                <sub_title>Pubis Fracture</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="6113"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3057"/>
              </event>
              <event>
                <sub_title>Radius Fracture</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="6113"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3057"/>
              </event>
              <event>
                <sub_title>Rectal Laceration Postoperative</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="6113"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3057"/>
              </event>
              <event>
                <sub_title>Renal Haematoma</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="6113"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3057"/>
              </event>
              <event>
                <sub_title>Rib Fracture</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="6113"/>
                <counts group_id="E2" events="3" subjects_affected="3" subjects_at_risk="3057"/>
              </event>
              <event>
                <sub_title>Road Traffic Accident</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="6113"/>
                <counts group_id="E2" events="5" subjects_affected="5" subjects_at_risk="3057"/>
              </event>
              <event>
                <sub_title>Scrotal Haematoma</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="6113"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3057"/>
              </event>
              <event>
                <sub_title>Seroma</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="6113"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3057"/>
              </event>
              <event>
                <sub_title>Skin Injury</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="6113"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3057"/>
              </event>
              <event>
                <sub_title>Spinal Compression Fracture</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="6113"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3057"/>
              </event>
              <event>
                <sub_title>Spinal Fracture</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="6113"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3057"/>
              </event>
              <event>
                <sub_title>Stab Wound</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="6113"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3057"/>
              </event>
              <event>
                <sub_title>Stress Fracture</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="6113"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3057"/>
              </event>
              <event>
                <sub_title>Subdural Haematoma</sub_title>
                <counts group_id="E1" events="6" subjects_affected="6" subjects_at_risk="6113"/>
                <counts group_id="E2" events="3" subjects_affected="3" subjects_at_risk="3057"/>
              </event>
              <event>
                <sub_title>Subdural Haemorrhage</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="6113"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3057"/>
              </event>
              <event>
                <sub_title>Tendon Rupture</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="6113"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3057"/>
              </event>
              <event>
                <sub_title>Thermal Burn</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="6113"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3057"/>
              </event>
              <event>
                <sub_title>Thoracic Vertebral Fracture</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="6113"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3057"/>
              </event>
              <event>
                <sub_title>Tibia Fracture</sub_title>
                <counts group_id="E1" events="4" subjects_affected="4" subjects_at_risk="6113"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3057"/>
              </event>
              <event>
                <sub_title>Toxicity To Various Agents</sub_title>
                <counts group_id="E1" events="4" subjects_affected="4" subjects_at_risk="6113"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3057"/>
              </event>
              <event>
                <sub_title>Tracheostomy Malfunction</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="6113"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3057"/>
              </event>
              <event>
                <sub_title>Traumatic Arthritis</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="6113"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3057"/>
              </event>
              <event>
                <sub_title>Traumatic Intracranial Haemorrhage</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="6113"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3057"/>
              </event>
              <event>
                <sub_title>Upper Limb Fracture</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="6113"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3057"/>
              </event>
              <event>
                <sub_title>Urethral Injury</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="6113"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3057"/>
              </event>
              <event>
                <sub_title>Urethral Stricture Postoperative</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="6113"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3057"/>
              </event>
              <event>
                <sub_title>Vascular Bypass Dysfunction</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="6113"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3057"/>
              </event>
              <event>
                <sub_title>Vascular Graft Occlusion</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="6113"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3057"/>
              </event>
              <event>
                <sub_title>Vascular Graft Thrombosis</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="6113"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3057"/>
              </event>
              <event>
                <sub_title>Vascular Pseudoaneurysm</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="6113"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3057"/>
              </event>
              <event>
                <sub_title>Wound</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="6113"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3057"/>
              </event>
              <event>
                <sub_title>Wound Dehiscence</sub_title>
                <counts group_id="E1" events="5" subjects_affected="3" subjects_at_risk="6113"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="3057"/>
              </event>
              <event>
                <sub_title>Wrist Fracture</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="6113"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3057"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Investigations</title>
            <event_list>
              <event>
                <sub_title>Anticoagulation Drug Level Above Therapeutic</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="6113"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3057"/>
              </event>
              <event>
                <sub_title>Aspiration Bronchial</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="6113"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3057"/>
              </event>
              <event>
                <sub_title>Blood Creatinine Increased</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="6113"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3057"/>
              </event>
              <event>
                <sub_title>Blood Potassium Decreased</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="6113"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3057"/>
              </event>
              <event>
                <sub_title>Carbon Dioxide Abnormal</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="6113"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3057"/>
              </event>
              <event>
                <sub_title>Cardiac Pacemaker Evaluation</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="6113"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3057"/>
              </event>
              <event>
                <sub_title>Coagulation Time Prolonged</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="6113"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3057"/>
              </event>
              <event>
                <sub_title>Electrocardiogram St Segment Elevation</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="6113"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3057"/>
              </event>
              <event>
                <sub_title>Influenza A Virus Test Positive</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="6113"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3057"/>
              </event>
              <event>
                <sub_title>International Normalised Ratio Increased</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="6113"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3057"/>
              </event>
              <event>
                <sub_title>Oxygen Saturation Decreased</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="6113"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3057"/>
              </event>
              <event>
                <sub_title>Prothrombin Time Abnormal</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="6113"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3057"/>
              </event>
              <event>
                <sub_title>Transaminases Increased</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="6113"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3057"/>
              </event>
              <event>
                <sub_title>Urine Output Decreased</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="6113"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3057"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Metabolism and nutrition disorders</title>
            <event_list>
              <event>
                <sub_title>Cachexia</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="6113"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3057"/>
              </event>
              <event>
                <sub_title>Central Obesity</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="6113"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3057"/>
              </event>
              <event>
                <sub_title>Decreased Appetite</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="6113"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3057"/>
              </event>
              <event>
                <sub_title>Dehydration</sub_title>
                <counts group_id="E1" events="5" subjects_affected="5" subjects_at_risk="6113"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3057"/>
              </event>
              <event>
                <sub_title>Diabetes Mellitus</sub_title>
                <counts group_id="E1" events="15" subjects_affected="12" subjects_at_risk="6113"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="3057"/>
              </event>
              <event>
                <sub_title>Diabetes Mellitus Inadequate Control</sub_title>
                <counts group_id="E1" events="11" subjects_affected="8" subjects_at_risk="6113"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="3057"/>
              </event>
              <event>
                <sub_title>Diabetic Complication</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="6113"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="3057"/>
              </event>
              <event>
                <sub_title>Diabetic Ketoacidosis</sub_title>
                <counts group_id="E1" events="4" subjects_affected="3" subjects_at_risk="6113"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="3057"/>
              </event>
              <event>
                <sub_title>Electrolyte Imbalance</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="6113"/>
                <counts group_id="E2" events="3" subjects_affected="3" subjects_at_risk="3057"/>
              </event>
              <event>
                <sub_title>Fluid Overload</sub_title>
                <counts group_id="E1" events="6" subjects_affected="4" subjects_at_risk="6113"/>
                <counts group_id="E2" events="13" subjects_affected="5" subjects_at_risk="3057"/>
              </event>
              <event>
                <sub_title>Gout</sub_title>
                <counts group_id="E1" events="6" subjects_affected="5" subjects_at_risk="6113"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3057"/>
              </event>
              <event>
                <sub_title>Hyperamylasaemia</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="6113"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3057"/>
              </event>
              <event>
                <sub_title>Hypercalcaemia</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="6113"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="3057"/>
              </event>
              <event>
                <sub_title>Hyperglycaemia</sub_title>
                <counts group_id="E1" events="12" subjects_affected="10" subjects_at_risk="6113"/>
                <counts group_id="E2" events="6" subjects_affected="6" subjects_at_risk="3057"/>
              </event>
              <event>
                <sub_title>Hyperglycaemic Hyperosmolar Nonketotic Syndrome</sub_title>
                <counts group_id="E1" events="3" subjects_affected="3" subjects_at_risk="6113"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3057"/>
              </event>
              <event>
                <sub_title>Hyperkalaemia</sub_title>
                <counts group_id="E1" events="6" subjects_affected="5" subjects_at_risk="6113"/>
                <counts group_id="E2" events="4" subjects_affected="4" subjects_at_risk="3057"/>
              </event>
              <event>
                <sub_title>Hyperuricaemia</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="6113"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3057"/>
              </event>
              <event>
                <sub_title>Hypervolaemia</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="6113"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3057"/>
              </event>
              <event>
                <sub_title>Hypoglycaemia</sub_title>
                <counts group_id="E1" events="11" subjects_affected="11" subjects_at_risk="6113"/>
                <counts group_id="E2" events="7" subjects_affected="6" subjects_at_risk="3057"/>
              </event>
              <event>
                <sub_title>Hypokalaemia</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="6113"/>
                <counts group_id="E2" events="2" subjects_affected="1" subjects_at_risk="3057"/>
              </event>
              <event>
                <sub_title>Hyponatraemia</sub_title>
                <counts group_id="E1" events="6" subjects_affected="6" subjects_at_risk="6113"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3057"/>
              </event>
              <event>
                <sub_title>Hypovolaemia</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="6113"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3057"/>
              </event>
              <event>
                <sub_title>Malnutrition</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="6113"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="3057"/>
              </event>
              <event>
                <sub_title>Metabolic Acidosis</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="6113"/>
                <counts group_id="E2" events="3" subjects_affected="3" subjects_at_risk="3057"/>
              </event>
              <event>
                <sub_title>Obesity</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="6113"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3057"/>
              </event>
              <event>
                <sub_title>Type 1 Diabetes Mellitus</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="6113"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3057"/>
              </event>
              <event>
                <sub_title>Type 2 Diabetes Mellitus</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="6113"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="3057"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Musculoskeletal and connective tissue disorders</title>
            <event_list>
              <event>
                <sub_title>Ankylosing Spondylitis</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="6113"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3057"/>
              </event>
              <event>
                <sub_title>Arthralgia</sub_title>
                <counts group_id="E1" events="10" subjects_affected="10" subjects_at_risk="6113"/>
                <counts group_id="E2" events="4" subjects_affected="4" subjects_at_risk="3057"/>
              </event>
              <event>
                <sub_title>Arthritis</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="6113"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3057"/>
              </event>
              <event>
                <sub_title>Arthrofibrosis</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="6113"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3057"/>
              </event>
              <event>
                <sub_title>Arthropathy</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="6113"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3057"/>
              </event>
              <event>
                <sub_title>Back Pain</sub_title>
                <counts group_id="E1" events="9" subjects_affected="8" subjects_at_risk="6113"/>
                <counts group_id="E2" events="10" subjects_affected="8" subjects_at_risk="3057"/>
              </event>
              <event>
                <sub_title>Bursitis</sub_title>
                <counts group_id="E1" events="3" subjects_affected="3" subjects_at_risk="6113"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="3057"/>
              </event>
              <event>
                <sub_title>Cervical Spinal Stenosis</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="6113"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3057"/>
              </event>
              <event>
                <sub_title>Chondropathy</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="6113"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3057"/>
              </event>
              <event>
                <sub_title>Chronic Recurrent Multifocal Osteomyelitis</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="6113"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3057"/>
              </event>
              <event>
                <sub_title>Collagen Disorder</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="6113"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3057"/>
              </event>
              <event>
                <sub_title>Costochondritis</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="6113"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3057"/>
              </event>
              <event>
                <sub_title>Exostosis</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="6113"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3057"/>
              </event>
              <event>
                <sub_title>Fistula</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="6113"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3057"/>
              </event>
              <event>
                <sub_title>Foot Deformity</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="6113"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3057"/>
              </event>
              <event>
                <sub_title>Fracture Nonunion</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="6113"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3057"/>
              </event>
              <event>
                <sub_title>Gouty Arthritis</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="6113"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3057"/>
              </event>
              <event>
                <sub_title>Intervertebral Disc Degeneration</sub_title>
                <counts group_id="E1" events="3" subjects_affected="3" subjects_at_risk="6113"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3057"/>
              </event>
              <event>
                <sub_title>Intervertebral Disc Disorder</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="6113"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3057"/>
              </event>
              <event>
                <sub_title>Intervertebral Disc Protrusion</sub_title>
                <counts group_id="E1" events="4" subjects_affected="4" subjects_at_risk="6113"/>
                <counts group_id="E2" events="3" subjects_affected="3" subjects_at_risk="3057"/>
              </event>
              <event>
                <sub_title>Joint Instability</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="6113"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3057"/>
              </event>
              <event>
                <sub_title>Joint Swelling</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="6113"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3057"/>
              </event>
              <event>
                <sub_title>Lumbar Spinal Stenosis</sub_title>
                <counts group_id="E1" events="4" subjects_affected="4" subjects_at_risk="6113"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="3057"/>
              </event>
              <event>
                <sub_title>Mobility Decreased</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="6113"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3057"/>
              </event>
              <event>
                <sub_title>Muscle Necrosis</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="6113"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3057"/>
              </event>
              <event>
                <sub_title>Muscle Spasms</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="6113"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3057"/>
              </event>
              <event>
                <sub_title>Musculoskeletal Chest Pain</sub_title>
                <counts group_id="E1" events="5" subjects_affected="5" subjects_at_risk="6113"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3057"/>
              </event>
              <event>
                <sub_title>Musculoskeletal Pain</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="6113"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3057"/>
              </event>
              <event>
                <sub_title>Myalgia</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="6113"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3057"/>
              </event>
              <event>
                <sub_title>Neck Pain</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="6113"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="3057"/>
              </event>
              <event>
                <sub_title>Osteitis</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="6113"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3057"/>
              </event>
              <event>
                <sub_title>Osteoarthritis</sub_title>
                <counts group_id="E1" events="51" subjects_affected="47" subjects_at_risk="6113"/>
                <counts group_id="E2" events="19" subjects_affected="19" subjects_at_risk="3057"/>
              </event>
              <event>
                <sub_title>Pain In Extremity</sub_title>
                <counts group_id="E1" events="3" subjects_affected="3" subjects_at_risk="6113"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3057"/>
              </event>
              <event>
                <sub_title>Pseudarthrosis</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="6113"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3057"/>
              </event>
              <event>
                <sub_title>Psoriatic Arthropathy</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="6113"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3057"/>
              </event>
              <event>
                <sub_title>Rhabdomyolysis</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="6113"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3057"/>
              </event>
              <event>
                <sub_title>Rotator Cuff Syndrome</sub_title>
                <counts group_id="E1" events="4" subjects_affected="4" subjects_at_risk="6113"/>
                <counts group_id="E2" events="3" subjects_affected="2" subjects_at_risk="3057"/>
              </event>
              <event>
                <sub_title>Scoliosis</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="6113"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="3057"/>
              </event>
              <event>
                <sub_title>Spinal Column Stenosis</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="6113"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="3057"/>
              </event>
              <event>
                <sub_title>Spinal Osteoarthritis</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="6113"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3057"/>
              </event>
              <event>
                <sub_title>Spondylitis</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="6113"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3057"/>
              </event>
              <event>
                <sub_title>Spondylolisthesis</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="6113"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3057"/>
              </event>
              <event>
                <sub_title>Tendonitis</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="6113"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3057"/>
              </event>
              <event>
                <sub_title>Tenosynovitis</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="6113"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3057"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Neoplasms benign, malignant and unspecified (incl cysts and polyps)</title>
            <event_list>
              <event>
                <sub_title>Abdominal Neoplasm</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="6113"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3057"/>
              </event>
              <event>
                <sub_title>Adenocarcinoma</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="6113"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3057"/>
              </event>
              <event>
                <sub_title>Adenocarcinoma Gastric</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="6113"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3057"/>
              </event>
              <event>
                <sub_title>Adenocarcinoma Of Colon</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="6113"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3057"/>
              </event>
              <event>
                <sub_title>Adenocarcinoma Pancreas</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="6113"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3057"/>
              </event>
              <event>
                <sub_title>Adrenal Adenoma</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="6113"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3057"/>
              </event>
              <event>
                <sub_title>Basal Cell Carcinoma</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="6113"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="3057"/>
              </event>
              <event>
                <sub_title>Benign Bone Neoplasm</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="6113"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3057"/>
              </event>
              <event>
                <sub_title>Bladder Cancer</sub_title>
                <counts group_id="E1" events="3" subjects_affected="3" subjects_at_risk="6113"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3057"/>
              </event>
              <event>
                <sub_title>Bladder Neoplasm</sub_title>
                <counts group_id="E1" events="3" subjects_affected="3" subjects_at_risk="6113"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3057"/>
              </event>
              <event>
                <sub_title>Bladder Transitional Cell Carcinoma Recurrent</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="6113"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3057"/>
              </event>
              <event>
                <sub_title>Bladder Transitional Cell Carcinoma Stage Ii</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="6113"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3057"/>
              </event>
              <event>
                <sub_title>Bone Cancer</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="6113"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3057"/>
              </event>
              <event>
                <sub_title>Brain Cancer Metastatic</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="6113"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3057"/>
              </event>
              <event>
                <sub_title>Brain Neoplasm</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="6113"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3057"/>
              </event>
              <event>
                <sub_title>Brain Neoplasm Malignant</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="6113"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3057"/>
              </event>
              <event>
                <sub_title>Breast Cancer</sub_title>
                <counts group_id="E1" events="4" subjects_affected="4" subjects_at_risk="6113"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="3057"/>
              </event>
              <event>
                <sub_title>Breast Cancer Metastatic</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="6113"/>
                <counts group_id="E2" events="2" subjects_affected="1" subjects_at_risk="3057"/>
              </event>
              <event>
                <sub_title>Breast Cancer Stage Ii</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="6113"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3057"/>
              </event>
              <event>
                <sub_title>Breast Neoplasm</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="6113"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3057"/>
              </event>
              <event>
                <sub_title>Bronchial Carcinoma</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="6113"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3057"/>
              </event>
              <event>
                <sub_title>Burkitt's Lymphoma</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="6113"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3057"/>
              </event>
              <event>
                <sub_title>Carcinoid Tumour Of The Duodenum</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="6113"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3057"/>
              </event>
              <event>
                <sub_title>Cervix Carcinoma</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="6113"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3057"/>
              </event>
              <event>
                <sub_title>Cervix Carcinoma Recurrent</sub_title>
                <counts group_id="E1" events="3" subjects_affected="1" subjects_at_risk="6113"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3057"/>
              </event>
              <event>
                <sub_title>Cervix Carcinoma Stage I</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="6113"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3057"/>
              </event>
              <event>
                <sub_title>Chronic Lymphocytic Leukaemia</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="6113"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3057"/>
              </event>
              <event>
                <sub_title>Clear Cell Renal Cell Carcinoma</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="6113"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3057"/>
              </event>
              <event>
                <sub_title>Colon Adenoma</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="6113"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3057"/>
              </event>
              <event>
                <sub_title>Colon Cancer</sub_title>
                <counts group_id="E1" events="3" subjects_affected="2" subjects_at_risk="6113"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3057"/>
              </event>
              <event>
                <sub_title>Colon Neoplasm</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="6113"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3057"/>
              </event>
              <event>
                <sub_title>Diffuse Large B-Cell Lymphoma</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="6113"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3057"/>
              </event>
              <event>
                <sub_title>Endometrial Adenocarcinoma</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="6113"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3057"/>
              </event>
              <event>
                <sub_title>Endometrial Cancer</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="6113"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3057"/>
              </event>
              <event>
                <sub_title>Eyelid Tumour</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="6113"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3057"/>
              </event>
              <event>
                <sub_title>Gallbladder Adenocarcinoma</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="6113"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3057"/>
              </event>
              <event>
                <sub_title>Gastric Adenoma</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="6113"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3057"/>
              </event>
              <event>
                <sub_title>Gastric Neoplasm</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="6113"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3057"/>
              </event>
              <event>
                <sub_title>Gastrointestinal Carcinoma</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="6113"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3057"/>
              </event>
              <event>
                <sub_title>Gastrointestinal Neoplasm</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="6113"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3057"/>
              </event>
              <event>
                <sub_title>Gastrointestinal Stromal Tumour</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="6113"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3057"/>
              </event>
              <event>
                <sub_title>Glioblastoma Multiforme</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="6113"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3057"/>
              </event>
              <event>
                <sub_title>Hepatic Cancer</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="6113"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3057"/>
              </event>
              <event>
                <sub_title>Hepatocellular Carcinoma</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="6113"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3057"/>
              </event>
              <event>
                <sub_title>Intraductal Papillary Mucinous Neoplasm</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="6113"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3057"/>
              </event>
              <event>
                <sub_title>Kaposi's Sarcoma</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="6113"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3057"/>
              </event>
              <event>
                <sub_title>Leiomyosarcoma</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="6113"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3057"/>
              </event>
              <event>
                <sub_title>Leukaemia</sub_title>
                <counts group_id="E1" events="3" subjects_affected="1" subjects_at_risk="6113"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3057"/>
              </event>
              <event>
                <sub_title>Lipoma</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="6113"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3057"/>
              </event>
              <event>
                <sub_title>Lung Adenocarcinoma</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="6113"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3057"/>
              </event>
              <event>
                <sub_title>Lung Cancer Metastatic</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="6113"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3057"/>
              </event>
              <event>
                <sub_title>Lung Carcinoma Cell Type Unspecified Recurrent</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="6113"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3057"/>
              </event>
              <event>
                <sub_title>Lung Carcinoma Cell Type Unspecified Stage Iv</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="6113"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3057"/>
              </event>
              <event>
                <sub_title>Lung Neoplasm</sub_title>
                <counts group_id="E1" events="2" subjects_affected="1" subjects_at_risk="6113"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3057"/>
              </event>
              <event>
                <sub_title>Lung Neoplasm Malignant</sub_title>
                <counts group_id="E1" events="3" subjects_affected="3" subjects_at_risk="6113"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3057"/>
              </event>
              <event>
                <sub_title>Lymphoma</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="6113"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="3057"/>
              </event>
              <event>
                <sub_title>Malignant Melanoma</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="6113"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3057"/>
              </event>
              <event>
                <sub_title>Malignant Neoplasm Of Eye</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="6113"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3057"/>
              </event>
              <event>
                <sub_title>Malignant Neoplasm Of Renal Pelvis</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="6113"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3057"/>
              </event>
              <event>
                <sub_title>Malignant Pleural Effusion</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="6113"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3057"/>
              </event>
              <event>
                <sub_title>Malignant Respiratory Tract Neoplasm</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="6113"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3057"/>
              </event>
              <event>
                <sub_title>Mantle Cell Lymphoma</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="6113"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3057"/>
              </event>
              <event>
                <sub_title>Mediastinum Neoplasm</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="6113"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3057"/>
              </event>
              <event>
                <sub_title>Meningioma</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="6113"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3057"/>
              </event>
              <event>
                <sub_title>Mesothelioma</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="6113"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3057"/>
              </event>
              <event>
                <sub_title>Metastases To Central Nervous System</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="6113"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3057"/>
              </event>
              <event>
                <sub_title>Metastases To Lung</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="6113"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3057"/>
              </event>
              <event>
                <sub_title>Metastatic Carcinoma Of The Bladder</sub_title>
                <counts group_id="E1" events="4" subjects_affected="2" subjects_at_risk="6113"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3057"/>
              </event>
              <event>
                <sub_title>Metastatic Neoplasm</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="6113"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3057"/>
              </event>
              <event>
                <sub_title>Neoplasm Malignant</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="6113"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3057"/>
              </event>
              <event>
                <sub_title>Neoplasm Of Thymus</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="6113"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3057"/>
              </event>
              <event>
                <sub_title>Neoplasm Prostate</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="6113"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3057"/>
              </event>
              <event>
                <sub_title>Neuroendocrine Tumour</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="6113"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3057"/>
              </event>
              <event>
                <sub_title>Nodal Marginal Zone B-Cell Lymphoma</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="6113"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3057"/>
              </event>
              <event>
                <sub_title>Non-Small Cell Lung Cancer</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="6113"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3057"/>
              </event>
              <event>
                <sub_title>Non-Small Cell Lung Cancer Recurrent</sub_title>
                <counts group_id="E1" events="4" subjects_affected="1" subjects_at_risk="6113"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3057"/>
              </event>
              <event>
                <sub_title>Oesophageal Carcinoma</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="6113"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3057"/>
              </event>
              <event>
                <sub_title>Ovarian Cancer</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="6113"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="3057"/>
              </event>
              <event>
                <sub_title>Ovarian Epithelial Cancer</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="6113"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3057"/>
              </event>
              <event>
                <sub_title>Pancreatic Carcinoma</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="6113"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3057"/>
              </event>
              <event>
                <sub_title>Pancreatic Carcinoma Metastatic</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="6113"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3057"/>
              </event>
              <event>
                <sub_title>Pancreatic Neuroendocrine Tumour</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="6113"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3057"/>
              </event>
              <event>
                <sub_title>Papillary Thyroid Cancer</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="6113"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3057"/>
              </event>
              <event>
                <sub_title>Parathyroid Tumour Benign</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="6113"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3057"/>
              </event>
              <event>
                <sub_title>Plasma Cell Myeloma</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="6113"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="3057"/>
              </event>
              <event>
                <sub_title>Prostate Cancer</sub_title>
                <counts group_id="E1" events="17" subjects_affected="17" subjects_at_risk="6113"/>
                <counts group_id="E2" events="3" subjects_affected="3" subjects_at_risk="3057"/>
              </event>
              <event>
                <sub_title>Prostate Cancer Metastatic</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="6113"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3057"/>
              </event>
              <event>
                <sub_title>Rectal Adenocarcinoma</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="6113"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3057"/>
              </event>
              <event>
                <sub_title>Rectal Cancer</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="6113"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3057"/>
              </event>
              <event>
                <sub_title>Renal Cell Carcinoma</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="6113"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3057"/>
              </event>
              <event>
                <sub_title>Renal Neoplasm</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="6113"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3057"/>
              </event>
              <event>
                <sub_title>Retroperitoneal Cancer</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="6113"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3057"/>
              </event>
              <event>
                <sub_title>Salivary Gland Adenoma</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="6113"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3057"/>
              </event>
              <event>
                <sub_title>Salivary Gland Cancer</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="6113"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3057"/>
              </event>
              <event>
                <sub_title>Small Cell Lung Cancer</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="6113"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3057"/>
              </event>
              <event>
                <sub_title>Small Intestine Carcinoma</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="6113"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3057"/>
              </event>
              <event>
                <sub_title>Squamous Cell Carcinoma</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="6113"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3057"/>
              </event>
              <event>
                <sub_title>Superficial Spreading Melanoma Stage Unspecified</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="6113"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3057"/>
              </event>
              <event>
                <sub_title>Testicular Neoplasm</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="6113"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3057"/>
              </event>
              <event>
                <sub_title>Transitional Cell Carcinoma</sub_title>
                <counts group_id="E1" events="3" subjects_affected="3" subjects_at_risk="6113"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3057"/>
              </event>
              <event>
                <sub_title>Uterine Cancer</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="6113"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3057"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Nervous system disorders</title>
            <event_list>
              <event>
                <sub_title>Altered State Of Consciousness</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="6113"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3057"/>
              </event>
              <event>
                <sub_title>Apallic Syndrome</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="6113"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3057"/>
              </event>
              <event>
                <sub_title>Arachnoid Cyst</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="6113"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3057"/>
              </event>
              <event>
                <sub_title>Ataxia</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="6113"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3057"/>
              </event>
              <event>
                <sub_title>Brain Stem Stroke</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="6113"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3057"/>
              </event>
              <event>
                <sub_title>Carotid Arteriosclerosis</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="6113"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3057"/>
              </event>
              <event>
                <sub_title>Carotid Artery Stenosis</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="6113"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3057"/>
              </event>
              <event>
                <sub_title>Carpal Tunnel Syndrome</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="6113"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="3057"/>
              </event>
              <event>
                <sub_title>Cerebral Artery Stenosis</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="6113"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3057"/>
              </event>
              <event>
                <sub_title>Cerebral Haemorrhage</sub_title>
                <counts group_id="E1" events="4" subjects_affected="4" subjects_at_risk="6113"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="3057"/>
              </event>
              <event>
                <sub_title>Cerebral Infarction</sub_title>
                <counts group_id="E1" events="5" subjects_affected="5" subjects_at_risk="6113"/>
                <counts group_id="E2" events="7" subjects_affected="7" subjects_at_risk="3057"/>
              </event>
              <event>
                <sub_title>Cerebral Ischaemia</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="6113"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3057"/>
              </event>
              <event>
                <sub_title>Cerebral Thrombosis</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="6113"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3057"/>
              </event>
              <event>
                <sub_title>Cerebrovascular Accident</sub_title>
                <counts group_id="E1" events="20" subjects_affected="19" subjects_at_risk="6113"/>
                <counts group_id="E2" events="8" subjects_affected="8" subjects_at_risk="3057"/>
              </event>
              <event>
                <sub_title>Cerebrovascular Disorder</sub_title>
                <counts group_id="E1" events="3" subjects_affected="3" subjects_at_risk="6113"/>
                <counts group_id="E2" events="3" subjects_affected="3" subjects_at_risk="3057"/>
              </event>
              <event>
                <sub_title>Cervical Myelopathy</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="6113"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3057"/>
              </event>
              <event>
                <sub_title>Cervicobrachial Syndrome</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="6113"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="3057"/>
              </event>
              <event>
                <sub_title>Chronic Inflammatory Demyelinating Polyradiculoneuropathy</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="6113"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3057"/>
              </event>
              <event>
                <sub_title>Convulsion</sub_title>
                <counts group_id="E1" events="15" subjects_affected="11" subjects_at_risk="6113"/>
                <counts group_id="E2" events="22" subjects_affected="9" subjects_at_risk="3057"/>
              </event>
              <event>
                <sub_title>Critical Illness Polyneuropathy</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="6113"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3057"/>
              </event>
              <event>
                <sub_title>Dementia</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="6113"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3057"/>
              </event>
              <event>
                <sub_title>Dementia Alzheimer's Type</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="6113"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3057"/>
              </event>
              <event>
                <sub_title>Dementia With Lewy Bodies</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="6113"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3057"/>
              </event>
              <event>
                <sub_title>Diabetic Neuropathy</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="6113"/>
                <counts group_id="E2" events="3" subjects_affected="2" subjects_at_risk="3057"/>
              </event>
              <event>
                <sub_title>Dizziness</sub_title>
                <counts group_id="E1" events="4" subjects_affected="4" subjects_at_risk="6113"/>
                <counts group_id="E2" events="4" subjects_affected="4" subjects_at_risk="3057"/>
              </event>
              <event>
                <sub_title>Dizziness Postural</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="6113"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3057"/>
              </event>
              <event>
                <sub_title>Embolic Stroke</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="6113"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3057"/>
              </event>
              <event>
                <sub_title>Encephalopathy</sub_title>
                <counts group_id="E1" events="5" subjects_affected="5" subjects_at_risk="6113"/>
                <counts group_id="E2" events="4" subjects_affected="4" subjects_at_risk="3057"/>
              </event>
              <event>
                <sub_title>Epilepsy</sub_title>
                <counts group_id="E1" events="3" subjects_affected="2" subjects_at_risk="6113"/>
                <counts group_id="E2" events="3" subjects_affected="1" subjects_at_risk="3057"/>
              </event>
              <event>
                <sub_title>Facial Paresis</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="6113"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3057"/>
              </event>
              <event>
                <sub_title>Haemorrhage Intracranial</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="6113"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3057"/>
              </event>
              <event>
                <sub_title>Haemorrhagic Stroke</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="6113"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3057"/>
              </event>
              <event>
                <sub_title>Headache</sub_title>
                <counts group_id="E1" events="3" subjects_affected="3" subjects_at_risk="6113"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="3057"/>
              </event>
              <event>
                <sub_title>Hemiplegic Migraine</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="6113"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3057"/>
              </event>
              <event>
                <sub_title>Hepatic Encephalopathy</sub_title>
                <counts group_id="E1" events="6" subjects_affected="2" subjects_at_risk="6113"/>
                <counts group_id="E2" events="7" subjects_affected="4" subjects_at_risk="3057"/>
              </event>
              <event>
                <sub_title>Hydrocephalus</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="6113"/>
                <counts group_id="E2" events="2" subjects_affected="1" subjects_at_risk="3057"/>
              </event>
              <event>
                <sub_title>Hypertensive Encephalopathy</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="6113"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3057"/>
              </event>
              <event>
                <sub_title>Hypoaesthesia</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="6113"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3057"/>
              </event>
              <event>
                <sub_title>Hypoglycaemic Encephalopathy</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="6113"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3057"/>
              </event>
              <event>
                <sub_title>Hypoxic-Ischaemic Encephalopathy</sub_title>
                <counts group_id="E1" events="3" subjects_affected="3" subjects_at_risk="6113"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3057"/>
              </event>
              <event>
                <sub_title>Intercostal Neuralgia</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="6113"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3057"/>
              </event>
              <event>
                <sub_title>Intracranial Aneurysm</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="6113"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="3057"/>
              </event>
              <event>
                <sub_title>Intracranial Pressure Increased</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="6113"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3057"/>
              </event>
              <event>
                <sub_title>Ischaemic Cerebral Infarction</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="6113"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3057"/>
              </event>
              <event>
                <sub_title>Ischaemic Stroke</sub_title>
                <counts group_id="E1" events="13" subjects_affected="11" subjects_at_risk="6113"/>
                <counts group_id="E2" events="5" subjects_affected="5" subjects_at_risk="3057"/>
              </event>
              <event>
                <sub_title>Lacunar Infarction</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="6113"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3057"/>
              </event>
              <event>
                <sub_title>Lumbar Radiculopathy</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="6113"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3057"/>
              </event>
              <event>
                <sub_title>Metabolic Encephalopathy</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="6113"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3057"/>
              </event>
              <event>
                <sub_title>Migraine</sub_title>
                <counts group_id="E1" events="3" subjects_affected="3" subjects_at_risk="6113"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3057"/>
              </event>
              <event>
                <sub_title>Neuropathy Peripheral</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="6113"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="3057"/>
              </event>
              <event>
                <sub_title>Normal Pressure Hydrocephalus</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="6113"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3057"/>
              </event>
              <event>
                <sub_title>Paraesthesia</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="6113"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3057"/>
              </event>
              <event>
                <sub_title>Partial Seizures</sub_title>
                <counts group_id="E1" events="2" subjects_affected="1" subjects_at_risk="6113"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3057"/>
              </event>
              <event>
                <sub_title>Pneumocephalus</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="6113"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3057"/>
              </event>
              <event>
                <sub_title>Polyneuropathy</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="6113"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3057"/>
              </event>
              <event>
                <sub_title>Post-Traumatic Headache</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="6113"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3057"/>
              </event>
              <event>
                <sub_title>Presyncope</sub_title>
                <counts group_id="E1" events="3" subjects_affected="3" subjects_at_risk="6113"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3057"/>
              </event>
              <event>
                <sub_title>Radicular Pain</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="6113"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3057"/>
              </event>
              <event>
                <sub_title>Radicular Syndrome</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="6113"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3057"/>
              </event>
              <event>
                <sub_title>Spinal Cord Compression</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="6113"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3057"/>
              </event>
              <event>
                <sub_title>Status Epilepticus</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="6113"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3057"/>
              </event>
              <event>
                <sub_title>Subarachnoid Haemorrhage</sub_title>
                <counts group_id="E1" events="3" subjects_affected="3" subjects_at_risk="6113"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3057"/>
              </event>
              <event>
                <sub_title>Syncope</sub_title>
                <counts group_id="E1" events="15" subjects_affected="14" subjects_at_risk="6113"/>
                <counts group_id="E2" events="9" subjects_affected="9" subjects_at_risk="3057"/>
              </event>
              <event>
                <sub_title>Tension Headache</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="6113"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3057"/>
              </event>
              <event>
                <sub_title>Thalamus Haemorrhage</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="6113"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3057"/>
              </event>
              <event>
                <sub_title>Toxic Encephalopathy</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="6113"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3057"/>
              </event>
              <event>
                <sub_title>Transient Global Amnesia</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="6113"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3057"/>
              </event>
              <event>
                <sub_title>Transient Ischaemic Attack</sub_title>
                <counts group_id="E1" events="21" subjects_affected="21" subjects_at_risk="6113"/>
                <counts group_id="E2" events="8" subjects_affected="8" subjects_at_risk="3057"/>
              </event>
              <event>
                <sub_title>Tremor</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="6113"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3057"/>
              </event>
              <event>
                <sub_title>Trigeminal Neuralgia</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="6113"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3057"/>
              </event>
              <event>
                <sub_title>Vertebrobasilar Insufficiency</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="6113"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3057"/>
              </event>
              <event>
                <sub_title>Vertigo Cns Origin</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="6113"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3057"/>
              </event>
              <event>
                <sub_title>Vocal Cord Paralysis</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="6113"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3057"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Psychiatric disorders</title>
            <event_list>
              <event>
                <sub_title>Alcohol Abuse</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="6113"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3057"/>
              </event>
              <event>
                <sub_title>Alcohol Withdrawal Syndrome</sub_title>
                <counts group_id="E1" events="3" subjects_affected="2" subjects_at_risk="6113"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3057"/>
              </event>
              <event>
                <sub_title>Completed Suicide</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="6113"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3057"/>
              </event>
              <event>
                <sub_title>Conversion Disorder</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="6113"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3057"/>
              </event>
              <event>
                <sub_title>Delirium</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="6113"/>
                <counts group_id="E2" events="4" subjects_affected="4" subjects_at_risk="3057"/>
              </event>
              <event>
                <sub_title>Depression</sub_title>
                <counts group_id="E1" events="5" subjects_affected="4" subjects_at_risk="6113"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3057"/>
              </event>
              <event>
                <sub_title>Drug Dependence</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="6113"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3057"/>
              </event>
              <event>
                <sub_title>Impaired Self-Care</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="6113"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3057"/>
              </event>
              <event>
                <sub_title>Major Depression</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="6113"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3057"/>
              </event>
              <event>
                <sub_title>Mental Disorder</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="6113"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3057"/>
              </event>
              <event>
                <sub_title>Mental Status Changes</sub_title>
                <counts group_id="E1" events="4" subjects_affected="4" subjects_at_risk="6113"/>
                <counts group_id="E2" events="5" subjects_affected="5" subjects_at_risk="3057"/>
              </event>
              <event>
                <sub_title>Panic Attack</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="6113"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3057"/>
              </event>
              <event>
                <sub_title>Psychotic Disorder</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="6113"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3057"/>
              </event>
              <event>
                <sub_title>Schizoaffective Disorder</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="6113"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3057"/>
              </event>
              <event>
                <sub_title>Schizophrenia</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="6113"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3057"/>
              </event>
              <event>
                <sub_title>Suicidal Ideation</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="6113"/>
                <counts group_id="E2" events="3" subjects_affected="3" subjects_at_risk="3057"/>
              </event>
              <event>
                <sub_title>Suicide Attempt</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="6113"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3057"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Renal and urinary disorders</title>
            <event_list>
              <event>
                <sub_title>Azotaemia</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="6113"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3057"/>
              </event>
              <event>
                <sub_title>Bladder Mass</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="6113"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3057"/>
              </event>
              <event>
                <sub_title>Bladder Neck Obstruction</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="6113"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3057"/>
              </event>
              <event>
                <sub_title>Bladder Outlet Obstruction</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="6113"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3057"/>
              </event>
              <event>
                <sub_title>Calculus Ureteric</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="6113"/>
                <counts group_id="E2" events="3" subjects_affected="2" subjects_at_risk="3057"/>
              </event>
              <event>
                <sub_title>Calculus Urinary</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="6113"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3057"/>
              </event>
              <event>
                <sub_title>Cystitis Interstitial</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="6113"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3057"/>
              </event>
              <event>
                <sub_title>Diabetic Nephropathy</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="6113"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3057"/>
              </event>
              <event>
                <sub_title>Haematuria</sub_title>
                <counts group_id="E1" events="8" subjects_affected="8" subjects_at_risk="6113"/>
                <counts group_id="E2" events="7" subjects_affected="6" subjects_at_risk="3057"/>
              </event>
              <event>
                <sub_title>Hydronephrosis</sub_title>
                <counts group_id="E1" events="4" subjects_affected="4" subjects_at_risk="6113"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3057"/>
              </event>
              <event>
                <sub_title>Lupus Nephritis</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="6113"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3057"/>
              </event>
              <event>
                <sub_title>Micturition Disorder</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="6113"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3057"/>
              </event>
              <event>
                <sub_title>Nephrolithiasis</sub_title>
                <counts group_id="E1" events="10" subjects_affected="9" subjects_at_risk="6113"/>
                <counts group_id="E2" events="2" subjects_affected="1" subjects_at_risk="3057"/>
              </event>
              <event>
                <sub_title>Nephrotic Syndrome</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="6113"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3057"/>
              </event>
              <event>
                <sub_title>Obstructive Uropathy</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="6113"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3057"/>
              </event>
              <event>
                <sub_title>Proteinuria</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="6113"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3057"/>
              </event>
              <event>
                <sub_title>Renal Failure</sub_title>
                <counts group_id="E1" events="8" subjects_affected="7" subjects_at_risk="6113"/>
                <counts group_id="E2" events="3" subjects_affected="3" subjects_at_risk="3057"/>
              </event>
              <event>
                <sub_title>Renal Failure Acute</sub_title>
                <counts group_id="E1" events="35" subjects_affected="31" subjects_at_risk="6113"/>
                <counts group_id="E2" events="9" subjects_affected="8" subjects_at_risk="3057"/>
              </event>
              <event>
                <sub_title>Renal Failure Chronic</sub_title>
                <counts group_id="E1" events="19" subjects_affected="17" subjects_at_risk="6113"/>
                <counts group_id="E2" events="3" subjects_affected="3" subjects_at_risk="3057"/>
              </event>
              <event>
                <sub_title>Renal Haemorrhage</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="6113"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3057"/>
              </event>
              <event>
                <sub_title>Renal Impairment</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="6113"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3057"/>
              </event>
              <event>
                <sub_title>Renal Injury</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="6113"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3057"/>
              </event>
              <event>
                <sub_title>Renal Tubular Necrosis</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="6113"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3057"/>
              </event>
              <event>
                <sub_title>Strangury</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="6113"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3057"/>
              </event>
              <event>
                <sub_title>Stress Urinary Incontinence</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="6113"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3057"/>
              </event>
              <event>
                <sub_title>Tubulointerstitial Nephritis</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="6113"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3057"/>
              </event>
              <event>
                <sub_title>Ureteric Stenosis</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="6113"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3057"/>
              </event>
              <event>
                <sub_title>Urethral Stenosis</sub_title>
                <counts group_id="E1" events="8" subjects_affected="7" subjects_at_risk="6113"/>
                <counts group_id="E2" events="9" subjects_affected="6" subjects_at_risk="3057"/>
              </event>
              <event>
                <sub_title>Urinary Incontinence</sub_title>
                <counts group_id="E1" events="5" subjects_affected="3" subjects_at_risk="6113"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3057"/>
              </event>
              <event>
                <sub_title>Urinary Retention</sub_title>
                <counts group_id="E1" events="8" subjects_affected="5" subjects_at_risk="6113"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="3057"/>
              </event>
              <event>
                <sub_title>Urinoma</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="6113"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3057"/>
              </event>
              <event>
                <sub_title>Vesicocutaneous Fistula</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="6113"/>
                <counts group_id="E2" events="2" subjects_affected="1" subjects_at_risk="3057"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Reproductive system and breast disorders</title>
            <event_list>
              <event>
                <sub_title>Benign Prostatic Hyperplasia</sub_title>
                <counts group_id="E1" events="8" subjects_affected="8" subjects_at_risk="6113"/>
                <counts group_id="E2" events="5" subjects_affected="5" subjects_at_risk="3057"/>
              </event>
              <event>
                <sub_title>Breast Enlargement</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="6113"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3057"/>
              </event>
              <event>
                <sub_title>Epididymitis</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="6113"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3057"/>
              </event>
              <event>
                <sub_title>Female Genital Tract Fistula</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="6113"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3057"/>
              </event>
              <event>
                <sub_title>Genital Prolapse</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="6113"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3057"/>
              </event>
              <event>
                <sub_title>Ovarian Cyst</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="6113"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3057"/>
              </event>
              <event>
                <sub_title>Postmenopausal Haemorrhage</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="6113"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3057"/>
              </event>
              <event>
                <sub_title>Prostatitis</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="6113"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="3057"/>
              </event>
              <event>
                <sub_title>Prostatomegaly</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="6113"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3057"/>
              </event>
              <event>
                <sub_title>Uterine Haemorrhage</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="6113"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3057"/>
              </event>
              <event>
                <sub_title>Vaginal Haemorrhage</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="6113"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3057"/>
              </event>
              <event>
                <sub_title>Vaginal Prolapse</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="6113"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3057"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Respiratory, thoracic and mediastinal disorders</title>
            <event_list>
              <event>
                <sub_title>Acute Pulmonary Oedema</sub_title>
                <counts group_id="E1" events="3" subjects_affected="3" subjects_at_risk="6113"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3057"/>
              </event>
              <event>
                <sub_title>Acute Respiratory Distress Syndrome</sub_title>
                <counts group_id="E1" events="4" subjects_affected="4" subjects_at_risk="6113"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3057"/>
              </event>
              <event>
                <sub_title>Acute Respiratory Failure</sub_title>
                <counts group_id="E1" events="29" subjects_affected="23" subjects_at_risk="6113"/>
                <counts group_id="E2" events="12" subjects_affected="10" subjects_at_risk="3057"/>
              </event>
              <event>
                <sub_title>Alveolitis Allergic</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="6113"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3057"/>
              </event>
              <event>
                <sub_title>Apnoea</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="6113"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3057"/>
              </event>
              <event>
                <sub_title>Aspiration</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="6113"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3057"/>
              </event>
              <event>
                <sub_title>Asthma</sub_title>
                <counts group_id="E1" events="23" subjects_affected="18" subjects_at_risk="6113"/>
                <counts group_id="E2" events="4" subjects_affected="3" subjects_at_risk="3057"/>
              </event>
              <event>
                <sub_title>Atelectasis</sub_title>
                <counts group_id="E1" events="3" subjects_affected="3" subjects_at_risk="6113"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3057"/>
              </event>
              <event>
                <sub_title>Bronchiectasis</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="6113"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3057"/>
              </event>
              <event>
                <sub_title>Bronchitis Chronic</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="6113"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="3057"/>
              </event>
              <event>
                <sub_title>Bronchospasm</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="6113"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3057"/>
              </event>
              <event>
                <sub_title>Chronic Obstructive Pulmonary Disease</sub_title>
                <counts group_id="E1" events="121" subjects_affected="84" subjects_at_risk="6113"/>
                <counts group_id="E2" events="71" subjects_affected="51" subjects_at_risk="3057"/>
              </event>
              <event>
                <sub_title>Chronic Respiratory Failure</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="6113"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3057"/>
              </event>
              <event>
                <sub_title>Dyspnoea</sub_title>
                <counts group_id="E1" events="15" subjects_affected="12" subjects_at_risk="6113"/>
                <counts group_id="E2" events="15" subjects_affected="15" subjects_at_risk="3057"/>
              </event>
              <event>
                <sub_title>Dyspnoea Exertional</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="6113"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3057"/>
              </event>
              <event>
                <sub_title>Emphysema</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="6113"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3057"/>
              </event>
              <event>
                <sub_title>Epistaxis</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="6113"/>
                <counts group_id="E2" events="5" subjects_affected="2" subjects_at_risk="3057"/>
              </event>
              <event>
                <sub_title>Haemoptysis</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="6113"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3057"/>
              </event>
              <event>
                <sub_title>Hydropneumothorax</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="6113"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3057"/>
              </event>
              <event>
                <sub_title>Hypoxia</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="6113"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3057"/>
              </event>
              <event>
                <sub_title>Idiopathic Pulmonary Fibrosis</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="6113"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3057"/>
              </event>
              <event>
                <sub_title>Interstitial Lung Disease</sub_title>
                <counts group_id="E1" events="8" subjects_affected="6" subjects_at_risk="6113"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3057"/>
              </event>
              <event>
                <sub_title>Lung Disorder</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="6113"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3057"/>
              </event>
              <event>
                <sub_title>Lung Hernia</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="6113"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3057"/>
              </event>
              <event>
                <sub_title>Mediastinal Disorder</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="6113"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3057"/>
              </event>
              <event>
                <sub_title>Mediastinal Haemorrhage</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="6113"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3057"/>
              </event>
              <event>
                <sub_title>Obstructive Airways Disorder</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="6113"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3057"/>
              </event>
              <event>
                <sub_title>Pleural Effusion</sub_title>
                <counts group_id="E1" events="22" subjects_affected="21" subjects_at_risk="6113"/>
                <counts group_id="E2" events="11" subjects_affected="10" subjects_at_risk="3057"/>
              </event>
              <event>
                <sub_title>Pleuritic Pain</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="6113"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3057"/>
              </event>
              <event>
                <sub_title>Pneumonia Aspiration</sub_title>
                <counts group_id="E1" events="4" subjects_affected="4" subjects_at_risk="6113"/>
                <counts group_id="E2" events="5" subjects_affected="3" subjects_at_risk="3057"/>
              </event>
              <event>
                <sub_title>Pneumonitis</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="6113"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3057"/>
              </event>
              <event>
                <sub_title>Pneumothorax</sub_title>
                <counts group_id="E1" events="6" subjects_affected="5" subjects_at_risk="6113"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3057"/>
              </event>
              <event>
                <sub_title>Pulmonary Congestion</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="6113"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3057"/>
              </event>
              <event>
                <sub_title>Pulmonary Embolism</sub_title>
                <counts group_id="E1" events="23" subjects_affected="23" subjects_at_risk="6113"/>
                <counts group_id="E2" events="17" subjects_affected="17" subjects_at_risk="3057"/>
              </event>
              <event>
                <sub_title>Pulmonary Fibrosis</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="6113"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3057"/>
              </event>
              <event>
                <sub_title>Pulmonary Hypertension</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="6113"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3057"/>
              </event>
              <event>
                <sub_title>Pulmonary Microemboli</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="6113"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3057"/>
              </event>
              <event>
                <sub_title>Pulmonary Oedema</sub_title>
                <counts group_id="E1" events="6" subjects_affected="6" subjects_at_risk="6113"/>
                <counts group_id="E2" events="3" subjects_affected="3" subjects_at_risk="3057"/>
              </event>
              <event>
                <sub_title>Respiratory Acidosis</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="6113"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3057"/>
              </event>
              <event>
                <sub_title>Respiratory Arrest</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="6113"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3057"/>
              </event>
              <event>
                <sub_title>Respiratory Disorder</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="6113"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3057"/>
              </event>
              <event>
                <sub_title>Respiratory Distress</sub_title>
                <counts group_id="E1" events="4" subjects_affected="3" subjects_at_risk="6113"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3057"/>
              </event>
              <event>
                <sub_title>Respiratory Failure</sub_title>
                <counts group_id="E1" events="18" subjects_affected="16" subjects_at_risk="6113"/>
                <counts group_id="E2" events="15" subjects_affected="12" subjects_at_risk="3057"/>
              </event>
              <event>
                <sub_title>Sinus Polyp</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="6113"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3057"/>
              </event>
              <event>
                <sub_title>Sleep Apnoea Syndrome</sub_title>
                <counts group_id="E1" events="5" subjects_affected="4" subjects_at_risk="6113"/>
                <counts group_id="E2" events="3" subjects_affected="3" subjects_at_risk="3057"/>
              </event>
              <event>
                <sub_title>Status Asthmaticus</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="6113"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3057"/>
              </event>
              <event>
                <sub_title>Tracheal Stenosis</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="6113"/>
                <counts group_id="E2" events="3" subjects_affected="1" subjects_at_risk="3057"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Skin and subcutaneous tissue disorders</title>
            <event_list>
              <event>
                <sub_title>Angioedema</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="6113"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3057"/>
              </event>
              <event>
                <sub_title>Decubitus Ulcer</sub_title>
                <counts group_id="E1" events="4" subjects_affected="4" subjects_at_risk="6113"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3057"/>
              </event>
              <event>
                <sub_title>Dermatitis Contact</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="6113"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3057"/>
              </event>
              <event>
                <sub_title>Diabetic Foot</sub_title>
                <counts group_id="E1" events="25" subjects_affected="24" subjects_at_risk="6113"/>
                <counts group_id="E2" events="14" subjects_affected="13" subjects_at_risk="3057"/>
              </event>
              <event>
                <sub_title>Diabetic Ulcer</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="6113"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3057"/>
              </event>
              <event>
                <sub_title>Ecchymosis</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="6113"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3057"/>
              </event>
              <event>
                <sub_title>Eczema</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="6113"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3057"/>
              </event>
              <event>
                <sub_title>Hidradenitis</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="6113"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3057"/>
              </event>
              <event>
                <sub_title>Rash</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="6113"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3057"/>
              </event>
              <event>
                <sub_title>Rash Erythematous</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="6113"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3057"/>
              </event>
              <event>
                <sub_title>Skin Necrosis</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="6113"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3057"/>
              </event>
              <event>
                <sub_title>Skin Ulcer</sub_title>
                <counts group_id="E1" events="12" subjects_affected="11" subjects_at_risk="6113"/>
                <counts group_id="E2" events="9" subjects_affected="7" subjects_at_risk="3057"/>
              </event>
              <event>
                <sub_title>Stevens-Johnson Syndrome</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="6113"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3057"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Surgical and medical procedures</title>
            <event_list>
              <event>
                <sub_title>Artificial Urinary Sphincter Implant</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="6113"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3057"/>
              </event>
              <event>
                <sub_title>Cardiac Pacemaker Battery Replacement</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="6113"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3057"/>
              </event>
              <event>
                <sub_title>Cardioversion</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="6113"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3057"/>
              </event>
              <event>
                <sub_title>Cerebrospinal Fluid Drainage</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="6113"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3057"/>
              </event>
              <event>
                <sub_title>Hip Arthroplasty</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="6113"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3057"/>
              </event>
              <event>
                <sub_title>Incisional Drainage</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="6113"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3057"/>
              </event>
              <event>
                <sub_title>Knee Arthroplasty</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="6113"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3057"/>
              </event>
              <event>
                <sub_title>Knee Operation</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="6113"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3057"/>
              </event>
              <event>
                <sub_title>Leg Amputation</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="6113"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3057"/>
              </event>
              <event>
                <sub_title>Metatarsal Excision</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="6113"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3057"/>
              </event>
              <event>
                <sub_title>Parathyroidectomy</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="6113"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3057"/>
              </event>
              <event>
                <sub_title>Rehabilitation Therapy</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="6113"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3057"/>
              </event>
              <event>
                <sub_title>Tooth Extraction</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="6113"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3057"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Vascular disorders</title>
            <event_list>
              <event>
                <sub_title>Aneurysm</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="6113"/>
                <counts group_id="E2" events="2" subjects_affected="1" subjects_at_risk="3057"/>
              </event>
              <event>
                <sub_title>Aneurysm Ruptured</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="6113"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3057"/>
              </event>
              <event>
                <sub_title>Aortic Aneurysm</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="6113"/>
                <counts group_id="E2" events="3" subjects_affected="3" subjects_at_risk="3057"/>
              </event>
              <event>
                <sub_title>Aortic Aneurysm Rupture</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="6113"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3057"/>
              </event>
              <event>
                <sub_title>Aortic Stenosis</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="6113"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="3057"/>
              </event>
              <event>
                <sub_title>Aortic Thrombosis</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="6113"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3057"/>
              </event>
              <event>
                <sub_title>Arterial Occlusive Disease</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="6113"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3057"/>
              </event>
              <event>
                <sub_title>Arterial Stenosis</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="6113"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3057"/>
              </event>
              <event>
                <sub_title>Arteriosclerosis</sub_title>
                <counts group_id="E1" events="4" subjects_affected="4" subjects_at_risk="6113"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3057"/>
              </event>
              <event>
                <sub_title>Circulatory Collapse</sub_title>
                <counts group_id="E1" events="2" subjects_affected="1" subjects_at_risk="6113"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3057"/>
              </event>
              <event>
                <sub_title>Deep Vein Thrombosis</sub_title>
                <counts group_id="E1" events="12" subjects_affected="12" subjects_at_risk="6113"/>
                <counts group_id="E2" events="5" subjects_affected="5" subjects_at_risk="3057"/>
              </event>
              <event>
                <sub_title>Essential Hypertension</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="6113"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="3057"/>
              </event>
              <event>
                <sub_title>Extremity Necrosis</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="6113"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3057"/>
              </event>
              <event>
                <sub_title>Femoral Artery Occlusion</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="6113"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3057"/>
              </event>
              <event>
                <sub_title>Haematoma</sub_title>
                <counts group_id="E1" events="4" subjects_affected="4" subjects_at_risk="6113"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="3057"/>
              </event>
              <event>
                <sub_title>Hypertension</sub_title>
                <counts group_id="E1" events="7" subjects_affected="7" subjects_at_risk="6113"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="3057"/>
              </event>
              <event>
                <sub_title>Hypertensive Crisis</sub_title>
                <counts group_id="E1" events="9" subjects_affected="9" subjects_at_risk="6113"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3057"/>
              </event>
              <event>
                <sub_title>Hypertensive Emergency</sub_title>
                <counts group_id="E1" events="3" subjects_affected="3" subjects_at_risk="6113"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3057"/>
              </event>
              <event>
                <sub_title>Hypotension</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="6113"/>
                <counts group_id="E2" events="5" subjects_affected="5" subjects_at_risk="3057"/>
              </event>
              <event>
                <sub_title>Hypovolaemic Shock</sub_title>
                <counts group_id="E1" events="4" subjects_affected="4" subjects_at_risk="6113"/>
                <counts group_id="E2" events="4" subjects_affected="4" subjects_at_risk="3057"/>
              </event>
              <event>
                <sub_title>Infarction</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="6113"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3057"/>
              </event>
              <event>
                <sub_title>Intra-Abdominal Haematoma</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="6113"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3057"/>
              </event>
              <event>
                <sub_title>Lymphoedema</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="6113"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3057"/>
              </event>
              <event>
                <sub_title>Orthostatic Hypotension</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="6113"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3057"/>
              </event>
              <event>
                <sub_title>Peripheral Arterial Occlusive Disease</sub_title>
                <counts group_id="E1" events="8" subjects_affected="7" subjects_at_risk="6113"/>
                <counts group_id="E2" events="4" subjects_affected="4" subjects_at_risk="3057"/>
              </event>
              <event>
                <sub_title>Peripheral Artery Aneurysm</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="6113"/>
                <counts group_id="E2" events="2" subjects_affected="1" subjects_at_risk="3057"/>
              </event>
              <event>
                <sub_title>Peripheral Artery Stenosis</sub_title>
                <counts group_id="E1" events="5" subjects_affected="4" subjects_at_risk="6113"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3057"/>
              </event>
              <event>
                <sub_title>Peripheral Artery Thrombosis</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="6113"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3057"/>
              </event>
              <event>
                <sub_title>Peripheral Embolism</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="6113"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3057"/>
              </event>
              <event>
                <sub_title>Peripheral Ischaemia</sub_title>
                <counts group_id="E1" events="15" subjects_affected="11" subjects_at_risk="6113"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3057"/>
              </event>
              <event>
                <sub_title>Peripheral Vascular Disorder</sub_title>
                <counts group_id="E1" events="13" subjects_affected="12" subjects_at_risk="6113"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3057"/>
              </event>
              <event>
                <sub_title>Phlebitis</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="6113"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3057"/>
              </event>
              <event>
                <sub_title>Phlebitis Deep</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="6113"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3057"/>
              </event>
              <event>
                <sub_title>Post Thrombotic Syndrome</sub_title>
                <counts group_id="E1" events="2" subjects_affected="1" subjects_at_risk="6113"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3057"/>
              </event>
              <event>
                <sub_title>Shock</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="6113"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3057"/>
              </event>
              <event>
                <sub_title>Shock Haemorrhagic</sub_title>
                <counts group_id="E1" events="5" subjects_affected="5" subjects_at_risk="6113"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3057"/>
              </event>
              <event>
                <sub_title>Subclavian Artery Stenosis</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="6113"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3057"/>
              </event>
              <event>
                <sub_title>Temporal Arteritis</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="6113"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3057"/>
              </event>
              <event>
                <sub_title>Thromboangiitis Obliterans</sub_title>
                <counts group_id="E1" events="2" subjects_affected="1" subjects_at_risk="6113"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3057"/>
              </event>
              <event>
                <sub_title>Thrombophlebitis Superficial</sub_title>
                <counts group_id="E1" events="2" subjects_affected="1" subjects_at_risk="6113"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3057"/>
              </event>
              <event>
                <sub_title>Varicophlebitis</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="6113"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3057"/>
              </event>
              <event>
                <sub_title>Varicose Ulceration</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="6113"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="3057"/>
              </event>
              <event>
                <sub_title>Vascular Insufficiency</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="6113"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3057"/>
              </event>
              <event>
                <sub_title>Venous Thrombosis</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="6113"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="3057"/>
              </event>
              <event>
                <sub_title>Venous Thrombosis Limb</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="6113"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="3057"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>5</frequency_threshold>
        <default_vocab>MedDra 16.0</default_vocab>
        <default_assessment>Systematic Assessment</default_assessment>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="1347" subjects_at_risk="6113"/>
                <counts group_id="E2" subjects_affected="401" subjects_at_risk="3057"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>General disorders</title>
            <event_list>
              <event>
                <sub_title>Injection Site Pain</sub_title>
                <counts group_id="E1" events="1252" subjects_affected="855" subjects_at_risk="6113"/>
                <counts group_id="E2" events="157" subjects_affected="127" subjects_at_risk="3057"/>
              </event>
              <event>
                <sub_title>Malaise</sub_title>
                <counts group_id="E1" events="456" subjects_affected="325" subjects_at_risk="6113"/>
                <counts group_id="E2" events="195" subjects_affected="135" subjects_at_risk="3057"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Musculoskeletal and connective tissue disorders</title>
            <event_list>
              <event>
                <sub_title>Arthralgia</sub_title>
                <counts group_id="E1" events="481" subjects_affected="345" subjects_at_risk="6113"/>
                <counts group_id="E2" events="205" subjects_affected="146" subjects_at_risk="3057"/>
              </event>
              <event>
                <sub_title>Myalgia</sub_title>
                <counts group_id="E1" events="556" subjects_affected="368" subjects_at_risk="6113"/>
                <counts group_id="E2" events="201" subjects_affected="132" subjects_at_risk="3057"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Nervous system disorders</title>
            <event_list>
              <event>
                <sub_title>Headache</sub_title>
                <counts group_id="E1" events="758" subjects_affected="531" subjects_at_risk="6113"/>
                <counts group_id="E2" events="327" subjects_affected="229" subjects_at_risk="3057"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>Principal Investigators are NOT employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>Sponsor must have the opportunity to review at least 60 days prior to submission for publication or presentation. If review indicates that potentially patentable subject matter would be disclosed, publication or public disclosure may be delayed for a maximum of an additional 60 days to allow for filing the necessary patent applications.</restrictive_agreement>
    </certain_agreements>
    <point_of_contact>
      <name_or_title>Medical Director</name_or_title>
      <organization>Sanofi Pasteur</organization>
      <phone>800-633-1610 ext 1#</phone>
      <email>Contact-US@sanofi.com</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>

